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Abstract
A novel substrate directed, palladium(II)-catalyst aza-Claisen rearrangement has been 
developed. Aza-Claisen rearrangement of a series of 6-ether substituted allylic 
trichloroacetimidates demonstrated that the oxygen atom in this position can effectively 
direct facial coordination of the palladium(II)-catalyst, with the MOM-ether substrate 
giving the most selective rearrangement reaction. An optimisation study was carried out 
using different catalysts and reaction conditions. The results from this study showed that 
bis(acetonitrile)palladium(II) chloride catalyst and non-coordinating solvents such as 
toluene give the most selective rearrangement resulting in the isolation of the anti- 
compound in up to 88% diastereomeric excess.
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This methodology was used as the key step in the novel diastereoselective synthesis of 13- 
hydroxy a-amino acids from enantiopure a-hydroxy acids. During the rearrangement step, 
a competing [1,3] pathway catalysed by palladium(O) was suppressed using p- 
benzoquinone as an in-situ oxidant in the reaction mixture.
OH | OH
A series of compounds based on the structure of the piperidine alkaloid (+)-a-conhydrine 
were synthesised using this newly developed ether-directed, palladium(II)-catalysed aza- 
Claisen rearrangement and a ring closing metathesis reaction as the key steps.
OH
(+)-a-Conhydrine
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1.0 Introduction
1.1 Introduction to [3,3] Sigmatropic Rearrangements.
The efficient synthesis of complex molecules is still a challenge in synthetic organic 
chemistry. This is the case because key components with defined stereochemistry must be 
generated as starting materials before the total synthesis of these complex molecules can be 
carried out.
A subclass of pericyclic reactions, [3,3]-sigmatropic rearrangements have proven to be 
reliable reactions with which to generate defined stereogenic carbon-carbon and carbon- 
heteroatom bonds.1 Sigmatropic rearrangments are so called because a a-bond appears to 
move from one place to another (Scheme 1). For acyclic substrates the reaction occurs 
with a highly ordered chair-like transition state via a concerted, suprafacial reaction 
pathway which obeys the Woodward-Hoffman rules.2
old bond broken here oi^ bond breaking here
i 1
new bond formed here new bond forming here
Scheme 1: [3,3]-sigmatropic rearrangement.
The Woodward-Hoffman rules state that in a thermal pericyclic reaction the total number 
of (4q + 2)s and (4r)a components must be odd.2 A component is a molecular orbital or 
bond participating in a pericyclic reaction. Thus, (4q + 2) and (4r) simply refer to the 
number of electrons in a component where q and r are integers. The suffix ‘s’ stands for a 
suprafacial component {i.e. forms new bonds on the same face at both ends). On the other 
hand, the suffix ‘a’ stands for an antarafacial component {i.e. forms new bonds on opposite 
faces at both ends).
The first example of a [3,3]-sigmatropic rearrangement was reported by Ludwig Claisen in
1912.3 Under thermal conditions, Claisen reacted ethyl 3-allyloxybut-2-enoate 1 in the 
presence of solid NH4C1 and isolated the p-keto ester as the [3,3]-sigmatropic 
rearrangement product 2 (Scheme 2).
Scheme 2: Original Claisen rearrangement.
Since Claisen’s original report nearly a century ago, the rearrangement now named after 
him has been developed to include numerous related [3,3]-sigmatropic rearrangements 
including the Carroll,4 Eschenmoser,5 Johnson,6 Ireland-Claisen7 and Reformatsky-Claisen8 
rearrangements as well as the Cope rearrangement9 (Scheme 3).
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Scheme 3: Common related [3,3]-rearrangements.
The [3,3]-sigmatropic rearrangement of six membered acyclic systems containing an 
oxygen and nitrogen atom is known as the aza-Claisen rearrangement.10 Many examples 
of this type of rearrangement have been reported,11 however the most predominant form is
the [3,3]-sigmatropic rearrangement of allylic imidates (occasionally called the “Claisen- 
imidate” rearrangement) (Scheme 4).la
X X
X = H, Ar, CCI3
Scheme 4: [3,3] sigmatropic rearrangement of allylic imidates
The thermal [3,3]-sigmatropic rearrangement of allylic imidates was first described by 
Mumm & Moller in 1937 (Scheme 5).12 Rearrangement of allylic benzimidate 3 was 
achieved at 210-125 °C to give allylic benzamide 4 in quantitative yield. The reaction is 
favoured due to the difference in enthalpy, 14 kcal/mol,13 between dialkyl amide and a 
imidic ester in the liquid phase.
p h 'NY °
Ph
Scheme 5: The first example of a thermal [3,3]-sigmatropic rearrangement of an allylic 
imidate.
1.2 Thermal Rearrangement of Allylic Trichloroacetimidates.
Overman developed the aza-Claisen reaction in 1974 and found that the thermal [3,3]- 
sigmatropic rearrangement of allylic trichloroacetimidates generates allylic trichloroamides 
(Scheme 6).14 This reaction is now generally referred to as the Overman rearrangement. It 
was also reported that allylic trichloroacetimidates could be easily generated from readily 
available allylic alcohols and trichloroacetonitrile using sodium hydride as base.
CCI3  CCI3
OH NaH, CI3 CCN J  a  L
1    HN-"T>   H N ^ O
Scheme 6: Preparation and rearrangement of trichloroacetimidates.
Thermal Overman rearrangements are carried out conveniently by dissolving the allylic 
trichloroacetimidate in an aprotic solvent (e.g. p-xylene) and heating the resulting solution 
under reflux. The rearrangements occur by an operationally concerted pericyclic 
mechanism with a negative change in enthalpy similar to that observed for the Claisen 
rearrangement. This results from the large enthalpic driving force associated with the 
conversion of the imidate to the amide functionality.13 In order to obtain evidence for this 
mechanism, attempts have been made to detect an intermediate from the rearrangement. 
However, this has not been possible even in the case of the proposed highly stablised 
allylic carbocation 7 that would be formed during the rearrangement of trichloroacetimide 
6, prepared from cinnamyl alcohol 5 (Scheme 7).15
1) NaH.THF
2) CI3 CCN
HI\U .O
A
HN
7
HN.
Scheme 7: Rearrangement of cinnamyl alcohol derived trichloroacetimidate with no 
detection of highly delocalised intermediate.
However, a concerted mechanism was established for the rearrangement by investigation 
of regioselectivity, solvent effects, thermodynamic parameters and stereoselectivity.
The regiochemical outcome of the thermal rearrangement supports a concerted mechanism. 
Complete oxygen-to-nitrogen transfer (aza-Claisen rearrangement) is observed while the 
formal [1,3]-rearrangement product 8 (anti-aza-Claisen rearrangement), arising from a 
non-concerted ionisation and recombination pathway, is rarely observed (Scheme 8).16
CCI3
8
Scheme 8: [3,3] vs [1,3] pathways.
The thermal Overman rearrangement follows first order kinetics, with the rate of reaction 
influenced by both steric and electronic substituent effects.15,17
Stabilisation of the partial positive charge on the oxygen-bearing carbon atom (a-position) 
in the transition state causes trichloroacetimidates generated from doubly allylic alcohols 
to react at room temperature, tertiary alcohols at 80 °C (t1/2 ~1 hour) and primary alcohols 
to react at 140 °C (t1/2 ~1 hour).15 Charge seperation in the transition state (i.e. partial 
negative charge on the electronegative HN=C(CC13)0  fragment and partial positive charge 
on the all-carbon allyl fragment) is postulated for the reaction mechanism (Scheme 9).15
Scheme 9: Evidence for charge separation in transition state.
Evidence for this originates from solvent effects observed from Overman rearrangement of 
the trichloroacetimidate 9 prepared from geraniol (Scheme 10). Rearrangement at 132 °C 
gives a five fold rate enhancement with changing solvent from xylenes to the more polar 
solvent nitrobenzene.15
CL XCI3
X X.-N H TA C
Xylene 10.8 (±1.1) 105 k,s' 1 
Nitrobenzene 55.0 (± 4.7) 105 k,s' 1
Scheme 10: Solvent effects in rearrangement of geraniol derived trichloroacetimidate.
Allylic trichloroacetimidates with E-alkene double bonds generally react faster than Z- 
alkenes. This is exemplified in the lower AH* value for the E-isomer of imidate 10 
compared to the Z-isomer 11 (Figure l).17
K L o
P  b
ccig 
10
E AH* = 25.6 kcal/mol Z AH* = 28.3 kcal/mol
Figure 1: Lower AH* value for E-isomer.
During the concerted, suprafacial transition state, substituents on the oxygen-bearing 
carbon prefer to adopt the equatorial postion and so effectively all thermal Overman 
rearrangements produce the allylic trichloroacetamide as the £ -geometrical isomer. For 
example, rearrangement of trichloroacetimidate 12 gives E-geometric isomer 13 in 92% 
yield due to the n-butyl group being in the equatorial position (Scheme 11).15
H
CI3C
CCI3
13C4 H9
CCI3
12 CI3 C
Scheme 11: Formation of the E-geometric isomer.
Excellent stereoselectivity observed for the Overman rearrangement is attributed to the 
concerted, suprafacial reaction mechanism. For example, the preferred chair-like transition 
state explains the enantioselectivity observed for Overman rearrangement of allylic 
trichloroacetimidate 14 to (E,E)-trichloroacetamide 15 (Scheme 12).18
Scheme 12: Stereoselectivity attributed to concerted, suprafacial reaction mechanism.
Substituent effects are prevalent in the Overman rearrangement and also support the 
proposed development of charge separation in the transition state.
The thermal Overman rearrangement is particularly effected by substitution of the allylic 
carbon skeleton. Steric effects resulting from substitution at the a-position can, in general 
be overcome by increasing the temperature of reaction. As discussed previously, higher 
temperatures are required as electron-donating substituents are replaced by hydrogen. 
Therefore, primary trichloroacetimidates require temperatures as high as 130-160 °C and 
secondary and tertiary trichloroacetimidates require 80 °C or less.15 Rearrangement of 
imidates with substitution at the y-position do occur; however, problems have been 
encountered due to steric clash of these substituents and the nucleophilic nitrogen of the 
trichloroacetimidate during rearrangement. For example, rearrangement of 
trichloroacetimidate 16 with a chloro-substituent in the or^o-position requires 24 hours 
and gives trichloroacetamide 17 in only 30% yield. However, with the chloro-substituent
toluene
I 110 °C
HISU JD  -------------
in the /?<zra-position the reaction is complete in 12 hours and gives the corresponding 
trichloroacetamide in 82% yield (Scheme 13).19
O
Cci \  HN^CCh
xylene, 138 °C 
Na2C03
16
ecu
ortho 24 h (30%) 
para 1 2  h (82%)
Scheme 13: Substitution at the y-position.
Several examples exist of rearrangements with trisubstituted allylic trichloroacetimidates 
having a second substituent at either the |3- or y-position (Scheme 14).20 However, as 
mentioned previously, 1,2-disubstituted Z double bonds require higher temperatures and 
are therefore more susceptible to degradation and so give lower yields.
O
toluene
(sealed tube) CI3 C ^ N HNH P
R = OMOM
140 °C
CI3C
)= N H
NBoc
H
toluene
110°C
CI3 C
NH
NBoc
H
Scheme 14: Rearrangements with trisubstituted allylic trichloroacetimidates.
Overman rearrangements are also influenced by the electronic effects of substituents 
attached at the (3- and y-positions of the allylic system.
In general, electron-donating groups favour rearrangement by releasing electrons into the 
concerted transition state, thus increasing the rate of reaction. For example, reaction of 
allylic alcohol 18 with trichloroacetonitrile and sodium hydride at 0 °C yields the 
rearranged product allylic trichloroacetamide 19 directly with the intermediate imidate not 
being detected (Scheme 15).21
X 0 °c \= J
HO O
18 19
Scheme 15: Rearrangement with electron-donating substituent on allyl system.
Electron-withdrawing groups on the allylic system are problematic in the thermal 
rearrangement. For example, reaction of allylic alcohol 20 with trichloroacetonitrile and 
sodium hydride gives the allylic trichloroacetimidate 21 without incident, however thermal 
rearrangement fails (Scheme 16).22
Scheme 16: Rearrangement with electron-withdrawing substituent on allyl system.
A density function theory (DFT) theoretical study and ab-initio study have yet to be 
carried out for the Overman rearrangement. Kakinuma and co-workers carried out 
MNDO-PM3 semi-empirical molecular orbital calculations for the template-based 
diastereoselective rearrangement of trichloroacetimidate derived from allyl alcohol.17 It 
was found that the reaction occurs by an ion pair transition state with an enthalpy of 
formation of 11 kcal/mol. This value is 10 kcal/mol lower than that calculated by 
Overman for formation of the transition state in the [3,3]-sigmatropic reaction pathway.15 
However, all other experimental evidence supports a concerted suprafacial sigmatropic 
reaction mechanism.
The major competing pathway with the thermal Overman rearrangement is acid-catalysed 
decomposition of the allylic trichloroacetimidate before rearrangement can occur. The 
acidic conditions appear to result from decomposition of the solvent {e.g. xylenes) at high 
temperatures. p-Toluic acid has been detected (by !H NMR spectroscopy) in crude 
samples of reaction mixures which have been heated in xylene, under reflux, overnight.23 
During studies on the synthesis of tetrodotoxin, Isobe and co-workers found that the use of 
K2C 0 3 (2 mg/mL) as base, can trap any acid generated during the rearrangement and so 
addition of this reagent to the reaction mixture gives increased yields.23 For example, the 
yield for rearrangement of trichloroacetimidate 22 can be increased from 74% to 90% with
2 ) CI3CCN Ph'
NH
20 21
the addition of K2C 03 to the reaction mixture (Scheme 17).23 Reactions have been carried 
out using this procedure on up to a 10 g scale with no decrease in yield of 
trichloroacetamide 23.23
O-
T
NH
p-xylene, 138 °C
74% without K2 CO3  
90% with K2 C 0 3  
(yields from allylic alcohol)
22 23
Scheme 17: Improved conditions for the Overman rearrangement.
Reilly and co-workers found a more dramatic increase in yield for rearrangement of 
trichloroacetimidate 24 using this improved procedure (Scheme 18).24 The rearrangement 
was initially carried out in various solvents, however the desired product was only 
produced in refluxing chlorobenzene and in a disappointing 50% yield. Decomposition 
residues generated from the acid degradation of the trichloroacetimidate were observed in 
the crude reaction mixture. Thus, the reaction was repeated in the presence of K2C 03 and 
gave trichloroacetimidate 25 in an excellent 95% yield. Trichloroacetamide 25 was then 
used to complete the enantiospecific synthesis of (3S,4R)-3-amino-4-ethylpiperidine.24
NH
Me
PhCI, 135 °C
50% without K2 CO3  
95% with K2 CO3  
(yields from allylic alcohol)
24 25
Scheme 18: Suppression of acid-catalysed degradation during the Overman
rearrangement.
The popularity of thermal Overman rearrangements stems from the usefulness of the 
allylic trichloroacetamides produced from the reaction. The trichloroacetyl group is readly 
cleaved using sodium hydroxide and so this gives easy access to allylic amines. Therefore, 
the Overman rearrangement has been extensively used for the synthesis of nitrogen 
containing compounds and several excellent reviews exist covering this topic and so will 
not be covered.1,11,25 An example in which the thermal Overman rearrangement has been 
utilised in the total synthesis of a complex natural product is Danishefsky’s total synthesis
of (±)-pancratistatin.26 Initially, synthesis of a trichloroacetimidate functional group on the 
less-hindered alcohol of diol 26 was attempted, however only orthoamide 27 was produced 
(Scheme 19).
OBn O
P
O
''OH
26
OBn O
NaH, CI3CCN 
THF, 0 °C
4sH
•'O nh2
H L J " 0  CCI3  
27
Scheme 19: Problems encountered with trichloroacetimidate synthesis.
This problem was overcome by first protecting the less-hindered alcohol of diol 26 as a 
PMB ether, protecting the resulting mono-alcohol 28 as the benzyl ether 29 and then 
removing the PMB group with DDQ to give alcohol 30 (Scheme 20). The imidate 31 was 
then prepared using sodium hydride and trichloroacetonitrile. The thermal Overman 
rearrangement was best achieved by reaction of neat imidate 31 at 100-105 °C under high 
vacuum to give trichloroacetamide 32 in 56% yield. This synthesis elegantly utilized the 
suprafacial nature of the Overman rearrangement to give the desired chirality on the 
trichloroacetamide product which was taken on to complete the first total synthesis of (±)- 
pancratistatin.
OBn O
O
<
O
OBn O
r  26 Ft1 = H, R2  = H
> 28 R1 = H, R2  = PMB
> 29 R1 = Bn, R2  = PMB 
 ^ 30 R1 = Bn, R2  = H
OH O
O
O
''OHHO'
OH
(±)-pancratistatin
NaH, CI3 CCN 
THF, 0 °C
O
O
NH
100-105 °C 
vacuum
OBn O
O
O
HN
A ,CI3 C "O  
32
Scheme 20: Thermal Overman rearrangement in natural product synthesis.
1.3 Metal Catalysed aza-Claisen Rearrangement of Allylic Imidates.
The thermal rearrangement of trichloroacetimidates has proven to be useful in the 
synthesis of nitrogen containing compounds. However, the harsh conditions (e.g. refluxing 
xylene) and long reaction times led to the development of a catalytic variant of the 
reaction. Several reviews on the metal catalysed rearrangement now exist.27 
Overman’s orginal paper on the thermal [3,3]-sigmatropic rearrangement of 
trichloroacetimidates also described the first known transition metal catalysed version of 
the reaction.14 Mercury(II) salts were shown to catalyse the rearrangement of 
trichloroacetimidates derived from various C-3 substituted primary allylic alcohols. For 
example, mercury trifluoroacetate was added to a NMR tube containing 
trichloroacetimidate 33 in THF (Scheme 21). The spectrum was recorded immediately and 
only the rearranged trichloroacetamide 34 was detected.14
By comparing the half-life of the catalytic rearrangement of trichloroacetimidate 35 at -60 
°C and the extrapolated half-life for the corresponding thermal rearrangement in xylene at - 
60 °C, an estimate of 1012 was made for the rate enhancement (Scheme 22).14
Hg(OCOCF3 ) 2
THF
CCI3
33
CCI3
34
Scheme 21: Mercury catalysed aza-Claisen rearrangement.
Hg(OCOCF3)2, THF
NHTAc
NH
35
Scheme 22: Calculation of rate enhancement.
Three general mechanisms have been suggested for the metal catalysed aza-Claisen 
rearrangement which are catalysed by electrophiles (Scheme 23). In the ionisation- 
recombination mechanism ( l)28 the electrophile is believed to bind to the X atom to form
B. The complex then undergoes heterolysis at the C-X bond to yield the intermediate C. 
This intermediate then recombines at the Y atom forming D and the electrophile leaves 
giving E as the product. With this mechanism, in compounds with X * Y, we would 
expect to see mixtures of regioisomers. An example of a reaction, which is believed to 
occur by this mechanism, is the acid-catalysed rearrangement of allylic esters.28 
Another mechanism in which the electrophile binds to the substrate at the heteroatom X is 
the concerted charge-induced [3,3]-sigmatropic rearrangement (2). In this mechanism, 
proposed by Schmid, Hansen and co-workers,29,30 complex B rearranges conceitedly to 
give D. Catalysis would therefore be observed if this concerted rearrangement occurred 
more rapidly than the thermal uncomplexed rearrangement.29 This mechanism is believed 
to occur in the rearrangement of allylaryl esters in trifluoroacetic acid.30 
The third mechanism first suggested by Henry for palladium(II) catalysed reactions,31 is 
called the concerted cyclization-induced rearrangement (3). This alternative mechanism 
occurs with the electrophile, instead of binding to the heteroatom X, coordinating to the 
allylic carbon-carbon tc bond and so promotes an intermolecular cyclization to give the key 
cyclic carbocation intermediate F. The thermodynamically favoured fragmentation of this 
intermediate would then yield E, driving the equilibrium to the right. This mechanism was 
also proposed by Lutz for an alumina catalysed Cope rearrangement.32
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Scheme 23: Possible mechanisms for catalysed rearrangement.
Overman proposed that the mercury(II) catalysed rearrangement of trichloroacetimidates 
also occurs by a concerted cyclization-induced rearrangement mechanism (Scheme 24).14 
Initially, the electrophilic mercury(II) catalyst reversibly coordinates to the allylic carbon- 
carbon double bond, promoted by the aprotic solvent. Intramolecular attack of the 
nucleophilic imidate nitrogen at C-3 causes the formation of a mercury bound six- 
membered cyclic carbocation intermediate. The negative charge is believed to reside 
either on the mercury atom with both ligands still attached or as a free ligand anion. The 
intermediate then rapidly collapses exothermically to produce the trichloroacetimidate 
product and regenerate the catalyst.
Scheme 24: Mechanism of Hg(II)-catalysed rearrangement of trichloroacetimidates.
In a second paper published by Overman in 1976 it was detailed that the mechanism 
assignment was based on the fact that absolute regiospecificity is obtained for these 
rearrangement reactions.15 It was also proposed that this mechanism explains the finite 
scope of the mercury(II) catalysed rearrangement.15,273 That is, substrates that do not 
favour attack of the nitrogen on C-3, such as imidate 36 are more likely to undergo 
elimination or attack at C-2. The reaction would therefore be restricted to substrates with 
substituents on C-3 that can assist attack at C-3 such as imidate 35 (Scheme 25).
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Scheme 25: Limitations of mercury(II)-catalysed rearrangement.
Although the concerted cyclization-induced rearrangement mechanism appears to be 
correct, the concerted charge-induced rearrangement mechanism could not be ruled out 
using the available experimental evidence.15
1.4 Palladium Catalysed aza-Claisen Rearrangement of Allylic Imidates.
The first example of a palladium(II)-catalysed rearrangement by this mechanism was 
reported by Henry for the rearrangement of allylic esters (Scheme 26).31 
Evidence for the proposed concerted cyclization-induced rearrangement mechanism was 
obtained from an lsO labelling study in which a complete transfer of 180  from ester to 
carbonyl was observed.31 A 500 fold rate decrease on changing R from -C 2H5 to -CF3 
provided further evidence for the proposed mechanism.31
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Scheme 26: Pd(II)-catalysed rearrangement of allylic esters.
In 1979, Overman and Knoll developed the palladium(II)-catalysed rearrangement of 
allylic esters by using soluble palladium(II)-salts.33 It was also shown that palladium(II)- 
salts are more effective than mercury(II)-salts at catalysing the rearrangement (Scheme 
27). Rearrangement of acetate 37 in the presence of bis(acetonitrile)palladium chloride 
gave rearranged acetate 38 in 88% isolated yield. Reaction under the same conditions 
using mercury trifloroacetate failed to give any of the rearranged product. Rearrangement 
using the palladium(II)-catalyst also gave high selectivity for the £-geomeric isomer.
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Scheme 27: PdCl2(MeCN)2 rearrangement of allylic esters.
Ikariya and co-workers described the use of palladium complexes for the rearrangement of 
allylic A-phenylformimidates to form A-allyl-Af-phenylformamides.34 It was also reported 
that the reaction mechanism is dependent on the oxidation state of the palladium 
complexes used in the reaction. Rearrangement of allylic imidate 39 using PdCl2(MeCN)2 
(e.g. a palladium(II)-complex) gave exclusively the formal [3,3]-rearrangement product,
amide 40. However, rearrangement of imidate 39 using Pd(PPh3)4 (e.g. a palladium(O)- 
complex) gave a mixture of formal [3,3]-rearrangement product 40 and formal [1,31- 
rearrangement product 41 (Scheme 28).34 It was concluded that palladium(O) complexes 
catalyse the rearrangement by the ionisation-recombination reaction mechanism. 
Palladium(II)-complexes, on the other hand follow the cyclisation-induced rearrangement 
mechanism, thus explaining the regioselectivity observed.
40 41
Scheme 28: Rearrangement with Pd(0) or Pd(II).
In 1985 Schenck and Bosnich provided further evidence for the palladium(II) versus 
palladium(O) selectivity for the rearrangement of allylic imidates.27c Rearrangement of 3- 
phenylallyl imidate 42 using palladium(O) was shown to give exclusively the formal [1,31- 
rearrangement product 43 (Scheme 29).270 Palladium(II) on the other hand gave 
exclusively the [3,3]-rearrangement product 44 and thus is in agreement with Ikariya’s 
assigned mechanisms.
44
Scheme 29: Rearrangement of 3-phenylallyl imidate 42 with Pd(0) or Pd(II).
The mechanism for the palladium(II)-catalysed rearrangement was confirmed using chiral 
allylic imidates. Rearrangement of imidate 45 using PdCl2(MeCN)2 gave exclusively the 
[3,3]-rearrangement products 46 and 47 (77 : 22 ratio respectively) and so it was suggested 
that the reaction proceeds by a cyclization-induced mechanism with a metal-bound six 
membered carbocation intermediate. Furthermore, it was elegantly proposed that the 
intermediate forms a chair-like conformation in which palladium favours the equatorial 
position. Therefore, initial olefin facial attack on the palladium catalyst determines the 
stereochemical outcome of the reaction (Scheme 30).27c
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Scheme 30: Proposed mechanism for the palladium catalysed rearrangement of a chiral 
allylic imidate.
Evidence for the palladium(0)-catalysed mechanism was obtained from a deuterium 
labelling study (Scheme 31).27c Scrambling of deuterium labelled allylic imidate 48 
confirmed that the reaction proceeds by an ionisation-recombination mechanism. 
Oxidative addition of the palladium(0)-catalyst to allylic imidate 48 gives a jx-allyl
intermediate that can undergo scrambling if it has a sufficiently long half-life. 
Nucleophilic attack of the ic-allyl intermediate by the amide anion gives a mixture of [1,31- 
amide 49 and [3,3]-amide 50.
[Pd(PPh3)4]
Pd(PPh3 ) 2
Scheme 31: Deuterium labelling study of palladium(0)-catalysed rearrangement of allylic 
imidate 48.
Further evidence for the palladium(0)-catalysed ionisation-recombination mechanism was 
obtained by trapping the Jt-allyl intermediate, formed from allylic imidate 51, with 
dimethyl malonate anion to form diester 52 (Scheme 32).27c
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Scheme 32: Trapping of Jt-allyl intermediate with dimethyl malate anion.
Finally, it was shown that rhodium(I)- and iridium(I)-complexes catalyse the 
rearrangement of allylic imidates, however by a different, unknown mechanism to that of 
the palladium(O)- and palladium(II)-catalysts.270
In a study by Metz and co-workers, the scope of the rearrangement of allylic imidates was 
broadened to include palladium(II)-catalysed rearrangement of Af-allyl-/V-phenylimidate 53 
to form amide 54 with nitrogen bound to a tertiary carbon centre (Scheme 33).27d
0 X N.Ph PdCI2 (PhCN) 2  QX N.Ph
90%
53 54
Scheme 33: Rearrangement to form an amide bound to a tertiary carbon centre.
Furthermore, palladium(II)-catalysed rearrangement of an allylic imidate with substitution 
on C-2 was achieved for the first time.27d Surprisingly, rearrangement of imidate 55 was 
achieved to form, exclusively, [3,3]-product 56 in 75% yield (Scheme 34).27d The result 
from this reaction would at first sight appear to disagree with the proposed cyclisation-
induced rearrangement mechanism for this type of reaction. In order for this reaction to 
occur, a a-bond from the palladium catalyst to a tertiary carbon must be formed. The 
authors propose that this is still possible at room temperature and can be explained by 
counteracting the adverse steric stituation through stabilisation of the transition state by an 
electron donating group (e.g. C-3 = Me).
?  PdCI2(PhCN)2 P
0A N.Ph thf, rt QA N.Ph
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Scheme 34: Palladium(II)-catalysed rearrangement with substitution at C-2.
Venkataratnam and co-workers were able to synthesise, otherwise unattainable jV-allylated 
pyridones using a palladium(II)-catalysed rearrangement (Scheme 35).35 Imidate 58 was 
prepared by allylation of pyridone 57 under basic conditions. Palladium(II)-catalysed 
rearrangement of imidate 58 then gave exclusively [3,3]-rearrangement product 59. 
Rearrangement of substrates with a methyl group at C-2 failed to give the [3,33- 
rearrangement product and instead gave ionisation-recombination product 60.
K2 C 0 3
PdCI2 (PhCN) 2
Scheme 35: N-Allylated pyridone synthesis using a palladium(II)-catalysed rearrangement.
Overman and Zipp have demonstrated that allylic dibenzamides can be prepared by 
palladium(II)-catalysed rearrangement of allylic A-benzoylbenzimidates (Scheme 36).36
The substrates for the rearrangement reaction are conveniently prepared by (9-alkylation of 
primary or secondary allylic alcohols using dibenzamide under Mitsunobu conditions. 
Products arising from TV-alkylation were only observed in 4% yield. Rearrangement of 
allylic N-benzoylbenzimidates was achieved within hours using 5 mol% PdCl2(MeCN)2 in 
toluene at room temperature to give allylic dibenzamides ([3,3]-products) in high yields. 
The authors also propose that since allylic TV-benzoylbenzimidates are less basic than 
trichloroacetimidates they should be amendable to catalysis by a wider range of metals.
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Scheme 36: Synthesis of allylic dibenzamides by palladium(II)-catalysed rearrangement.
In summary, the mechanisms of both the palladium(O)- and palladium(II)-catalysed 
rearrangements of allylic imidates are now well understood. The palladium(II)-catalysed 
rearrangement follows a cyclisation-induced mechanism with a cyclic carbocation 
intermediate which adopts a chair-like transition state.
This therefore allows accurate prediction of both the regio- and stereochemical outcome of 
these reactions. In general, the palladium(II)-catalysed rearrangement of primary and 
secondary allylic imidates can be carried out at room temperature giving good yields and 
rate enhancements of ~1012. Like the thermal rearrangement, the palladium(II)-catalysed 
version of the reaction gives complete suprafacial transfer of chirality and high selectivity 
for the amide as the £ -geomeric isomer. The reaction is restricted by the requirement of a 
substituent on C-3 which favours attack of the imidate nitrogen and also the limited 
reactivity of imidates that have substitution on C-2.
1.5 Enantioselective PaIladium(II)-Catalysed aza-Claisen Rearrangement 
of Allylic Imidates
Given this understanding of the reaction mechanism and the use of a metal catalyst, the 
plausiblity of an asymmetric catalytic rearrangement of prochiral allylic imidates by a 
chiral metal complex has been the subject of most recent investigations.
While the use of palladium(II)-catalysts for the rearrangment of allylic imidates had been 
carried out, it was not until 1997 that the first enantioselective palladium(II)-catalysed 
rearrangement was demonstrated by Overman and co-workers.37 Design of the catalyst 
was based on Bosnich’s study of the rearrangement of chiral allylic amides (Scheme 30).27c 
In the study, complexation of the palladium(II)-catalyst to the alkene is reversible and 
showed face selectivity. Asymmetric induction of a catalytic reaction could therefore be 
determined from the cyclization step, which is the first irreversible enantiodifferentiating 
step. Initially, phosphine-containing palladium(II)-catalysts were screened, however these 
gave disappointing results due to the strong electron donating nature of the ligands. This 
inhibits nucleophilic attack of the alkene by the imidate nitrogen. Thus, a series of 
palladium(II) complexes containing chiral diamine ligands were prepared. The major issue 
with rearrangements using these catalysts was the formation of the [1,3]-product, N-4- 
trifluoromethylphenyl)benzamide, presumed to result form coordination of the cationic 
palladium complex to the imidate nitrogen, followed by ionisation-recombination. 
However, Q  symmetric dimer 65 was found to be the best of these complexes and was 
easily prepared form A-Boc-L-proline 61 (Scheme 37).37 A-Boc-L-proline 61 was coupled 
to 1,3-dihydroisoindole to give amide 62 in 58% yield. Reduction gave diamine 63 which 
was then complexed with Na2PdCl4 in ethanol to give palladium(II) complex 64 as a 10:1 
mixture of diastereomers. The dichloride compounds were catalytically inactive and so the 
cationic dimers were prepared in order to increase lability of the palladium sphere. 
Reaction of dichloride 64 with silver tetrafluoroborate gave Q  symmetric dimer 65 in 
quantitative yield.
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Scheme 37: Synthesis of asymmetric tetraaminodipalladium(II)-catalyst.
Rearrangement of allylic benzimidate 66 using palladium(II) complex 65 in CD2C12 at 40 
°C gave benzamide 67 in 66% e.e. and 69% yield (Scheme 38).37
Scheme 38: Enantioselective tetraaminodipalladium(II)-catalysed rearrangement.
The R absolute configuration of amide 67 was determined by correlation with (R)- 
norvaline.37 The authors then described that the major pathway of the catalysed 
cyclisation-induced rearrangement mechanism requires the palladium(II)-catalyst to
Leung and co-workers have also reported that similar ortho-metallated complexes such as 
(R,R)-di-|a-chlorobis{9-[(l-dimethylamino)ethyl]-10-phenanthrenyl-CyV}dipalladium 68 
can catalyse the enantioselective rearrangement of a non-activated allyl imidate 69 in up to 
79% enantiomeric excess (Scheme 39).38 However, no yields for the reactions are given 
and the absolute stereochemistry of the amide product 70 has yet to be determined. It was 
also reported that an electronically neutral palladium(II)-complex is required for this 
catalytic reaction.
66 67
coordinate to the si-face of the alkene forcing the imidate nitrogen to attack from the re­
face.
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Scheme 39: Enantioselective cyclopalladated-amine catalysed rearrangement.
The first examples of cyclopalladiated ferrocenyl amine complexes in enantioselective 
catalysis were reported by Overman and Hollis in 1997.39 The design of these second 
generation catalysts was based on the superior yields and reaction times obtained for 
rearrangement with PdCl2(MeCN)2 compared to complex 65 (Scheme 37).39 Also, 
PdCl2(MeCN)2 forms a neutral Pd-olefin complex and the Pd-olefin complex formed from 
catalyst 65 would be cationic. Thus, development of a neutral cyclopalladiated catalyst 
series led to cyclopalladated ferrocenyl trifluoroacetate amine complex 71 giving optimal 
results. Therefore, by using a neutral catalyst, suppression of the competing ionisation- 
recombination pathway was achieved. Rearrangement of allylic benzamide 66 was 
achieved with 5 mol% of catalyst 71 to give amide 67 in a modest 61% e.e. however in 
excellent 98% yield.
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Figure 2: Enantioselective cyclopalladiated ferrocenyl amine catalyst.
Overman and Cohen then went on to develop planar-chiral cyclopalladated ferrocenyl 
amine and imine catalysts (i.e. without substitution a  to the coordinating nitrogen) for the 
enatioselective rearrangement of allylic imidates.40 Initially, these catalysts were prepared 
as the cyclopalladated amines 72 (Figure 3). However, no improvement of the rate of 
reaction or enantioselectivity was observed compared with complex 71.
Me
Me
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Figure 3: Planar-chiral cyclopalladated ferrocenyl amine catalysts.
Thus, attention turned to cyclopalladated ferrocenyl imines. These ferrocenyl 
palladacycles were prepared from enantiopure iodoferrocenecarboxyaldehyde 73 in two 
steps (Scheme 40). Preparation of imines 74 was carried out by condensing aldehyde 73 
with a range of anilines under reflux. These imines 74 were then reacted with 
Pd2(dba).CHCl3 in benzene at room temperature to give iodide-bridged dimer ferrocenyl 
palladacycles 75 in 22-57% yield over two steps. These iodide-bridged dimers did not 
catalyse the rearrangement of allylic benzimide 66 unlike the chloro-bridged amines. 
However, activation to the cationic palladium(II) complexes by dehalogenation using 
thalium triflate gave compounds which catalysed the rearrangement.
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Scheme 40: Synthesis of cyclopalladated ferrocenyl imine catalysts.
The rearrangement of benzimidate 66 was then carried out using these catalysts and 
although good yields of R-benzamide 67 were observed the enantioselectivities were 
inferior compared with earlier reported catalysts. Interestingly, rearrangement of the 
corresponding (Z)-allylic benzimidate gave the opposite absolute configuration of allylic 
benzamide 77 and in slightly higher enantioselectivity (i.e. S-benzamide 67 in 73% e.e.). 
Rearrangement of benzimidate 66 has also been carried out using a series of homochiral 
cationic palladium complexes by Hayashi and co-workers.41 Rearrangement using the 
most enantioselective complex, prepared from PdCl2[(5')-2-(2-diphenylphosphino)phenyl- 
4-benzyloxazoline] 76 (Figure 4) and silver tetrafluoroborate, gave S-allylic benzamides in 
enantioselectivities of up to 81%. However, significant amounts of the elimination product 
/V-[4-(trifluoromethyl)phenyl]benzamide were obtained for this cationic catalysed 
rearrangement via the competing ionisation pathway and so yields of benzamide 67 were 
generally poor.
Figure 4: PdCl2[(5')-2-(2-diphenylphosphino)phenyl-4-benzyloxazoline].
The first tridentate ligand for the enantioselective rearrangement of allylic imidates was 
reported by Zhang and co-workers in 1999.42 A series of these ligands were prepared and 
reacted with [Pd(MeCN)4](BF4)2 to form cationic palladium(II)-catalysts. These catalysts 
were then used for the rearrangement of a series of allylic imidates. The most 
enantioselective of these complexes was prepared from (R)-Ph-ambox (77, bis[4-(R)- 
phenyloxazolin-2-yl-methyl]amine) and gave R-allylic benzamide 67 in 83% e.e. and 71% 
yield (Scheme 41). However the elimination product and/or [1,3]-rearrangement product 
were obtained for rearrangement of the majority of other allylic imidates and so the scope 
of the rearrangement is severly limited with these cationic catalysts.
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Scheme 41: Synthesis of cyclopalladated ferrocenyl imine catalysts.
Donde and Overman were able to significantly increase the enantioselectively of the 
rearrangement of allylic imidates using cyclopalladated catalysts containing 
ferrocenyloxazoline ligands.43,44 The ligands were convienently prepared from 
enantioenriched oxazoline complex 78 (Scheme 42). Ortholithiation followed by reaction 
with diiodoethane gave a single stereoisomer of iodide 79 after recrystallisation. Oxidative 
addition of palladium(O) to these iodides gave iodide-bridged dimers 80. Again, these 
iodide-bridged dimers proved to be inactive and so conversion to active trifluoroacetate 
catalysts was carried out by reaction with 2 equivalents of silver trifluoroacetate.
Scheme 42: Synthesis of ferrocenyloxazoline palladacycle (FOP) catalysts.
Rearrangement of benzimidates 81 to form R-benzamides 82 was achieved using 5 mol% 
of these ferrocenyloxazoline palladacyclic (FOP) catalysts with enantioselectivities of up 
to 96% being observed and in high yields (Scheme 42). In general, the Z-benzimidates 
gave higher enantioselectivities than the ^-benzimidates.
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Scheme 43: Enantioselective cyclopalladated ferrocenyl-oxazoline catalysed
rearrangement.
In order to improve the usefulness of the amides produced from these reactions, 
rearrangement using these cyclopalladated ferrocenyl-oxazoline catalysts was carried out 
with imidates that would result in amides with substituents on nitrogen that could be easily 
deprotected. FOP-catalysed rearrangement of (£)-3-hexenyl trichloroacetimidate gave the 
corresponding allylic trichloroacetamide in a disappointing 43% e.e. and with only 50% 
conversion after 6 days at 40 °C. Rearrangement of both (Z)-3-hexenyl N- 
benzoylbenzimidate and a terr-butylsulfonamide (BUS) nitrogen protected benzimidate 
was also attempted. However, the desired benzamide product was not observed for either 
substrate.
This type of catalyst was further developed by Kang and co-workers with the synthesis of 
bis(palladacycles) and their implementation in the aza-Claisen rearrangement of allylic 
benzimidates.45 The complexes were designed to stabilise the palladacycle using tri- 
coordinating ligands. Synthesis of the palladacycles was carried out from chiral 1,1’- 
bis(oxazolinyl)-ferrocene 83 by ortholithiation followed by reaction with diiodoethane to 
give diiodide 84 (Scheme 44). Hydrolysis, acetylation and then saponification gave diacid 
85 in good yields over the three-steps. Subsequent reaction with oxalyl chloride gave the 
corresponding acid chloride, which was converted to the corresponding tertiary amides 86 
by reaction with a range of amines. Oxidative addition of Pd(dba)3.CHCl3 with these 
amides gave the desired bis(palladacycles), which were reacted with silver trifluoroacetate 
to give the catalytically active trifluoroacetate salts (e.g. 87).
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Scheme 44: Synthesis of bis(palladacycle) catalysts.
Enantioselective aza-Claisen rerrangement of a series of the allylic benzimidates 88 was 
then carried out to give allylic benzamides 89 in good yields (Scheme 45). 
Bis(palladacycle) 87 was found to be the most enantioselective (>95% e.e.). The 
selectivity is believed to be a result of conformational rigidity from the o-phenylene tether 
and steric bulk from the isopropoxy group generating a more chiral environment. 
Interestingly, the E/Z configuration of the imidate substrates does not significantly affect 
the enantioselectivity.
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Scheme 45: Enantioselective bis(palladacycle) catalysed aza-Claisen rearrangement.
Following on from this work, Kang and co-workers reported the enantioselective aza- 
Claisen rearrangement of allylic benzimidates using a cobaltocenyl oxazoline palladacycle
(COP) 90,46 which was prepared in 7 steps from diphenylacetylene using a known 
synthesis (Figure 5).47
90 X = Cl
91 X = OCOCF3
Figure 5: Cobaltocenyl oxazoline palladacycle (COP) catalysts.
Compound 90 did not catalyse the rearrangement and so was activated to catalyst 91 using 
silver trifluoroacetate. Catalytic rearrangement of (Z)-allylic benzimidates 92 was then 
achieved to give (R)-allylic benzamides 93 in good yields and enantioselectivities of up to 
95% (Scheme 46). However, rearrangement of (£)-allylic benzimidates gave poor 
enantioselectivities (i.e. 45-68% e.e.). The rational for these observations was a transition 
state in which the (r]4-tetraphenyl-cyclobutadiene)cobalt moiety blocks the Si-face of the 
olefin forcing the imidate nitrogen to attack the Re-face, thus producing the R product.
Scheme 46: Enantioselective activated cobaltocenyl oxazoline palladacycle catalysed aza- 
Claisen rearrangement.
Around the same time the Overman/Richards groups reported the enantioselective aza- 
Claisen rearrangement of allylic A-aryl trifluoroacetimidates using cobaltocenyl oxazoline 
palladacycle 90 (COP-C1).48 This methodology had two advantages over that reported by 
Kang and co-workers.46 Rearrangement of (£)-allylic trifluoroimidates can be achieved 
using complex 90, without being activated, to give excellent enantioselectivities and yields 
of (^-allylic amides 95 (Scheme 47). Rearrangement of (Z)-allylic trifluoroimidates 94 
can be achieved using the activated trifluoroacetate catalyst 91, again in excellent
R
92 93
enantioselectivities and yields to give (R)-allylic amides 95. Thus, either enantiomer of the 
allylic amide may be prepared with careful selection of substrate and catalyst.
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Scheme 47: Enantioselective cobaltocenyl oxazoline palladacycle (COP-C1) catalysed aza- 
Claisen rearrangements.
The second advantage of using trifluoroacetimidates as substrates for the rearrangement is 
the easy deprotection of the trifluoroacetamide functional group to give enantioenriched 
allylic amines (Scheme 48). Removal of the trifluoroacetamide group is achieved using 
sodium ethoxide to give amines 96. Subsequent oxidative dearylation using eerie 
ammonium nitrite (CAN) followed by reaction with maleic acid gave salts 97 in good 
yields. Prochiral allylic alcohols can therefore be converted to highly desireable 
enantioenriched chiral allylic amines.
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Scheme 48: Synthesis of enantioenriched chiral allylic amines.
This methodology was further developed by Anderson and Overman in 2003 by using (E)- 
allylic trichloroacetimidates 99 which were easily prepared from allylic alcohols 98 using 
DBU and trichloroacetonitrile.49 Subsequent enantioselective aza-Claisen rearrangement 
of these substrates using catalyst 90 gave the desired (S^-allylic trichloroacetamides 100 in 
high yield and excellent enantioselectivities (92-98% e.e.) (Scheme 49). However, 
rearrangement of (Z)-allylic trichloroacetimidates to give (R)-allylic trichloroacetamides 
generally gave low yields and enantioselectivities. Also, a study on functional group
tolerence in the rearrangement using the COP-C1 catalyst found that hydroxyl groups are 
tolerated in the allylic trichloroacetimidate structure although amine or thio groups are not.
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Scheme 49: Synthesis and enantioselective cobaltocenyl oxazoline palladacycle (COP-C1) 
catalysed aza-Claisen rearrangement of trichloroacetimidates.
Nevertheless, deprotection of the allylic trichloroacetimidate functional group was then 
easily achieved under acidic conditions to yield the corresponding enantioenriched allylic 
amines. The unity of this methodology was then demonstrated by the synthesis of the 
GABA aminotransaminase inhibitor (5)-vigabatrin 101 and also the protected (S)-a-amino 
ester 102 (Scheme 50).49 This clearly illustrates that the trichloroacetimidate is easily 
cleaved and that functional group manipulation can be carried out in the precence of the 
protected amine.
CCI3  @
^  6  M HCI NH3
Mg0 2C 100 °c
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Scheme 50: Synthesis of (S')-vigabatrin 101 and a-amino ester 102.
In order to increase the solubility of the catalyst and thus allow solvents with varying 
polarity to be used for the aza-Claisen rearrangement of allyic trichloroacetimidates, 
Overman and co-workers developed COP-hfacac catalyst 103 (Figure 6).50 The 
monomeric stucture of this catalyst was confirmed using single-crystal X-ray 
crystallography.
Figure 6: Monomeric COP-hfacac catalyst.
Rearrangement of allylic trichloroacetimidate 104 was achieved in a variety of solvents 
(e.g. cyclohexane, toluene, DCM, ethyl acetate, acetone, acetonitrile and THF to give 
allylic trichloroacetamide 105 in excellent yields and enantioselectivities (Scheme 51).
5 mol% 103
solvent 
92-97% e.e.
CCI 3
HN^X)
104 105
Scheme 51: Enantioselective COP-hfacac catalysed aza-Claisen rearrangement of 
trichloroacetimidate 102 in various solvents.
More recently Peters and co-workers described the use of ferrocenylimidazoline 
palladacycle (FIP) catalysts for the aza-Claisen rearrangement of A-/?<zra-methoxyphenyl 
trifluoroacetimidates.51 The ferrocenylimidazoline ligands were conveniently prepared 
from amides 106 (Scheme 52). Activation as the iminium ethers, followed by 
sulfonylation gave imidazolines 107. Subsequent cyclopalladation using Na2PdCl4 / 
NaOAc gave dimeric FIP-C1 complexes 108 in good yields.
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Scheme 52: Synthesis of ferrocenylimidazoline palladacycle (FIP) catalysts.
Enantioselective aza-Claisen rearrangement of a series of A^-para-methoxyphenyl 
trifluoroacetimidates 94 was then carried out using these FIP-C1 catalysts (Scheme 53). 
Optimal results were obtained by activating the catalysts using silver trifluoroacetate and 
carrying out the reaction in DCM in the presence of a proton sponge (gave higher e.e. 
values and cleaner reactions). Enantioselectivities for all rearranged imidate substrates 
were improved from those reported using other catalysts. Interestingly, the R-enantiomers 
(>99.7% e.e.) of rearrangement products 95 were obtained by rearrangement of (£)- 
imidates and the S-enantiomers (>96% e.e.) from rearrangement of (Z)-imidates, the 
opposite from that observed by Overman / Richards for rearrangement of these substrates 
using the COP-C1 catalyst.48
Scheme 53: Enantioselective ferrocenylimidazoline palladacycle (FIP-C1) catalysed aza- 
Claisen rearrangements.
Different methodology has also been used for the palladium(II)-catalysed rearrangement of 
allylic trichloroacetimidates. Heteroatom-directed reactions have been extensively utilised 
in asymmetric organic synthesis.52 That is, reactions in which the incoming reagent {e.g. 
metal catalyst) is directed by the substrate, in a non-covalent manner, to influence the 
regio- or stereochemical outcome of the reaction.
Ag(OCOCF3) 
PS, DCM, RT
94 95
E-imidates > 82% yield, 96% e.e.(R) 
Z-imidates > 94% yield, 99.7% e.e.(S)
Bellus and co-workers have used such a reaction for the diastereoselective synthesis of 1,2- 
diamines.53 The key step in the synthesis was a heteroatom-directed palladium(II)- 
catalysed aza-Claisen rearrangement of chiral allylic trichloroacetimidates. These were 
prepared by chain elongation of the appropriate a-amino alcohol followed by reaction with 
sodium hydride and trichloroacetonitrile. Subsequent rearrangement under thermal 
conditions gave the corresponding trichloroacetamides 110 in good yield but low 
diastereoselectivity. However, rearrangement of the trichloroacetimidates 109 in the 
presence of bis(acetonitrile)palladium(II) chloride at room temperature gave the 
trichloroacetamides 109 in reasonable yield and excellent diastereoselectivity O  99:1 in all 
cases) (Scheme 54). Inhibition of this diastereoselectivity was observed when the chiral 
nitrogen was doubly protected with either tert-butyl carbamate (i.e. Boc2N), benzyl (i.e. 
Bn2N) or a mixture of the two groups (i.e. BocNBn).
PdCI2 (MeCN) 2  R
(6 -8 mol%) NH
>99:1
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Scheme 54: Substrate directed palladium(II)-catalysed aza-Claisen rearrangements.
The diastereoselectivity observed for the palladium(II)-catalysed reaction was explained 
using transition state 111 (Figure 7). The substrate adopts a chair-like transition state 
minimising 1,3-diaxial interactions with the chiral amine group causing the olefin faces to 
be diastereotopic. The palladium(II)-catalyst coordinates to this chiral amine and is 
directed to the back face. The imidate nitrogen is then forced to attack the olefin from the 
front face. Thus, the /ram-diastereomer is produced exclusively from this rearrangement.
Figure 7: Transition state.
The usefulness of the rearrangement products was demonstrated by the synthesis of 
(25,35')-diaminobutanoic acid 112, a component of several important biological molecules 
(Scheme 55).53
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Scheme 55: Substrate directed palladium(II)-catalysed aza-Claisen rearrangements.
A similar study has been carried out by Doherty towards the synthesis of 3- 
aminodeoxystatine derivatives for use in a renin inhibitor program.54 Initially thermal and 
mercury(II)-catalysed rearrangements of an allylic trichloroacetimidate with a nitrogen 
heteroatom in the 6-position gave a mixture of products and isomers. However, a 
subsequent palladium(II)-acetate catalysed rearrangement gave the desired allylic amide as 
a single isomer.
Ham and co-workers have carried out a study in which a diastereoselective aza-Claisen 
rearrangement of allylic trichloroacetimidates was used as the key step in the synthesis of 
allylic trichloroacetimidates 114 (Scheme 56).55 The trichloroacetimidate substrates for the 
rearrangement reaction were prepared from the corresponding a-amino acid. Subsequent 
rearrangement of these allylic trichloroacetimidates 113 in the presence of 
bis(acetonitrile)palladium(II) chloride gave the trichloroacetamide 114 products with 
varying degrees of diastereoselectiviy (1.4:1 to 10:1). However, in contrast to the effect 
reported by Bellus for the corresponding amine compounds,53 the authors explain that the 
diastereoselectivity observed is a result of the steric bulk of the substituents. Thus, the 
larger the chiral 6-ether protecting group and the smaller the R group, the more 
diastereoselective the rearrangement becomes.
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Scheme 56: Steric bulk directed palladium(II)-catalysed aza-Claisen rearrangements.
The palladium(II)-catalysed rearrangement of allylic imidates has been used in the 
synthesis of a number of natural products and other medicinally important complex 
molecules. For example, the synthesis of highly functionalised carbocycles has been 
achieved by van Boom and co-workers utilising a palladium(II)-catalysed rearrangement 
(Scheme 57).56 Trichloroacetimidate 115 underwent an aza-Claisen rearrangent in the 
presence of bis(acetonitrile)palladium(II) chloride to give trichloroacetamide 116 as a 
single diastereomer. Subsequent transformation of trichloroacetimidate 116 via ring 
closing metathesis gave the conduramine analogue 117.
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Scheme 57: Diastereoselective synthesis of a conduramine analogue 117.
As previously demonstrated by Bellus and co-workers,53 the trichloroacetamides produced 
from the palladium catalysed aza-Claisen rearrangement can easily be converted to a- 
amino acids. Mehamandoust et al. have utilised this methodology for the enantioselective 
synthesis of (E)-p,y-unsaturated a-amino acids.57 Likewise, Salaiin and co-workers used a 
palladium(II)-catalysed aza-Claisen rearrangement of A-aryl allylic imidates for the 
synthesis of 1-aminocyclopropane-carboxylic acids.58
Finally, Sutherland and co-workers carried out the first enantioselective synthesis of 
(25,35,4/?)-y-hydroxyisoleucine 120, the amino acid constituent of the natural product, 
funebrine (Scheme 58).59 Allylic trichloroacetimidate 118 was synthesised in 7 steps from 
poly (/?)-hydroxybutanoate. Subsequent rearrangement under thermal conditions gave the 
corresponding trichloroacetamides in a diastereomeric ratio of 3 : 2, with the desired 
diastereomer being the minor isomer. However, catalysis using
bis(benzonitrile)palladium(II) chloride, a switch in the diastereoselectivity was observed 
and the desired isomer 119 was obtained in a 7 : 1 ratio and in 71% yield. The 
diastereoselectivity for the palladium(II)-catalysed reaction was explained by the fact that 
the palladium catalyst coordinates to the less sterically hindered /te-face of the olefin and 
so the imidate nitrogen is forced to attack from the 57-face, thus giving the (35)-isomer as
the major product. Subsequent oxidation then deprotection of the resulting 
trichloroacetamide completed the total synthesis of the enantiopure amino acid 120.
TBDPSO HN PdCI2 (PhCN) 2  JBDPSO HN O
71%
118 119 120
Scheme 58: Diastereoselective synthesis of (2S,35,4/?)-Y-hydroxyisoleucine 120.
1.6 Conclusion
In 1912 the first thermal [3,3]-sigmatropic rearrangement was reported by Claisen.3 The 
mechanism of the reaction has been determined by several studies on the regioselectivity, 
thermodynamic parameters, stereoselectivity and solvent effects. A negative change in 
enthalpy during the reaction was identified as the driving force and the concerted, 
suprafacial transition state gives the products as predominantly the ^-geometrical isomer 
with excellent stereoselectivity. This reaction has subsequently been developed to include 
several related rearrangement reactions including the thermal rearrangement of allylic 
trichloroacetimidates.
Succeeding this, the development of a catalysed version of the reaction allowed the 
rearrangement to be carried out at room temperature with rate enhancements of up to 
1012.14 Catalysis was initially carried out using mercury(II)-salts, however palladium(II)- 
salts proved to more effective catalysts for the rearrangements. Studies of these catalysed 
rearrangement reactions revealed a cyclisation-induced mechanism with a cyclic 
carbocation intermediate that readily collapses, exothermally, to give the amide products. 
More recently, the enantioselective palladium(II)-catalysed rearrangement of allylic 
imidates has been the focus of most research in this area. Initially, cationic palladium 
diamine complexes were used to catalyse the rearrangement of allylic imidates, however 
these only gave moderate enantioselectivities and poor yields due to a competing 
ionisation pathway. The use of neutral cyclopalladated ferrocenyl catalysts suppressed 
these competing reactions and so gave increased yields. Enantioselectivities were 
increased using using planar chiral cyclopalladated ferrocenyl catalysts. Development of 
cobaltocenyl oxazoline palladacycle (COP) catalysts which when utilised for the 
rearrangement of allylic imidates further increased yields and enantioselectivities. More 
importantly, these compounds catalysed the rearrangement of trichloroacetimidates to give 
trichloroacetamides, which can be deprotected giving enantioenriched chiral amines. 
Ferrocenylimidazoline palladacycle (FIP) catalysts have also been shown to 
enantioselectively catalyse the rearrangement of allylic imidates to allylic amides which 
can be deprotected to form allylic amines.
The use of a heteroatom-directed palladium(II)-catalysed aza-Claisen rearrangement has 
been reported for the diastereoselective synthesis of 1,2-diamines. Also, the 
diastereoselective synthesis of anti- 1,2-amino alcohols and y-hydroxy a-amino acids has 
been achieved using steric effects in a palladium(II)-catalysed aza-Claisen rearrangement. 
The development of these [3,3]-sigmatropic rearrangements has thus led to their use in the 
asymmetric synthesis of many medicinally important molecules and natural products.
Future developments in this area will no doubt lead to the more efficient asymmetric 
catalysis of the rearrangement of allylic imidates to allylic amides that can easily be 
deprotected and converted to more complex nitrogen containing compounds.
2.0 Results and Discussion
In order to investigate whether palladium(II)-catalysed aza-Claisen rearrangements can be 
influenced by stereogenic centres within the substrate, a program to synthesise and test a 
series of trichloroacetimidates with varying ether protecting groups was proposed. Oxygen 
was chosen as the heteroatom due to precedent that the rearrangement products could be 
converted to highly desirable p-hydroxy allylic amines.59 It was also proposed that these 
allylic amines could then be converted to p-hydroxy a-amino acids or used for the 
synthesis of more complex nitrogen containing molecules.
2.1 Studies of a Heteroatom Directing Effect.
2.1.1 Development of a Synthetic Route to Six Trichloroacetimidates with 
Varying Ether Protecting Groups.
The initial aim in this project was the development of a flexible efficient route for the 
synthesis of a series of E-allylic trichloroacetimidates (Scheme 59) from commercially 
available ethyl (5)-lactate 121.
Protection of the secondary alcohol moiety of ethyl (5)-lactate 121 was achieved using the 
Williamson ether synthesis (sodium hydride, alkyl halide)60 to yield compounds 124, 125 
and 127. Compounds 122,123 and 126 were produced using imidazole, DBU and Hiinig’s 
base respectively.60 Reduction of the ester functional group using 1.1 equivalents of 
DIBAL-H gave the aldehydes 128-131.60 Yields of the DIBAL-H reductions were 
significantly increased by changing the solvent from THF to diethyl ether. The method of 
work-up was also improved in order to optimise the yields. Rather than using methanol 
and Rochelle’s salt, saturated ammonium chloride was used to quench the reaction. This 
produced a white precipitate, which could be filtered and washed with diethyl ether. 
Initially, the use of a stabilised phosphorus ylide in a Wittig reaction was investigated in 
order to produce preferentially the ^-geometrical isomer of the a,p-unsaturated esters.61 
However, subsequent reaction with triethyl phosphonacetate under Homer-Wadsworth- 
Emmons (HWE) conditions gave a,p-unsaturated esters 134-136 and 139 with only the E- 
geometrical isomer observed by !H NMR spectroscopy.61 Masamune-Roush conditions are 
used for all HWE reactions due to the mild conditions employed during this procedure.62 
Decomposition and volatility problems associated with the Me and MOM substituted 
aldehydes were overcome by reducing these compounds to the corresponding alcohols 132
and 133 using 2.2 equivalents of DIBAL-H. A one-pot, Swern oxidation-HWE reaction63 
gave the (£)-a,P-unstaturated esters 137 and 138. Reduction of all the (£)-cx,|3- 
unstaturated esters 134-139 to allylic alcohols 140-145 was achieved again using 2.2 
equivalents of DIBAL-H.61 Finally, reaction with sodium hydride and trichloroacetonitrile 
using an Overman group protocol64 gave substrates 146-151 for the rearrangement 
reaction. Allylic trichloroacetimidates are known to be relatively unstable15 and thus, the 
work-up and purification of these compounds involves simply washing the reaction 
mixture through a short pad of aluminium oxide followed by removal of the solvent in 
vacuo.25b Hence yields quoted for all rearrangements are calculated from the allylic 
alcohols 140-145 (over two steps).
OH 1) Base2) R-X
'C 02Et
121
OR
DIBAL-H (1.1 equiv.) 
Et20, -78 °C to RT
'C 02Et
122 R= TBDMS (100%)
123 R= Tr (100%)
124 R= Bn (95%)
125 R= Me (48%)
126 R= MOM (91%)
127 R= MEM (100%)
OR
128 R= TBDMS (61%)
129 R= Tr (82%)
130 R= Bn (100%)
131 R= MEM (100%)
DIBAL-H (2.2 equiv.) 
Et20, -78 °C to RT
triethyl phosphonoacetate 
LiCI, DBU, MeCN
DMSO, (COCI)2, NEt3 
OR -78 °C, then
. . .  r------------- ^  0O2Et^  v  triethyl phosphonoacetate
LiCI, DBU, MeCN
132 R= MOM (82%) 134 R= TBDMS (81 %)
133 R= Me 135 R= Tr (78%)
136 R= Bn (93%)
137 R= Me (58% over two steps)
138 R= MOM (65%)
139 R= MEM (28%)
DIBAL-H (2.2 equiv.) 
Et20, -78 °C to RT
HN v .0
146 R= TBDMS
147 R= Tr
148 R= Bn
149 R= Me
150 R= MOM
151 R= MEM
1) NaH, THF, 0 °C
2) CI3CCN OR
OH
140 R= TBDMS (52%)
141 R= Tr (97%)
142 R= Bn (52%)
143 R= Me (87%)
144 R= MOM (96%)
145 R= MEM (89%)
Scheme 59: Synthesis of a series Zs-allylic trichloroacetimidates.
An approach was also attempted to prepare all six analogues via one route. This was tried 
by deprotecting the silyl group of a,p-unsaturated ester 134 and then reprotecting the 
resulting hydroxyl moiety (Scheme 60). Although deprotection was achieved without 
incident, the resulting allylic alcohol 152 could not be reprotected as either the methyl- or 
benzyl-ether. Protection of allylic alcohol 152 as the MOM-ether was also attempted, 
however gave low yield due to a MOM-ester by-product.
OTBDMS
'C 02Et
134
TBAF OH
1) Base
2) P-X OP
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152 P = protecting group
Scheme 60: Attempted deprotection and reprotection of a,p-unstaturated ester 134.
2.1.2 Aza-Claisen rearrangements.
Allylic trichloroacetimidates 146-151 were initially subjected to thermal [3,3]-sigmatropic 
rearrangement in p-xylene (140 °C) for 24-120 hours.15 In general, the *H NMR spectrum 
of the crude reaction mixture showed a 2:1 (3R:3S) ratio of diastereomers (Table 1). 
Rearrangement from the least hindered front face of the alkene is preferred, giving the 
(3R,4S) allylic amides 153a-158a as the major products. The poor diastereoselectivity of 
this process can be explained by the small energy difference between the two possible 
reacting conformers at high temperatures. Purification of the reaction mixture by column 
chromatography gave the two diastereomers in very modest yields (21-44%) with a 
number of unidentifiable decomposition products. The low yields from these reactions are 
due to acid degradation of the trichloroacetimidates before rearrangement has occurred to 
the more stable trichloroamides.23
Table 1: Thermal [3,3]-sigmatropic rearrangement diastereoselectivities and yields
OR OR OR
p-xylene
CCI3  CCI3  CCI3
a b
Entry R Yield3  (%) Ratiob ( a : b)
1 TBDMS (153) 27% 1 : 1
2 Tr (154) 36% 2  : 1
3 Bn (155) 44% 2  : 1
4 Me (156) 38% 2  : 1
5 MOM (157) 2 1 % 2  : 1
6 MEM (158) 37% 2  : 1
a Isolated combined yields of a and b from E-allylic alcohols 140-145. 
b Ratio in crude reaction mixture.
Using a modified thermal rearrangement procedure developed by Isobe and co-workers,23 
involving the addition of potassium carbonate to neutralise any acid formed during the
reaction, rearrangement of the lowest yielding imidate, the MOM-ether substrate was 
carried out giving the rearrangement products 157a and 157b in a much improved yield of 
91% (Scheme 61).
OMOM p-xylene
K2 C 0 3
OMOM OMOM
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+
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Scheme 61: Thermal rearrangement in presence of K2C 03.
Allylic trichloroacetimidates 146-151 were then subjected to rearrangement conditions 
using bis(acetonitrile)palladium(II) chloride catalyst in THF for 24 hours at room 
temperature (Table 2).59
The results show that the larger sterically bulky ether groups (entries 1, 2 and 3) hinder the 
palladium(II)-catalyst from efficiently coordinating to the ether oxygen and so allylic 
trichloroacetamides 153-155 are produced with low diastereoselectivity. However, 
rearrangement of the smaller methyl ether group (entry 4) gives a significant increase in 
diastereoselectivity. This is a result of the palladium catalyst now being able to effectively 
coordinate to the ether oxygen than to the olefin, blocking the back face of the molecule 
and forcing the imidate nitrogen to attack the olefin from the front face. This result led to 
an investigation into whether having additional oxygen atoms within the ether side chain 
would further enhance this effect. Gratifingly, use of the MOM group (entry 5) gave 157a 
and 157b in an excellent 10:1 ratio. In an attempt to enhance this effect even further, 
rearrangement with a MEM-ether substrate (entry 6) containing three oxygen atoms, was 
attempted. Although this group gave a highly selective rearrangement, no improvement on 
the diastereoselectively observed for the MOM group was obtained. In the case of the 
MEM-ether derivative, which has three oxygens in the chain, the third oxygen is probably 
too far away to coordinate effectively with the palladium(II)-catalyst. The larger bulk of 
the MEM-ether compared to the MOM-ether is most likely the cause of the slightly 
decreased selectivity.
Table 2: Bis(acetonitrile)palladium(II) chloride catalysed aza-Claisen rearrangement
diastereoselectivities and yields
OR
PdCI2 (MeCN) 2  
( 1 0  mol%)
OR OR
HN
v °
CCI3
THF, RT H N ^ O
CCI3
a
H N ^ O
CCI3
b
Entry R Yield* (%) Ratio** (a : b)
1 TBDMS (153) 6 8 % 2  : 1
2 Tr (154) 70% 3 : 1
3 Bn (155) 62% 3 :1
4 Me (156) 48% 7 : 1
5 MOM (157) 64% 1 0  : 1
6 MEM (158) 60% 8  : 1
a Isolated combined yields of a and b from E-allylic alcohols 140-145. 
b Ratio in crude reaction mixture.
Allylic trichloroacetimidates 146-151 were then subjected to rearrangement conditions 
using bis(benzonitrile)palladium(II) chloride as catalyst in THF for 24 hours at room 
temperature.59 As expected, bis(benzonitrile)palladium(II) chloride gave similar yields and 
ratio of diastereomers when treated with allylic trichloroacetimidates 146-151 (Table 3). 
On coordination of the catalyst with the MOM-ether and then the olefin both benzonitrile 
ligands are likely lost from the metal centre forming a similar intermediate as that for the 
acetonitrile catalyst.
Purification of the products generated from the bis(acetonitrile)palladium(II) chloride 
catalysed reaction proved easier due to co-eluting of benzonitrile derived compounds with 
the rearrangement products.
Overman and Knoll have also reported contamination of products from the rearrangement 
reaction with benzonitrile ligands originating from the bis(benzonitrile)palladium(II) 
chloride catalyst.33
Table 3: Bis(benzonitrile)palladium(II) chloride catalysed aza-Claisen rearrangement
diastereoselectivities and yields.
HISU .0
PdCI2 (PhCN) 2  
( 1 0  mol%)
THF, RT
OR OR
HN. ^O HN.
Entry R Yield* (%) Ratio** (a : b)
1 TBDMS (153) 6 8 % 2  : 1
2 Tr (154) 44% 3 :1
3 Bn (155) 58% 4 :1
4 Me (156) 48% 6  : 1
5 MOM (157) 57% 9 :1
6 MEM (158) 52% 8  : 1
a Isolated combined yields of a and b from E-allylic alcohols 140-145. 
b Ratio in crude reaction mixture.
2.1.3 NOE study.
Oxazolidin-2-ones 160a and 160b were synthesised in order to prove the relative 
stereochemistry of the rearrangement products using nuclear Overhauser effect (NOE) 
experiments. The silyl ether protecting groups of trichloroacetamides 153a and 153b (2:1 
ratio) were deprotected using tetra-«-butylammonium fluoride (TBAF) to give the 
secondary alcohols 159a and 159b (Scheme 62).60 Reaction of these alcohols with 
potassium hydroxide in isopropanol gave the oxazolidin-2-ones 160a and 160b (2:1 ratio) 
in 41 % yield over the two steps.
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H N y 0
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Scheme 62: Oxazolidin-2-ones synthesis.
The relative stereochemistry of the rearrangment products could then be determined using 
NOE experiments of these oxazolidin-2-ones (Figure 8).65
O 2  NH NH
★ \'
o
160a 160b
Figure 8: NOE experiments of these oxazolidin-2-ones.
Unfortunately oxazolidin-2-ones 160a and 160b could not be separated by column 
chromatography. However the ‘H NMR spectra of the 2:1 mixture of major and minor 
diastereomers clearly shows different peaks for the methyl substituents on C-5 (Figure 9). 
The peaks for the proton on C-4 of the minor diastereomer and the proton on C-5 of the 
major diastereomer are also very distinct.
Me'
Me'
160aMe'',160a
160b
160b
m
Figure 9: NMR spectra of the 2:1 mixture of major and minor oxazolidin-2-ones.
When the 5-H of the major diastereomer 160a was irradiated, an increase in intensity of
the peaks for both 4-H and 5-CH3 was observed (Figure 10).
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Figure 10: Irradiation of the 5-H on major diastereomer.
Irradiating the 5-CH3 of the major diastereomer 160a gave an increase in the intensity of 
both the l ’-H and 5-H peaks (Figure 11).
NH
160a
Figure 11: Irradiation of the 5-CH3 of the major diastereomer.
Irradiating the 4-H of the minor diastereomer 160b gave an increase in intensity of the 1*-
H and 5-CH3 peaks (Figure 12).
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Figure 12: Irradiation of the 4-H on minor diastereomer.
Irradiation of the 5-CH3 of the minor diastereomer 160b gave an intensity increase for the 
4-H peak and also the 5-H peak (Figure 13).
★
160b
Figure 13: Irradiation of the 5-CH3 of minor diastereomer.
These results confirmed that the 3^,45' diastereomer is the major compound obtained from 
these rearrangement reactions.
The diastereoselectivity for these reactions and the stereochemistry for the two products 
can be explained by the reacting conformations 161a and 161b (Scheme 63). The 
stereochemistry of the major compound 162a can be explained by reacting confomer 161a. 
The palladium(II)-catalyst initially coordinates to the ether oxygen and is then directed to 
the back face of the olefin. The trichloroacetimidate then adopts a chair-like conformation 
which minimises 1,3-allylic strain between the 6- and p-proton. The imidate nitrogen is 
then forced to attack the activated olefin from the front face and as a result the anti- 
diastereomer 162a is produced.
The minor diastereomer 162b produced in these reactions can be explained by reacting 
conformer 161b. The catalyst coordinates to the less sterically hindered front face of the 
olefin which then adopts a chair-like conformation minimising 1,3-allylic strain. The 
imidate nitrogen is then forced to attack the activated olefin from the back face and the 
^-diastereom er 162b is produced.
Thus, for smaller protecting groups the palladium(II)-catalyst can efficiently coordinate to 
the ether oxygen and so diastereomer 162a is the major product. However, with larger 
protecting groups the second pathway becomes more competitive and so low 
diastereoselectivity is observed for these substrates.
RO
HN. ^.0
162a
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H N ^ O
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Scheme 63: Transition states resulting in major and minor diastereomers.
2.1.4 Catalyst Screen.
Having demonstrated the heteroatom-directing effect of the MOM-ether in the aza-Claisen 
rearrangement of allylic trichloroacetimidates with both bis(acetonitrile)palladium(II) 
chloride and bis(benzonitrile)palladium(II) chloride (Table 4, entries 1 and 2) giving 
greatly increased diastereoselectivities than the thermal rearrangement, other palladium 
catalysts were sought in order to further enhance the diastereoselectivity of the reaction.
A study was carried out using palladium(II) compounds with different sized ligands in 
order to observe what effect this would have on the selectivity of the reaction (Table 4). 
Palladium(II)-chloride, palladium(II)-bromide and palladium(II)-acetate gave high but 
similar ratios of diastereomers to that of the palladium(II) nitrile catalysts (entries 3-4 and 
6). However, palladium(II)-iodide and palladium(II)-triflate showed no catalytic activity 
for this rearrangement (entries 5 and 7). Moreover, these palladium(II)-catalysts were only 
partially soluble in THF and thus, reaction times were considerably longer than for the 
reactions involving the palladium(II) nitrile catalysts. It is believed that these longer 
reaction times result in partial decomposition of allylic trichloroacetimidate 150 leading to 
lower yields of allylic trichloroacetamides 157a and 157b.
During Overman’s initial studies on the enantioselective rearrangement of allylic imidates, 
phosphine-containing palladium(II)-catalysts were screened.37 However, the catalysts gave 
disappointing results due to the electron-donating nature of the ligands inhibiting 
nucleophilic attack of the alkene by the imidate nitrogen. In order to investigate whether a 
similar effect would be observed for these substrates, reaction of allylic 
trichloroacetimidate 150 with dichloro[l,r-bis(diphenylphosphino)ferrocene]- 
palladium(II) dichloromethane adduct was attempted (entry 8). As expected no catalytic 
activity for the rearrangement was observed.
Ikariya and co-workers have reported that the oxidation state of the palladium catalyst 
determines the regiochemical outcome of these rearrangement reactions with palladium(II) 
giving solely the [3,3] products and palladium(O) giving a mixture of [3,3] and [1,3] 
products.34 Surprisingly, tetrakis(triphenylphosphine)palladium(0) showed no catalytic 
activity for the rearrangement of this substrate (entry 9).
Table 4: Rearrangement of allylic trichloroacetimidate 150 using palladium catalysts.
OMOM
150
Catalyst 
(10 mol%)
THF
OMOM
157a
OMOM
H N ^ O
CCI3
157b
Entry Catalyst Reaction time / h Yield' Ratiob (157a : 157b)
1 PdCI2 (MeCN) 2 24 64% 1 0  : 1
2 PdCI2 (PhCN) 2 24 57% 9 :1
3 PdCI2 1 2 0 45% 1 1  : 1
4 PdBr2 72 44% 9 :1
5C Pdl2 - - . . . . . . . .
6 Pd(OAc) 2 96 18% 9 :1
1 ° Pd(OTf) 2
Ph Ph 
\  /  
cis p
. . . . . . . . . . . .
8 ° Pd pe 
Cl" V -c fe fr
Ph7  Ph
9° Pd(PPh3 ) 4 --- — —
isolated combined yields of 157a and 157b from E-allylic alcohol 144. 
^Ratio in crude reaction mixture, 
reaction after 1 2 0  hours.
A number of “soft” electrophilic transition metal catalysts have been used in the 
rearrangement of Claisen-type reactions.273,66 Some of these metal catalysts were screened 
for catalytic activity in the rearrangement of allylic trichloroacetimidate 150 and are listed 
in Table 5.
Complexes of nickel(II) and copper(II), residing in the fourth row of the periodic table, 
showed no catalytic activity for the rearrangment even after 5 days (entries 1-3). From the 
fifth row of the periodic table, complexes of ruthenium(II) proved to be catalytically 
inactive (entries 4-6). Since the electronic nature of the lanthanides resides between the
fifth and sixth rows of the periodic table, ytterbium(III) was tested, however it also showed 
no catalytic activity (entry 7).
Table 5: Rearrangement of allylic trichloroacetimidate 150 using electrophilic metal 
catalysts.
OMOM Catalyst 
( 1 0  mol%)
THF
OMOM
150
OMOM
H N ^ O
CCI3
157b
Entry Catalyst Reaction time / h Yield Ratio (157a : 157b)
3a
4a
NiCI2
Ph Ph
\  /
Ck  /
Ni
Cl" >
/  \
Ph Ph
CuCI2
CI2 Ru(PPh3 ) 3
7a YbCI3 .H20
aNo reaction after 120 hours.
The catalytic rearrangement of allylic trichloroacetimidates was first observed by Overman 
using mercury(II) salts.14,15 However, these reactions were limited by the requirement of a 
substituent on C-3 that favours attack of the imidate nitrogen on the olefin (i.e. initiates 3- 
C to be 6+). Mercury(II)-triflate and mercury(II)-chloride, showed no activity for the 
rearrangement of 150 (Table 6, entries 1 and 2). This can therefore be explained by the
fact that the MOM-ether side chain does not exert an electron-withdrawing effect on C-3 
and as a result C-3 is not 6+. Also residing in the sixth row of the periodic table, 
iridium(III) showed no catalytic activity for the rearrangement reaction (entry 3).
Finally, hydrogen tetrachloroaurate(III) hydrate and platinium(II)-chloride catalysed the 
rearrangement of allylic trichloroacetimidate 150 to give allylic trichloroacetamides 157a 
and 157b in good yields over the two steps (entries 4 and 5). However, the 
diastereoselectivity could not be improved on that observed for the palladium(II)-catalysts. 
In accordance with these results Jaunzeme and Jirgensons have also recently shown that 
platinum and gold catalyse the rearrangement of allylic trichloroacetimidates.67
Table 6: Rearrangement of allylic trichloroacetimidate 150 using sixth row transtion metal 
catalysts.
OMOM _ , , , OMOM OMOM: Catalyst 7  7
CCI3 CCI3 CCI3
150 157a 157b
Entry Catalyst Reaction time / h Yield3 Ratio^ (157a : 157b)
1 c HgCI2 . . . . —
2° Hg(OTf) 2 . . . . . . . .
3C lrCI3 .3H20 . . . . . . . .
4 HAuCI2 .3H20  48 49% 6  : 1
5 PtCI2  144 49% 1 0  : 1
isolated combined yields of 157a and 157b from E-allylic alcohol 144. 
^Ratio in crude reaction mixture.
°No reaction after 120 hours.
Thus, for optimal rate of reaction, ease of purification, high yield and high 
diastereoselectivity the preferred catalyst for this ether-directed rearrangement is 
bis(acetonitrile)palladium(II) chloride.
2.2 Further Evidence for the Directing Effect and Enhancement of 
Stereoselectivity
2.2.1 Synthesis and Rearrangement of MOM-ether Analogues.
The results so far strongly suggest that the high diastereoselectivity observed in these 
rearrangement reactions are the result of the ether oxygen atoms coordinating to the 
palladium catalyst and directing it to one face of the olefin ultimately resulting in a highly 
selective reaction. However, further evidence for this effect was required and so an 
investigation of the palladium(II)-catalysed rearrangement of a carbon analogue of the 
most diastereoselective MOM-ether substrate was carried out.
This carbon analogue of the MOM-ether substrate was synthesised with the aid of Myer’s 
pseudoephedrine chiral auxiliary (Scheme 64).68 Acylation of (lR,2R)-(-)- 
pseudoephedrine 163 with hexanoic anhydride in THF produced amide 164 in quantitative 
yield. Myers reported a fast oxygen-nitrogen shift of the alkyl group and so only the 
desired product 164 was observed.68 Amide 164 was then deprotonated at C-2 with lithium 
diisopropylamine (LDA). Two equivalents of LDA were required as the secondary alcohol 
is also deprotonated. Methylation of the resulting enolate with methyl iodide gave the 
desired 2R isomer 165 in 99% yield. Cleavage of the chiral auxiliary to give the primary 
alcohol 166 was then carried out using the milder variant of LiAlH4, lithium ammonia- 
borane (LAB).68 A subsequent one pot Swem oxidation-HWE reaction produced the a,|3- 
unsaturated ester 167 regioselectively with only the E-geometrical isomer observed by [H 
NMR spectroscopy.63 Reduction of the a,p-unsaturated ester 167 to the E-allylic alcohol 
168 was carried out using 2.2 equivalents of DIBAL-H. Finally, reaction with sodium 
hydride and trichloroacetonitrile gave allylic trichloroacetimidate 169 for the 
rearrangement reaction.64
Me
P h ^ A NH 
OH Me
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Hexanoic
anhydride
100%
Me O
OH Me
164
'C02Et
167
DIBAL-H (2.2 equiv.) 
Et2 0, -78 °C to RT 45%
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LiCI' Mel P h ^ A
99%
N
OH Me
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LiH2 NBH3  
THF, -78 °C
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triethyl phosphonoacetate, 
LiCI, DBU, MeCN
34%
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2) CI3CCN
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Scheme 64: Synthesis of MOM-ether carbon analogue.
The catalysed rearrangement reaction was carried out in THF at room temperature for 12 
hours using bis(acetonitrile)palladium(II) chloride (10 mol%) producing the 
trichloroacetamides 170a and 170b in 59% combined yield, over two steps and in a ratio of 
1:2 (3R:3S) (Scheme 65).59
HN^ .0
PdCI2 (MeCN) 2  
THF, RT
59%
169 170a 1 :2
H N ^O
CCI3
170b
Scheme 65: Rearrangement of MOM-ether carbon analogue.
The dihedral angle (({)) between two adjacent protons in a compound can be calculated 
theoretically using the Karplus equations (Figure 14) and the vicinal coupling constants 7ab 
obtained from the ‘H NMR spectra. This allows the assignment of relative stereochemistry 
of compounds such as 170a and 170b.65
Jab = J° cos2  (j) - 0.28 (0° < (j) < 90°)
Jab = J 1 8 0  cos2  (J) - 0.28 (90° < (j) < 180°)
(J1 8 0  and are constants which depend upon 
the substituents on the carbon atoms)
Figure 14: Karplus equations.
However the J3A coupling constants could not be obtained from the 'H NMR spectra of 
trichloroacetamides 170a and 170b, even using a variety of deuteriated solvents and so the 
syn- and anft'-diastereomers could not be assigned using the Karplus equations.65 
However, the diastereoselectivity observed for the MOM substrate (10:1) has been lost 
with the carbon analogue (1:2) and so this is additional proof that the rearrangement is an 
ether directed process and not directed by the steric bulk of the substituents on C-4.
This result demonstrates that without an ether oxygen in the 6-position to direct the 
palladium catalyst the reaction proceeds with low selectivity. The most likely major 
pathway for this reaction can be explained by reacting confomer (Scheme 66). Initially the 
palladium catalyst coordinates to the least hindered front face of the olefin, the 
trichloroacetimidate then adopts a chair-like configuration which minimises 1,3-allylic 
strain and the imidate nitrogen attacks the olefin from the back face to give the sy«-isomer 
as the major product.
HN. .O
[Pd] l HN. 1-fo -[Pd]
H N ^O
CCI3
170b
Scheme 66: Transition state for the non-coordinating aza-Claisen rearrangement.
During discussions about the ether-directed aza-Claisen rearrangement it was suggested 
that a hydroxyl functional group in place of the MOM-ether would coordinate more 
strongly to the palladium(II)-catalyst resulting in a more diastereoselective reaction.
Thus, our aim was the synthesis of 6-hydroxy substituted allylic trichloroacetimidate 171 
(Scheme 67). Allylic alcohol 140 was synthesised as described above from ethyl (S)- 
lactate 121. Subsequent reaction with DBU and trichloroacetonitrile gave
trichloroacetimidate 146. This transformation can be carried out using sodium hydride as 
base.64 However, it was found that the use of DBU as base and filtering the crude reaction 
mixture through a small plug of silica is more reliable, giving allylic trichloroacetimidates 
in higher yields.57 The silyl ether protecting group was then removed using TBAF to give 
the desired allylic trichloroacetimidate 171. The catalysed rearrangement reaction was 
carried out in THF at room temperature using bis(acetonitrile)palladium(II) chloride (10 
mol%).59 Trichloroamides 159a and 159b were produced in 31% yield over three steps, 
and in a ratio of 4:1 (3R,3S).
OH
OTBDMS
OH
140
OH
DBU, CI3CCN 
DCM, 0 °C
PdCI2 (MeCN) 2  
THF, RT
31% over 
three steps
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HN^ .O
TBAF
OH
HNU .0
Scheme 67: Synthesis and rearrangement of hydroxyl compound.
The diastereoselectivity of this rearrangement (4:1) is significantly lower than that 
observed for the rearrangement of the MOM-ether substrate (10:1). This result therefore 
conflicts with the ideal that the free hydroxyl group would coordinate more strongly to the 
palladium(II)-catalyst and give a more selective reaction. Some other effect must therefore 
be assisting the MOM-ether in directing the palladium(II)-catalyst during the reaction. 
Thus, it was proposed that the oxygen in the 7-position of the MOM-ether substrate could 
be assisting coordination of the catalyst giving the observed enhancement of selectivity.
In order to specifically investigate this theory and, which of the oxygens in the MOM-ether 
group are responsible for coordinating to and directing the palladium(II)-catalyst during 
the rearrangement, the synthesis and rearrangement of two MOM-ether substrate analogues 
172 and 173 was carried out (Figure 15). This would effectively show whether both of the 
oxygen atoms can bind to and coordinate the palladium(II)-catalyst independently and also 
whether both oxygen atoms are required for the enhanced selectivity observed for the 
MOM-ether substrate. Additionally, these two substrates, the carbon analogue and the
MOM-ether substrate are all of similar size. Therefore, if steric bulk is responsible for the 
selectivities in these rearrangements, very similar results in diastereoselectivity would be 
expected for all four substrates. However, if the directing effect is responsible, the 
diastereoselectivities should be very different. Thus, this study will conclusively 
demonstrate whether the selectivity for these rearrangement reactions is caused by a 
directing effect, or by steric bulk as proposed by Ham and co-workers.55
CCI3 CCI3
172 173
Figure 15: MOM-ether analogues.
The trichloroacetimidate analogue of the MOM-ether substrate containing the oxygen atom 
at the 5-position 172 was synthesised from ethyl (^-lactate 121 in six steps (Scheme 68). 
Protection of alcohol 121 was carried out using sodium hydride and allyl bromide 174. 
The alkene was then hydrogenated using hydrogen and 10% palladium on carbon to give 
the propyl protected lactate 176.69 Reduction of the ester moiety of 176 to the alcohol 177 
was carried out using 2.2 equivalents of DIBALrH.61 A subsequent one pot Swem-HWE 
reaction, under Masamune-Roush conditions, produced the a,p-unsaturated ester 178.62,63 
Reduction of the a,p~unsaturated ester 178 to allylic alcohol 179 was carried out again 
using 2.2 equivalents of DIBAL-H. Finally, trichloroacetimidate 172 was synthesised 
from alcohol 179 using DBU and trichloroacetonitrile.57
OH
^ C 0 2Et
121
NaH, THF
Br'
174
100%
o
178
DIBAL-H (2.2 equiv.) 
Et2 0, -78 °C to RT 66%
'O
179
'9  H2, Pd/C
^ C 0 2Et 71% 'C 02Et
175 176
DIBAL-H (2.2 equiv.) 
Et2 0, -78 °C to RT 51%
DMSO, (COCI)2) NEt3  
-78 °C, then
triethyl phosphonoacetate, 
LiCI, DBU, MeCN
41%
DBU, CI3CCN 
DCM, 0 °C
HI\U .0
Scheme 68: Synthesis of MOM-ether analogue with oxygen in 5-position.
The trichloroacetimidate analogue of the MOM-ether substrate containing only the oxygen 
in the 7-position was synthesised with the aid of Myer’s peusdoephedrine chiral auxiliary 
(Scheme 69).68 y-Butyrolactone 180 was reacted with sodium and methanol to give 4- 
methoxybutanoic acid 181.70 Carboxylic acid 181 was activated as the mixed anhydride 
and reacted with A-acetylation of (-)-(lR,2R)-peusdoephedrine 163 to give amide 182 in 
97% yield over the two steps. Amide 182 was then deprotonated at C-2 with LDA. 
Methylation of the resulting enolate with methyl iodide gave the desired amide product 
183 in 65% yield.68 Reduction of the pseudoephedrine amide to form aldehyde 184 was 
achieved using Brown and Tsukamoto’s lithium triethoxyaluminium hydride reagent.71 
The reaction was quenched with trifluoroacetic acid in 1M aqueous hydrochloric acid 
solution in order to complete the conversion of an aminal to the desired aldehyde.68 Due to 
the volatile nature of the aldehyde produced it was reacted directly in a Horner- 
Wadsworth-Emmons reaction, under Masamune-Roush conditions,62 producing a,p- 
unsaturated ester 185 with only the E-geometrical isomer observed by !H NMR 
spectroscopy. Reduction of a,p-unsaturated ester 185 to allylic alcohol 186 was carried 
out using 2.2 equivalents of DIBAL-H. Finally, trichloroacetimidate 173 was prepared 
from alcohol 186 using DBU and trichloroacetonitrile.57
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Scheme 69: Synthesis of MOM-ether analogue with oxygen at 7-position.
With both allylic trichloroacetimidates in hand, the rearrangement reactions were carried 
out using bis(acetonitrile)palladium(II) chloride (10 mol%) in THF at room temperature 
(Table 7).59
The allylic trichloroacetimidate substrate containing the oxygen atom at the 5-position 
underwent the rearrangement reaction to give the corresponding trichloroacetamide 
products 187a and 187b in 77% yield over the two steps from allylic alcohol 179 and in a 
ratio of 5:1 (3R,3S) (entry 3).
Rearrangement of the allylic trichloroacetimidate substrate containing the oxygen atom at 
the 7-position gave the allylic trichloroacetamide products 188a and 188b in 60% yield 
over the two steps and in a ratio of 1:2 (3R,3S) (entry 4).
Like the carbon analogue, allylic trichloroacetamides 188a and 188b could not be 
converted to the corresponding oxazolidin-2-ones in order to determine the relative 
stereochemistry using NOE. However, careful comparison of the *H NMR spectra of these
two products with the other allylic amides produced in this study shows clearly that the 
peaks for 1-H2, 2-H and 5-H3 are especially distinctive for the two diastereomers a and b. 
Therefore, diastereomer b was confirmed as the major compound produced from the 
rearrangement of the carbon analogue 168 and allylic trichloroacetimidate 173 by careful 
examination of the !H NMR spectra.
Table 7: Rearrangement of MOM-ether analogues.
HI\U .O
PdCI2 (MeCN) 2  
THF, RT
R
H N ^ O  + H N ^ O
CCI3  CCI3
a b
Entry R group Yield9  (%) Ratio6  (a : b)
'O O (157) 64% 10 : 1
(170) 59% 1 : 2
'O (187) 77% 5 :1
'O' (188) 60% 1 : 2
a Isolated combined yields of a and b from E-allylic alcohols. 
6  Ratio in crude reaction mixture.
Rearrangement of allylic trichloroacetimidate 150 gave the allylic trichloroacetamide 
products 157a and 157b in an excellent 10:1 ratio (entry 1). On the other hand, the carbon 
analogue 169 produced the rearrangement products 170a and 170b in low 
diastereoselectivity (1:2) and so the directing effect has been lost (entry 2). This was also 
observed with the rearrangement of allylic trichloroacetimidate 173 to give rearrangement 
products 188a and 188b. Allylic trichloroacetimidate 172 gave a similar ratio of 
diastereomers as the hydroxyl compound 171 (5:1).
In the case of the carbon analogue no directing effect is observed and so the 
diastereoselective outcome of the rearrangement is controlled by the steric effects of the 
substituents on C-4. The catalyst therefore coordinates to the least sterically hindered front 
face of the olefin and forces the imidate nitrogen to attack the resulting activated olefin
from the back face (Scheme 66). The sy«-diastereomer b is therefore produced as the 
major product.
The same diastereomeric ratio was obtained for the rearrangement of trichloroacetimidate 
173 and so this suggests that the oxygen atom in the 7-position can not independently 
coordinate to and direct the palladium(II)-catalyst during the rearrangement reaction. 
Rearrangement of allylic imidate 172 (5:1) and the hydroxyl substrate 171 (4:1) gave 
similar results, with the tmft-diastereomer now being produced as the major product. This 
demonstrates that the oxygen atom in the 5-position effectively coordinates to the 
palladium(II)-catalyst and directs it to the back face of the olefin. Thus, the imidate is 
forced to attack the activated olefin from the front face and so the arcfr'-diastereomer is 
produced as the major product (Scheme 63).
The same effect is observed with the MOM-ether substrate 150. However, greatly 
increased selectivity is observed with this substrate (10:1). It is believed that the oxygen 
atom in the 7-position must therefore assist the oxygen atom in the 5-position in 
coordinating to and directing the palladium(II)-catalyst during the rearrangement of this 
substrate as shown in reacting confomation 189 and so an enhancement of selectivity is 
observed (Scheme 70).
- 0 ^ 0  H - 0 ^ 0
[Pd] ' [Pd]
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Scheme 70: Transition state for the MOM-ether directed aza-Claisen rearrangement.
These four substrates are very similar in size and yet undergo palladium(II)-catalysed 
rearrangement to give very different diasteromeric ratios of the corresponding allylic 
trichloroacetamides. This, therefore, provides conclusive evidence that the 
diastereoselectivities observed for the palladium(II)-catalysed rearrangements of chiral 
allylic trichloroacetimidates, with a heteroatom a  to the olefin, are the result of a 
heteroatom-directed process and not controlled by the steric bulk of the C-4 substituents. 
Having demonstrated that both oxygen atoms in the MOM-ether substrate coordinate to the 
palladium(II)-catalyst leading to a highly selective reaction, a brief attempt was made to 
investigate whether other heteroatoms in the 7-position could enhance this selectivity.
A methylthiomethyl (MTM)-ether analogue of the MOM-ether substrate 150 was therefore 
prepared. The hypothesis for using this substrate was that the sulfur atom would
coordinate more strongly to the palladium(II)-catalyst, thus giving an enhancement of 
selectivity.
The MTM-ether allylic trichloroacetimidate 194 required for the rearrangement reaction 
was prepare from ethyl (5)-lactate 121 (Scheme 71). The MTM-ether 190 was synthesised 
from ethyl (S)-lactate 121 by reaction with chloromethylmethyl sulfide and silver nitrate in 
21% yield.72 Procedures for the efficient synthesis of MTM-ethers from primary and 
tertiary alcohols are known.73 However the synthesis of MTM-ethers from secondary 
alcohols has previously been shown to be low yielding.72 The reaction procedure involving 
silver nitrate was therefore carried out on a large enough scale to produce sufficient 
amounts of MTM-protected lactate 190 to complete the synthesis of allylic 
trichloroacetimidate 194. The MTM protected lactate 190 was then reduced to the 
corresponding alcohol 191 using 2.2 equivalents of DIBAL-H.61 (£)-a,|3-Unsaturated ester 
192 was then synthesised using a one-pot, Swem oxidation-HWE reaction.63 Reduction, 
again using 2.2 equivalents of DIBAL-H gave the desired allylic alcohol 193. Finally, 
treatment of allylic alcohol 193 with DBU and trichloroacetonitrile provided allylic 
trichloroacetimidate 194.57
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Scheme 71: Syntheis of MOM-ether thio-analogue.
The aza-Claisen rearrangement of allylic trichloroacetimidate 194 was attempted at room 
temperature using bis(acetonitrile)palladium(II) chloride (10 mol%) in THF (Scheme 12).59 
However, after 72 hours only starting material was observed by ]H NMR spectroscopy. 
Having previously demonstrated that gold(III) and platinum(II) complexes can also 
catalyse this type of rearrangement, the reaction was repeated using platinum(II) chloride 
and hydrogen tetrachloroaurate(III) hydrate. However, in both these reactions, only
starting material was observed in the ’H NMR spectra after 72 hours. Sulfur is known to 
poison heterogeneous catalysts and so inhibit catalysed reactions.74 This may be the case 
with the MTM-substrate 194.
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Scheme 72: Attempted rearrangement of MTM-substrate 194.
2.2.2 Solvent Effects in the ether-directed, Palladium(II)-Catalysed aza- 
Claisen rearrangement.
Having conclusively shown that the rearrangements are ether-directed and since all the 
rearrangement reactions to date have been carried out in THF, it was suggested that as 
THF is an ether, this solvent may compete with the MOM group for the coordination of the 
Pd(II)-catalyst and thus restrict the directing effect. Using a non-coordinating solvent 
should therefore decrease this effect and lead to an enhancement of the diastereoselectivity 
observed. The rearrangement of 150 was therefore repeated with 
bis(acetonitrile)palladium(II) chloride and various solvents (Table 8). As mentioned 
above, bis(acetonitrile)palladium(II) chloride is soluble in organic solvents and so the 
reactions were complete in 24 h. Changing the solvent to diethyl ether and 
dichloromethane gave an increase in diastereoselectivity to 12:1. However, the largest 
increase in diastereoselectivity was observed with toluene as solvent. The reaction 
produced the allylic trichloroamides 157a and 157b in an excellent 15:1 ratio and in 56% 
yield. The reaction was also repeated using a highly coordinating solvent, the 
commercially available ionic liquid, l-butyl-3-methylimidazolium tetrafluoroborate. The 
increased viscosity of the ionic liquid compared with the other organic solvents led to a 
longer reaction time of 146 h. However, the allylic trichloroacetamides 157a and 157b 
were still isolated in 37% yield over the two steps and more importantly in a ratio of 5:1, 
effectively demonstrated that a strongly coordinating solvent can disrupt coordination of 
the palladium(II)-catalyst to the MOM-ether and decrease diastereoselectivity.
Table 8: Rearrangement of allylic trichloroacetimidate 150 using various solvents.
OMOM PdCI2(MeCN)2 OMOM OMOM 
( 1 0  m ol% )
H N ^ O
CCI3
150
S o lven t
H N y D  T
CCI3
157a
H N ^ O
CCI3
157b
E ntry  S o lv en t R eac tio n  T im e (h) Y ielda R a tio *7 (a : b)
1 TH F 24 64% 1 0  : 1
2  E t20 24 47% 1 2  : 1
3 M eCN 24 32% 9 :1
4  C H 2 CI2 24 4 9% 1 2  : 1
5 T o lu en e 2 4 5 6% 15 :1
6  (BMI) BF 4 148 3 7% 5 :1
a Iso la ted  co m b in ed  y ie lds of 157a a n d  157b from  E-allylic 
a lcoho l 144.
b R atio  in c ru d e  reac tio n  m ixture.
In summary, conclusive evidence for the ether-directed, palladium(II)-catalysed aza- 
Claisen rearrangement has been obtained.
Rearrangement of a carbon analogue of the most diastereoselective MOM-ether substrate 
resulting in a loss of selectivity demonstrated that the diastereoselective rearrangement is 
an ether-directed process. Further more, by investigating the palladium(II)-catalysed 
rearrangement of two MOM-ether analogues and a hydroxyl substrate it was established 
that the oxygen atom in the 5-position is essential for this heteroatom-directed effect to be 
observed in the rearrangement. Also, the oxygen atom in the 7-position of the MOM-ether 
is able to assist the oxygen atom in the 5-position and so an enhancement in 
diastereoselectivity is observed for the palladium(II)-catalysed rearrangement of the 
MOM-ether substrate 150.
A brief investigation into the use of different heteroatoms was also attempted with the 
synthesis of a MTM-ether substrate. However, catalyst poisoning by the sulfur moiety 
prevented successful rearrangement.
Additionally, a study on the solvent utilised in the ether-directed, palladium(II)-catalysed 
aza-Claisen rearrangement revealed that the use of non-coordinating solvents such as 
toluene results in an enhancement of diastereoselectivity by minimising competition for 
coordination with the catalyst. Also, for the first time the rearrangement reaction was 
carried out using the highly coordinating ionic liquid, l-butyl-3-methylimidazolium 
tetrafluoroborate which disrupts binding of the palladium(II)-catalyst to the MOM-ether 
giving the allylic trichloroacetamide products with only moderate diastereoselectivity.
2.2.3 Future work on methodology development.
Future work on this project could be carried out towards the synthesis of allylic 
trichloroacetimidates containing ether protecting groups which give a more effective 
directing effect in the palladium(II)-catalysed aza-Claisen rearrangement.
For example, protection of ethyl (S)-lactate 121 using dihydropyran and toluenesulfonic 
acid would give tetrahydropyranyl (THP) ether lactate 195 which would be used in our 
general route to generate allylic trichloroacetimidate 196 (Scheme 73).60 aza-Claisen 
rearrangement of allylic trichloroacetimidate 196 would show whether the rigidity of the 
ring can push the two oxygen atoms closer together and thus result in a more effective 
directing effect.
TsOH
196
Scheme 73: Proposed synthesis of THP-substrate 196.
Additionally, protection of ethyl (5)-lactate 121 using 2-methoxypropene and 
toluenesulfonic acid would yield compound 197 that would again be used in our general 
route to prepare allylic trichloroacetimidate 198 (Scheme 74).60 Subsequent ether-directed, 
palladium(II)-catalysed aza-Claisen rearrangement would allow an investigation into 
whether the Thorpe-Ingold effect can force the two oxygen atoms together for a more 
effective directing effect.75
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Scheme 74: Proposed synthesis of 1-methyl-1-methoxyethyl ether substrate 198.
2.3 Application of Ether-directed, Pd(II)-catalysed aza-Claisen 
Rearrangement in Natural Product Synthesis.
Having developed an ether-directed, Pd(II)-catalysed aza-Claisen rearrangement it was 
decided to investigate the versatility of this reaction for the general synthesis of chiral 
allylic amides. The aim was to then utilise these compounds for the stereoselective 
synthesis of biologically important p-hydroxy-a-amino acids and alkaloids.
2.3.1 P-Hydroxy-a-amino acids.
p-Hydroxy-a-amino acids are an important class of molecules. They are defined as a- 
amino acids that contain a hydroxy group in the P-postion of the side chain. Not only are 
they classed as natural products in their own right, they are also found as constituents of 
more complex natural products and other biological and medicinally important 
molecules.76 For example, P-hydroxytyrosine and p-hydroxyphenylalanine moieties are 
found in medicinally important glycopeptide antibiotics, such as vancomycin,77 
bouvardin,78 and orienticins.79 P-Hydroxyleucine is found in lysobactin and MeBmt in 
cyclosporine.80 These highly functionalised small molecules have also been used as chiral 
building blocks for the asymmetric synthesis of p-lactams,81 p-fluoro a-amino acids82 and 
sugars.
As a result of their importance, a number of different methodologies have been employed 
for the asymmetric synthesis of P-hydroxy-a-amino acids. These include, asymmetric 
aldol,84 Sharpless asymmetric epoxidation,85 Sharpless asymmetric dihydroxylation,86 
Sharpless asymmetric aminohydroxylations,87 utilisation of chiral auxilaries such as 
oxazolidinones80,88 and oxazolidines,89 cycloaddition of chiral azomethine ylides,90 
enzymatic transformations,91 stereoselective hydrolysis of aziridine carboxylate esters,92 
sulfonamide mediated asymmetric Strecker reactions,93 imino [1,2]-Wittig rearrangements 
of hydroximates94 and various others.95 However, the majority of these methods involve 
the use of chiral auxiliaries or catalysts and involve multiple steps. Although most 
methods generate at least one of the chiral centres in an enantio-enriched form, few have 
also been able to generate a diastereoeselective reaction.
For example, Seebach and Blaser have synthesised a series of p-hydroxy-a-amino acids 
using a diastereoselective aldol reaction (Scheme 75).84a Reaction of oxazolidinone 199 
with lithium hexamethyldisilazide (LHMDS) gave the lithium enolate 200 that rapidly 
undergoes aldol additions to aldehydes. Quenching the reaction with acetic acid gave
compounds 201 in excellent diastereoselectivity (typically >98% d.e.). Subsequent 
deprotection in ethyl acetate, addition of water and evaporation gave the corresponding |3- 
hydroxy-a-amino acids 202. However, although both the L and D a-amino acids may be 
prepared asymmetrically, synthesis of the anti-isomers is not possible and so this restricts 
the scope of this method.
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Scheme 75: p-Hydroxy-a-amino synthesis using asymmetric aldol.
Evans and Weber used a chiral auxiliary approach for the synthesis of cyclosporine’s 
unusual p-hydroxy-a-amino, MeBmt 206.80 A stannous triflate mediated aldol reaction of 
compound 203 and a range of aldehydes gave the syn aldol product 204 which could be 
isolated as the oxazolidinthiones 205 in good yield and excellent diastereoselectivity after 
purification (> 99%) (Scheme 76). Oxazolidinethiones 205 were then converted to the 
corresponding p-hydroxy-a-amino acids 206 by transesterification, bismethylation and 
hydrolysis, giving the desired compounds in excellent yield. However, this methodology 
suffers from having multiple steps in order to reach the desired p-hydroxy-a-amino acids 
and only the jyrc-isomers may be prepared.
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Scheme 76: P-Hydroxy-a-amino acid synthesis using chiral auxiliary approach.
Wong and co-workers have utilised L-threonine aldolase for the preparation of a series of 
novel P-hydroxy-a-amino acids.91 Enzymatic aldol reaction of a series of aldehydes 208 
with glycine 207 was achieved producing a range of L-a-amino acids 209 (Scheme 77). 
However, the new chiral center at the p-position was not generated stereoselectively in 
these reactions.
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Scheme 77: P-Hydroxy-a-amino acid synthesis using an enzymatic aldol reaction.
Joullie and co-workers have utilised a regio- and diastereoselective asymmetric Sharpless 
aminohydroxylation strategy for the synthesis of a p-hydroxyphenylalanine derivative 
(Scheme 78).87a The 2-amino-3-hydroxyl functionality was inserted into a,p-unsaturated 
ester 210 using a Sharpless asymmetric aminohydroxylation to give regioisomers 211a and 
211b in a 7:3 ratio and excellent enantioselectivity. Deprotection of isomer 211a using 
trifluoroacetic acid (TFA) gave the desired P-hydroxy-a-amino acid 212 in 85% yield. 
Unfortunately, the aminohydroxylation reaction is highly substrate dependent and only the 
sy«-isomers may be prepared using this methodology.
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Scheme 78: P-Hydroxy-a-amino acid synthesis using Sharpless asymmetric
aminohydroxylation.
In conclusion, p-hydroxy-a-amino acids are an important class of molecules. They are 
found as constituents of complex natural products and other biological and medicinally 
important compounds. As such, a variety of different methods have been developed for 
the synthesis of p-hydroxy-a-amino acids. However, a short synthesis that is 
regioselective, diastereoselective and can produce both syn and anti isomers of P-hydroxy- 
a-amino acids is still desired. Therefore, this is likely to be the subject of further research
2.3.2 Retrosynthetic Analysis of P-hydroxy-a-amino acids.
Since the products of the ether-directed, palladium(II)-catalysed rearrangement are 
protected 1,2-aminoalcohols, conversion to p-hydroxy-a-amino acids can easily be 
envisaged.
The proposed retrosynthetic analysis of P-hydroxy-a-amino acids 213 is shown in Scheme 
79. Retrosynthesis of the p-hydroxy-a-amino acids 213 would lead back to the allylic 
trichloroacetamide 214 through oxidation of the alkene and deprotection of both the 
MOM-ether and trichloroacetamide groups. The C-3 chiral centre could then be generated 
asymmetrically by the ether-directed, palladium(II)-catalysed aza-Claisen rearrangement 
of allylic trichloroacetimidates 215. These allylic trichloroacetimidates 215 would be 
prepared from a-hydroxy esters 216 using the previously described general route to these 
compounds (Scheme 59). Further retrosynthesis would lead back to the commercially 
available a-amino acids 217. Not only would this constitute a new synthesis of these 
biologically important molecules, it would also allow the absolute stereochemistry of the 
rearrangement products to be confirmed.
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Scheme 79: Retrosynthetic analysis of p-hydroxy-a-amino acids.
2.3.3 Synthesis of P-hydroxy-a-amino acids.
a-Hydroxy esters that could be taken through the general route to form the 
trichloroacetimidate substrates for the rearrangement reaction were prepared. 
Commercially available a-amino acids, L-valine 218 and L-leucine 219 were converted to 
a-hydroxy esters 220 and 221 through initial formation of the diazonium salts, 
intramolecular displacement by hydrolysis under aqueous conditions followed by 
esterification using hydrochloric acid and methanol (Scheme 80).96 Carried out on a large 
scale this procedure gave sufficient quantities of product to complete the synthesis of the 
allylic trichloroacetimidates.
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Scheme 80: Synthesis of a-hydroxy esters.
a-Hydroxy ester 225 was prepared from L-malic acid 222 in 25% yield over four steps as 
described by Mi and co-workers (Scheme 81).97 Reaction of acetic anhydride, acetyl 
chloride and L-malic acid 222 gave (25)-acetoxysuccinic anhydride 223 in quantitative 
yield. Friedel Crafts acylation gave a-hydroxy-carboxylic acid 224 with the desired 2S 
configuration. Hydrogenolysis of the benzyl ketone 224 and esterification of the 
carboxylic acid using hydrochloric acid and methanol gave (25)-hydroxy ester 225 in 46% 
yield over the two steps.
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Scheme 81: Synthesis of phenyl a-hydroxy ester.
With the three a-hydroxy esters in hand, synthesis of the trichloroacetimidates 238-240 
was achieved using the route described in scheme 82. MOM protection of a-hydroxy 
esters 220, 221 and 225 was achieved using bromomethyl methyl ether and Hiinig’s base.60 
Previous reported examples of this protection were carried out using the Williamson 
methodology,60 however this reaction uses less toxic reagents and gives higher yield. 
Protection of this alcohol was also attempted using methodology described by Gras et al 
using dimethoxymethane, lithium bromide and p-toluenesulfonic acid.98 However, by 
varying the reaction conditions and equivalents of reagents no higher than 50% conversion 
was observed. The MOM protected a-hydroxy esters 226-228 were then reduced using 
2.2 equivalents of DIBAL-H to give the corresponding alcohols 229-231 in good yields.61 
These were then converted to E-allylic esters 232-234 using a one-pot, Swem oxidation- 
HWE reaction.63 Reduction, again using 2.2 equivalents of DIBAL-H gave allylic alcohols 
235-237. Finally, treatment with DBU and trichloroacetonitrile provided allylic 
trichloroacetimidates 238-240, the substrates required for the directed aza-Claisen 
rearrangement.57
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Scheme 82: Synthesis of amino acid derived trichloroacetimidates.
The aza-Claisen rearrangement of E-allylic trichloroacetimidates 238-240 was carried out 
at room temperature using bis(acetonitrile)palladium(II) chloride as catalyst (Table 9).59
Table 9: Rearrangement of amino acid derived trichloroacetimidates.
OMOM
HN.v .0
PdCI2(MeCN)2 
THF, RT R
OMOM
HI\L ^.0
OMOM
H N ^ O
CCI3
OMOM
O yN H
CCI3
Entry R group Yield3 (%) Ratiofc (a : b : c)
'Pr(241)
'Bu (242) 
PhCH2CH2 (243)
58%
60%
65%
0 : 1 : 2  
14:1 :1 
9 : 1 : 4
a Isolated combined yields of a and b from E-allylic alcohols. 
b Ratio in crude reaction mixture.
As reported above, rearrangement of substrate 150 (R = Me) gives an excellent 10:1 ratio 
of diastereomers 157a and 157b ([3,3]-Claisen products) in 64% yield. However, the 
palladium(II)-catalysed rearrangement of allylic trichloroacetimidate 238 requires 48 hours 
for completion of the reaction and gave allylic trichloroacetamide 241b and the [1,33- 
rearrangement product 241c (anti-Claisen) as the major products in a ratio of 1:2 
respectively. Trace amounts of an elimination by-product were also observed by *H NMR 
spectroscopy. Unexpectedly, none of the usual (3R,45)-diastereomer 241a was produced 
from this rearrangement.
As described in the introduction chapter, the groups of Ikariya and Bosnich have 
investigated the mechanism of the aza-Claisen rearrangement using different palladium 
catalysts.34,27c Both groups found that palladium(O) complexes catalyse the rearrangement 
by a non-concerted ionisation mechanism to yield a mixture of [l,3]-product (anti-Claisen) 
and [3,3]-product (Claisen) (Scheme 28). The isolation of the [l,3]-product has also been 
reported by Overman and co-workers.27a
The relatively slow reaction rate and fomation of both the [1,3]-product and elimination 
by-product suggests that the ether-directed, palladium(II)-catalysed rearrangement of 
allylic trichloroacetimidate 238 is suppressed by the steric bulk of the isopropyl group 
(Figure 16).
CCI3
Figure 16: Suppresion of ether-directed, Pd(II)-catalysed rearrangement of allylic 
trichloroacetimidate.
This steric hinderence will also slow the rate of the pathway to the (35,45)-diastereomer 
241b. This isomer is produced when the palladium(II)-catalyst coordinates to the less 
sterically hindered front face of the olefin, forcing the imidate nitrogen to the back face of 
the now activated olefin, thus yielding the syrc-diastereomer.
According to the work of Ikariya and Bosnich, the major product from this reaction must 
be produced from a palladium(O)-catalysed [1,3] rearrangement (Scheme 83).34,27c It is 
therefore proposed that trace amounts of a palladium(O) complex is produced via a 
competing |3-elimination process during the slow palladium(II)-catalysed rearrangement of 
allylic trichloroacetimidate 238. This palladium(O) complex can then very quickly catalyse 
the [1,3]-rearrangement to give compound 241c as the major product from this reaction.
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Scheme 83: Pd(0) catalysed allylic substitution reaction.
Fortunately, allylic trichloroacetimidates 239 and 240 underwent the ether-directed, 
palladium(II)-catalysed aza-Claisen rearrangement to give the desired allylic 
trichloroacetamides 242a and 243a in good yield and excellent diastereoselectivity (>14:1) 
(Table 9).
trichloroacetimidates 239 and 240 is far enough away that the ether-directed rearrangement 
can take place.
However, notable quantities of the [1,3] rearrangement products were still produced during 
these rearrangements. These reactions therefore, must be slow enough for trace amounts 
of palladium(O) to be produced and catalyse the [1,3] rearrangement. Therefore, in an 
attempt to optimise the yields of these reactions a suitably mild oxidising agent was 
required which could rapidly re-oxidise palladium(O) to palladium(II) before the [1,3] 
rearrangement could take place. In the palladium(II)-catalysed oxidation of alkenes, p- 
benzoquinone is used frequently for this purpose.99,100 Thus, the palladium(II)-catalysed 
rearrangement of allylic trichloroacetimidates 239 and 240 were repeated in the presence 
of 2 equivalents of p-benzoquinone. Gratifingly, the [3,3]-products were produced with 
increased yields and again in excellent diastereoselectivity (Table 10).
Unlike the valine derived substrate 238, the sterically bulky moiety of the side chains in
Table 10: Rearrangements of with p-benzoquinone.
OMOM OMOM OMOM
paui2(MeuN)2 
THF, RT
Entry R group Yield9  (%) Ratio*’ (a : b)
1 'Bu (242) 73% 14:1
2  PhCH2 CH2  (243) 69% 9 :1
a Isolated combined yields of a and b from E-allylic alcohols. 
b Ratio in crude reaction mixture.
These reactions not only demonstrate that palladium(O) is produced during the 
palladium(II)-catalysed rearrangement of these substrates, but also that the competing 
palladium(0)-catalysed [1,3] rearrangement can be suppressed by using /7-benzoquinone as 
an additive in the reaction mixture.
The allylic amides produced from the MOM-ether directed, palladium(II)-catalysed aza- 
Claisen rearrangements were separated by column chromatography and the (3R,45)-allylic 
amides 157a, 242a and 243a were then converted to the corresponding (2S,3S)-|3-hydroxy- 
a-amino acids 249, 250 and 252 (Scheme 84). Allylic amide 243a was prepared and 
converted to its corresponding (21S,35)-P-hydroxy-a-amino acid 251 by a co-worker in the 
Sutherland group, Kate Fanning.101 Initially oxidation of the allylic carbon-carbon double 
bonds was attempted by ozonolysis,59 however this reaction failed to yield the desired 
products. Successful oxidation was carried out according to the Sharpless protocol using 
catalytic ruthenium(III) trichloride hydrate and sodium metaperiodate.102 The carboxylic 
acids 245-248 were then heated under reflux in 6 M hydrochloric acid resulting in 
deprotection of both the MOM and trichloroacetamide protecting groups. The resulting |3- 
hydroxy-a-amino acids 249-252 were purified by ion exchange chromatography giving the 
desired compounds in 48-67% yield over the two steps.59
The (2S,,35)-(3-hydroxy-a-amino acids gave spectroscopic data which was consistent with 
literature reports.103,104 The absolute stereochemistry of the major diastereomers produced 
from the ether-directed, palladium(II)-catalysed rearrangement could therefore be assigned 
as the (SR^Sj-diastereomers. This is therefore in agreement with previous stereochemical
assignment of the rearrangement products using NOE experiments on oxazolidin-2-one 
derivatives.
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Scheme 84: Synthesis of p-hydroxy-a-amino acids.
In summary, a novel asymmetric synthesis of P-hydroxy-a-amino acids has been achieved. 
These molecules are natural products and are also found as constituents of both drugs and 
more complex natural products. They are therefore an important class of compounds due 
to their interesting biological properties. The key step in the synthesis is an ether-directed, 
palladium(II)-catalysed aza-Claisen rearrangement which occurs with excellent levels of 
diastereoselectivity (s» 14:1). A limitation on the scope of this reaction was observed with 
the failed rearrangement of a valine derived substrate. The steric bulk of the isopropyl 
group hindering this ether-directed, palladium(II)-catalysed pathway. A competing [1,3]- 
rearrangement reaction catalysed via a palladium(O) pathway was suppressed using p- 
benzoquinone to re-oxidise palladium(O) back to palladium(II) thus resulting in higher 
yields for some substrates. Subsequent oxidation and deprotection of the rearrangement 
products completed this novel synthesis of the P-hydroxy-a-amino acids.
A limitation on the preparation of p-hydroxy-a-amino acids by this method is that only the 
anti-isomers may be synthesised. However, previous reported syntheses of p-hydroxy-a- 
amino acids have, in general, been for the sy«-isomers and so this method complements 
previous reported methods for the synthesis of these natural products.
2.3.4 Piperidine Alkaloids and a-Conhydrine.
Alkaloids are one of the most important classes of natural products. These are compounds 
that are synthesised by secondary metabolism in living organisms. Piperidine alkaloids are 
one of the most common groups of alkaloids, thus one of the most frequently occuring 
structural motifs found in nature is the piperidine ring.105 These structural building blocks 
have also been extensively utilised in the development of pharmacologically active 
agents.105 For example, several alkaloids containing a 2-(l-hydroxyalkyl)piperidine moiety 
have been shown to exhibit potent glycosidase inhibitor, antiviral and antitumor 
properties.106 Two such piperidine alkaloids are (+)-a-conhydrine 253 and (-)-P- 
conhydrine 254 (Figure 17). These natural products are found in the seeds and leaves of 
the poisonous Hemlock plant, Conium maculatum L.107
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Figure 17: Piperidine alkaloids (+)-a-conhydrine and (-)-p-conhydrine.
The biological and medicinal importance of these compounds has lead to a variety of 
synthetic methods being developed for their preparation and are mainly based on auxiliary- 
supported or chiral pool strategies.108,109
For example, Kumar and co-workers reported a stereoselective synthesis of (+)-a- 
conhydrine and (-)-|3-conhydrine from L-aspartic acid (Scheme 85).109a Amino aldehyde 
256 was prepared from L-aspartic acid 255 using literature procedures.110 
Diastereoselective alkylation of amino aldehyde 256 was then achieved using 
ethylmagnesium bromide to yield arcft'-diastereomer 257a. On the other hand, the syn- 
diastereomer 257b was prepared as a single isomer by reaction of amino aldehyde 256 
with diethylzinc. Subsequent protecting group manipulation, chain extension and 
reduction gave alcohol 258. Finally, cyclisation using methanesulfonyl chloride and 
triethylamine followed by Boc deprotection completed the synthesis of (+)-a-conhydrine 
253. (-)-p-conhydrine 254 was synthesised following the same route using the syn- 
diastereomer 257b.
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Scheme 85: Kumar and co-worker’s synthesis of (+)-a-conhydrine.
This therefore constituents a practical and stereocontrolled synthesis of both (+)-a- 
conhydrine and (-)-|3-conhydrine. Nevertheless, new stereoselective routes that can also be 
utilised to synthesise analogues of this important structural motif are still required.
2.3.5 Retrosynthetic Analysis of a-Conhydrine.
Having developed an ether directed, Pd(II)-catalysed aza-Claisen rearrangement and used 
it as the key step in a novel synthesis of p-hydroxy-a-amino acids, it was proposed that 
this chemistry could be used for the asymmetric synthesis of a series of nitrogen containing 
heterocycles including the piperidine alkaloid natural product (+)-a-conhydrine 253 
(Figure 18).
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Figure 18: Target alkaloid compounds.
The proposed retrosynthetic analysis of the piperidine alkaloid (+)-a-conhydrine 253 is 
shown in Scheme 86. Retrosynthesis of (+)-a-conhydrine 253 would lead back to allylic 
amine 261 via a ring closing metathesis (RCM) reaction. Trichloroacetamides 262 could 
be deprotected to the secondary amine and alkylated to give allylic amines 261. 
Derivatisation could be envisaged at this step by alkylation using different alkyl chains. 
The C-3 chiral centre could then be generated asymmetrically by the ether-directed, 
palladium(II)-catalysed aza-Claisen rearrangement of allyic trichloroacetimidate 263. The 
allyic trichloroacetimidate 263 could be prepared from alcohol 264 using the previously 
described general route to these compounds (Scheme 59). Further retrosynthesis would 
lead back to either the commercially available a-amino acid 265 or (^-glycidol 266. 
However, previous studies revealed that the preparation of compounds similar to 
alcohol 264 from a-amino acids are low yielding and so the synthetic route from (S)- 
glycidol 266 was chosen for this investigation.
The key steps in this synthesis was therefore an ether-directed, palladium catalysed aza- 
Claisen rearrangement reation to generate a new chiral centre and a RCM reaction to form 
the piperidine ring moiety. Not only would this constitute a new synthesis of this 
biologically important molecule, it would also allow for the synthesis of a series of 
analogues of (+)-a-conhydrine to be prepared.
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Scheme 86: Retrosynthetic analysis of the piperidine alkaloid (+)-a-conhydrine 253.
2.3.6 Synthesis of a-Conhydrine and Other Nitrogen Containing 
Heterocyclic Analogues.
The substrate for the directed rearrangement reaction, trichloroacetimidate 263 was 
prepared from (S)-glycidol 266 (Scheme 87). Silyl protection of (5)-glycidol 266 gave 
epoxide 267 which was reacted with methylmagnesium bromide and copper(I) bromide- 
dimethyl sulfide complex resulting in a regioselective copper Grignard epoxide ring- 
opening reaction giving alcohol 268, with the desired 2R stereocentre.111 The copper 
Grignard reagent preferentially attacks the least hindered carbon of the epoxide and so the 
C-2 methyl isomer was not observed by !H NMR spectroscopy. Protection of the alcohol 
moiety using bromomethyl methyl ether and Hiinig’s base gave MOM-ether 269 in 83% 
yield.60 The silyl protecting group was removed using TBAF to give alcohol 264 in 59% 
yield.60 A one-pot Swem oxidation-HWE reaction gave (£)-a,|3-unsaturated ester 270 in 
86% yield.63 Reduction of the ester functional group with 2.2 equivalents of DIBAL-H 
then gave allylic alcohol 271.61 Finally, trichloroacetimidate 263 was prepared using 
trichloroacetonitrile and DBU.57
TBDMSCI
imidazole
L>\^OTBDM S
MeMgBr
CuBr.SMe-
OTBDMS
266
88% THF
90% 268
MOMBr
EtN'Pr2  83% 
DCM "
DMSO, (COCI)2, NEt3  
-78 °C, then TBAF
  \^J^O TBD M S
59%
269
OH
270
C 02Et triethyl phosphonoacetate 
LiCI, DBU, MeCN
86%
264
DIBAL-H
(2 . 2  equiv.) 
Et20  
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DBU, CI3CCN 
DCM, 0 °C
Scheme 87: Synthesis of (S')-glycidol derived trichloroacetimidate.
Rearrangement of allylic trichloroacetimidate 263 was carried out at room temperature 
using the optimised conditions of bis(acetonitrile)palladium(II) chloride catalyst in toluene 
(Scheme 88). Trichloroacetamides 262a and 262b were produced in an excellent 16:1 
ratio and in 54% yield from the allylic alcohol 271. However, significant amounts (15% 
yield) of impurity 262c were produced during the reaction.
'O O
PdCI2(MeCN)2 
toluene, RT
H N ^ O
CCI3
263
H N y 0
CCI3
262a
OH
+ +
262b
16 : 1 : 3
262c
Scheme 88: Rearrangement of (S^-glycidol derived trichloroacetimidate.
Trichloroacetimidates 242 and 243 could be rearranged with the suppression of the 1,3 
(anti-Claisen) rearrangement by addition of /7-benzoquinone. This additive was able to 
reoxidise palladium(O), produced during the reaction, back to palladium(II). However, the 
addition of /7-benzoquinone did not suppress the formation of this impurity. This suggests 
that this impurity, produced by an unknown elimination pathway does not involve 
palladium(O).
The products of the rearrangement were separated by column chromatography and 
trichloroacetamide 262a was used to complete the synthesis of a-conhydrine 253 (Scheme 
89).
Hydrolysis of the trichloroamide functional group using cesium carbonate in DMF was 
attempted,112 however optimal yields were achieved using sodium hydroxide. Initially, 
attempts were made to alkylate the resulting amine using 4-bromobutene, however none of 
the desired product was produced. Further attempts were then made using the triflate 
derivative of 3-buten-l-ol. Even under various conditions, successful alkylation of this 
amine could not be achieved. The synthetic strategy was therefore modified and acylation 
of the amine was attempted. This change in strategy was deemed acceptable because it 
would allow for a further derivative of a-conhydrine to be prepared (discussed later). 
Acylation was successfully achieved via hydrolysis of the trichloroacetamide functional 
group using 2 M sodium hydroxide solution to give the secondary amine that was 
subsequently coupled to 3-butenoyl chloride using triethylamine as base to give amide 272 
in 52% yield over two steps (Scheme 89). Ring closing metathesis using Grubbs’ first 
generation catalyst gave unsaturated lactam 273 in quantitative yield.113 Hydrogenation
under standard conditions gave lactam 274. Finally, reduction of the amide functional 
group using boron-THF complex,114 followed by deprotection under acidic conditions 
completed the synthesis of (+)-a-conhydrine 253.
1) 2M NaOH
CCI3
262a
2) NEt3  Cl
O
52% over two steps
BH3 .THF
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H2, Pd/C
100%
273
Scheme 89: Synthesis of (+)-a-conhydrine 253.
This alternative synthesis of (+)-a-conhydrine via 6-lactam 274 allowed for the synthesis 
of a new analogue. Thus, the removal of the MOM-group of 6-lactam 274 gave 6-lactam 
260 (Scheme 90).
Scheme 90: Synthesis of 6-lactam analogue of (+)-a-conhydrine.
The pyrrolidine analogue of a-conhydrine was prepared in 6 steps from trichloroacetamide 
262a (Scheme 91). Hydrolysis of the trichloroacetamide functional group, again using 
sodium hydroxide solution followed by reprotection using di-terr-butyl dicarbonate gave 
carbamate 276 in 74% over two steps. Alkylation was achieved by a procedure developed 
by Hartley and co-workers in which sodium hydride was added portionwise to a solution 
of allyl bromide and carbamate 276 in DMF to give 277 in 72% yield.115 Ring closing 
metathesis using Grubbs’ first generation catalyst then gave dihydropyrrole 278.113 
Hydrogenation under standard conditions gave pyrrolidine 279 in good yield. Finally, 
removal of both the Boc- and MOM-protecting groups completed the synthesis of a- 
hydroxy-pyrrolidine 259. a-Hydroxy-pyrrolidine 259 was prepared as the hydrochloride 
salt for ease of purification and handling.
H N y D
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Scheme 91: Synthesis of pyrrolidine analogue of (+)-a-conhydrine.
In summary, the piperidine ring motif is one of the most common structural building 
blocks found in nature and has been extensively used in the development of 
pharmacologically active agents. A novel synthesis of the piperidine alkaloid (+)-a- 
conhydrine, along with two analogues of this compound has been achieved. The key steps 
in the synthesis of these compounds are an ether-directed, palladium catalysed aza-Claisen 
rearrangement reation which generated a new stereogenic centre with excellent 
diastereoselecitvity (16:1) and a RCM reaction which formed the heterocyclic ring.
2.3.7 Future work.
Future work on this project would include the synthesis of a 7-membered ring analogue of 
a-conhydrine (Figure 19). Pyrrolidine 259, a-conhydrine 253 and aza-cycloheptane 
analogue 280 could then be used in a structure-activity-relationship (SAR) study into the 
biological effect observed with varying ring size in these nitrogen containing heterocycles.
OH
280
Figure 19: Future target compound.
Preparation of aza-cycloheptane analogue of a-conhydrine could be envisaged from 
trichloroacetamide 262a (Scheme 92). Acetylation of trichloroacetamide 262a with 4- 
pentenoyl chloride would afford amide 281 which would undergo ring closing metathesis 
using either Grubbs’ first or second generation catalysts to give 7-membered lactam 282.113 
Hydrogenation under standard conditions would give the saturated lactam 283. Finally, 
reduction followed by deprotection under acidic conditions would give aza-cycloheptane 
280.114
OMOM
HN^ 0
CCI3
262a
1) 2M NaOH
2) NEt3  Cl
OMOM
OMOM OMOM
Scheme 92: Proposed synthesis of aza-cycloheptane analogue of a-conhydrine.
Other further future work in this area will be toward the stereoselective synthesis of 
polyhydroxylated pyrrolidines. This project will investigate a new approach for the 
synthesis of four polyhydroxylated pyrrolidines (Figure 20). Three of these 284-286 are 
known compounds and have been shown be potent inhibitors of mannosidases.116 The 
fourth compound 287 is a novel polyhydroxylated pyrrolidine.
284 285 286 287
Figure 20: Target polyhydroxylated pyrrolidines.
The synthesis of these compounds will again utilise the ether-directed, palladium(II)- 
catalysed aza-Claisen rearrangement to generate a new chiral centre and a RCM reaction to 
prepare the pyrrolidine ring system. The allylic trichloroacetimidate substrate 289 for the 
rearrangement reaction will be prepared in two steps from known compound 288 by 
DIBAL-H reduction to give the corresponding allylic alcohol, followed by treatment with 
DBU and trichloroacetonitrile to give the desired substrate 289 (Scheme 93). Based on our 
previous studies, allylic trichloroacetimidate 289 will undergo a highly diastereoselective 
ether-directed, palladium(II)-catalysed aza-Claisen rearrangement to yield predominantly 
diastereomer 290.
C 02Et
1) DIBAL-H
 -►
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288
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CCI3
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Scheme 93: Proposed synthesis of ally he amide 290.
The trichloroacetamide group of allylic amide 290 will then be cleaved and the resulting 
amine reprotected to give the carbamate 291 (Scheme 94). Subsequent alkylation using 
allyl bromide and sodium hydride would give tertiary amine 292.115 A RCM reaction using 
Grubbs’ first generation catalyst will then yield alkene 293, which is the key intermediate 
for the synthesis of all four polyhydroxylated pyrrolidines.
hnY °
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Scheme 94: Proposed synthesis of alkene 293.
Dihydroxylation of alkene 293 would then yield diols 294 and 295 which would then 
undergo acid deprotection to complete the synthesis of the two syrc-diol-pyrrolidine 
compounds 284 and 285 (Scheme 95).117
K2OSO4.2H2O
Scheme 95: Proposed synthesis of syrc-diol pyrrolidine compounds 284 and 285.
Similarly, oxidation of alkene 293 using MCBPA would give the corresponding epoxides 
297 and 298 (Scheme 96).118 A one-pot ring opening and deprotection procedure would 
then complete the synthesis of the two anti-diol pyrrolidine compounds 287 and 288.
mCPBA
BocN BocN
296 297
H2 S 0 4  ; H20  
♦
H2 S 0 4  i h 2o  
t
'OH
Scheme 96: Proposed synthesis of a/iri-diol-pyrrolidine compounds 286 and 287.
2.4 Conclusions
Synthesis and rearrangement of six chiral allylic trichloroacetimidates with various ether 
protecting groups in the 6-position demonstrated that the oxygen atom in this position can 
effectively direct facial coordination of the palladium(II)-catalyst during the aza-Claisen 
rearrangement with the MOM-ether substrate giving the most selective rearrangement 
reaction (10:1). The relative stereochemistry of the rearrangement products was then 
determined by a NOE study on oxazolidin-2-ones derived from the TBDMS-ether allylic 
trichloroacetamides produced from the directed rearrangement reaction.
Following this a range of electrophilic catalysts were screened in an attempt to enhance the 
stereoselectivity observed in these rearrangements. Bis(acetonitrile)palladium(II) chloride 
proved to be the best catalyst for this ether-directed, palladium(II)-catalysed aza-Claisen 
rearrangement on the basis of optimal rate of reaction, ease of purification, high yield and 
high diastereoselectivity.
Further evidence for the ether-directing effect was then obtained by the rearrangement of a 
series of chiral 6-substituted allylic trichloroacetimidate analogues of the most selective 
MOM-ether substrate. These experiments demonstrated that the diastereoselectivity of the 
reaction is controlled by the directing effect of an oxygen atom in the 5-position and not by 
steric bulk of substituents on C-4. Furthermore, the oxygen atom in the 7-position of the 
MOM-ether substrate can also coordinate to the palladium(II)-catalyst and so enhances the 
directing effect leading to a highly diastereoselective process (Scheme 70).
In order to further investigate the mechanism of this ether-directed rearrangement reaction 
a range of solvents were screened. An enhancement of stereoselectivity was observed 
using non-coordinating solvents such as toluene, which can minimise the competition 
between the solvent and ether group for coordination of the catalyst and also provides 
further evidence for the directing effect.
This methodology was then used as the key step in the novel diastereoselective synthesis 
of p-hydroxy a-amino acids from enantiopure a-hydroxy acids (Figure 21). During the 
rearrangement step, a competing [1,3] pathway catalysed by palladium(O) was suppressed 
using p-benzoquinone as an additive in the reaction mixture.
249 250 251 252
Figure 21: Successfully synthesised p-hydroxy a-amino acids.
Finally, a novel synthesis of the piperidine alkaloid (+)-a-conhydrine along with two 
analogues of this compound has been achieved using the ether-directed, palladium 
catalysed aza-Claisen rearrangement reaction as a key step in which to generated a new 
stereogenic centre with excellent diastereoselecitvity (16:1) (Figure 22). A RCM reaction 
was also used as a key step in this synthesis with which to form the heterocyclic ring 
moieties.
OH
HN.
253
(+)-a-Conhydrine
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259 260
Figure 22: Successfully synthesised alkaloid and analogues.
The ether-directed, palladium(II)-catalysed aza-Claisen rearrangement of allylic imidates 
with chiral heteroatoms in the 6-position is a highly diastereoselective process which 
occurs through a cyclisation induced mechanism. As such, the reaction is likely to be 
utilised in the synthesis of other complex natural products and medicinally important 
molecules.
Experimental Data and Characterisation of Compounds
General Experimental
All reactions were performed under a nitrogen atmosphere unless otherwise noted. 
Reagents and starting materials were obtained from commercial sources and used as 
received. Tetrahydrofuran (THF) and diethyl ether were distilled from sodium and 
benzophenone. Dichloromethane (DCM) and toluene are distilled from calcium hydride. 
Petroleum ether refers to petroleum ether (40-60). Lithium chloride was oven dried (110 
°C) for at least 12 h before use. Brine refers to a saturated solution of sodium chloride. 
Flash column chromatography was carried out using Fisher Matrex silica 60. Macherey- 
Nagel aluminium backed plates pre-coated with silica gel 60 (UV254) were used for thin 
layer chromatography and were visualised by staining with KMn04.
'H NMR and 13C NMR spectra were recorded on a Bruker DPX 400 spectrometer with 
chemical shift values in ppm relative to residual chloroform (6H 7.28 & 6C 77.2) as 
standard. J  values are given in Hz. Infrared spectra were recorded using Golden Gate 
apparatus on a JASCO FTIR 410 spectrometer and mass spectra were obtained using a 
JEOL JMS-700 spectrometer. Optical rotations were determined as solutions irradiating 
with the sodium D line (X= 589 nm) using an AA series Automatic polarimeter. [a]D 
values are given in units 10'1degcm2g'1.
1) Development of a synthetic route to six trichloroacetimidates with 
varying ether protecting groups.
General procedure 1: Williamson ether protection of ethyl (S)-lactate.60
NaH, R-X 
OH THF 0 °C PR'
R ^ C 0 2Et " R ^ C 0 2Et
Sodium Hydride (60% in mineral oil) (1.2 equiv.) was washed with petroleum ether ( 3 x 3  
mL). The grey powder was then suspended in THF and cooled to 0 °C. Ethyl (S)-lactate 
(1 equiv.) was then added dropwise and the solution was allowed to stir for 0.5 h. The 
alkyl halide (1.4 equiv.) was added and, after 0.75 h, the reaction mixture was allowed to 
warm to room temperature and stirred for 12 h. The reaction mixture was concentrated, 
acidified with 2 M hydrochloric acid (20 mL) and extracted with ethyl acetate (2 x 40 mL).
The organic layers were combined, dried (MgS04) and concentrated in vacuo. Purification 
was carried out by flash column chromatography using diethyl ether / petroleum ether as 
eluent.
General procedure 2a: DIBAL-H reduction to the aldehyde.61
DIBAL-H (1.1 equiv.)
Et2 0, -78 °C to RT 9R
---------------------------   * ' ^ Y h
o
The ester (1.0 equiv.) was dissolved in diethyl ether (30 mL) and cooled to -78 °C. 
DIBAL-H (1 M in hexane) (1.1 equiv.) was added dropwise and the reaction mixture was 
allowed to stir at -78 °C for 1 h then for 12 h at room temperature. The reaction mixture 
was cooled to 0 °C before being quenched by the addition of a saturated solution of 
ammonium chloride (20 mL), diluted with diethyl ether (30 mL) and warmed to room 
temperature with vigorous stirring over 1 h, producing a white precipitate. The precipitate 
was filtered through a pad of Celite® and washed with diethyl ether (3 x 100 mL). The 
filtrate was then dried (MgSOJ and concentrated in vacuo. Purification was carried out by 
flash column chromatography using diethyl ether / petroleum ether as eluent.
General procedure 2b: DIBAL-H reduction to the alcohol.61
DIBAL-H (2.2 equiv.)
OR Et2 0 , -78 °C to RT OR
R,/V"C02Et R'>n^ 0H
The ester (1.0 equiv.) was dissolved in diethyl ether (30 mL) and cooled to -78 °C. 
DIBAL-H (1 M in hexane) (2.2 equiv.) was added dropwise and the reaction mixture was 
allowed to stir at -78 °C for 1 h then overnight at room temperature. The reaction mixture 
was cooled to 0 °C before being quenched by the addition of a saturated solution of 
ammonium chloride (20 mL), diluted with diethyl ether (30 mL) and warmed to room 
temperature with vigorous stirring over 1 h, producing a white precipitate. The precipitate 
was filtered through a pad of Celite® and washed with diethyl ether (3 x 100 mL). The 
filtrate was then dried (MgS04) and concentrated in vacuo. Purification was carried out by 
flash column chromatography using diethyl ether / petroleum ether as eluent.
OR
R, / x C 02Et
General procedure 3a: Horner-Wadsworth-Emmons reaction.61
triethyl phosphonoacetate, ^  
? R LiCI, DBU, MeCN VH
R CHO R v  C 02Et
A suspension of lithium chloride (1.5 equiv.), triethyl phosphonoacetate (1.5 equiv.) and 
l,8-diazabicyclo(5,4,0)undec-7-ene (1.5 equiv.) in acetonitrile (30 mL) was stirred for 0.5 
h before being added to a solution of the aldehyde (1.0 equiv.) in acetonitrile (40 mL) and 
the reaction mixture was allowed to stir for 2 h at room temperature. The reaction mixture 
was concentrated in vacuo. The resulting residue was dissolved in ethyl acetate (100 mL), 
washed with water (2 x 70 mL), dried (MgS04) and concentrated in vacuo. Purification 
was carried out by flash column chromatography using diethyl ether / petroleum ether as 
eluent.
General procedure 3b: One-pot Swern-Horner-Wadsworth-Emmons reaction.62,63
DMSO, (COCI)2, NEt3  
OR- -78 °C, then qR'
triethyl phosphonoacetate, R '^ Vs/""Vv‘C0 2Et 
LiCI, DBU, MeCN
Methyl sulfoxide (2.4 equiv.) was added to a stirred solution of oxalyl chloride (1.2 equiv.) 
in DCM (20 mL) at -78 °C. This mixture was stirred for 0.25 h before the alcohol (1 
equiv.) in DCM (30 mL) was added. The mixture was stirred for a further 0.25 h before 
triethylamine (5 equiv.) was added. This reaction mixture was then allowed to stir for 2 h. 
Meanwhile, a solution of lithium chloride (1.5 equiv.), triethyl phosphonoacetate (1.5 
equiv.) and l,8-diazabicyclo[5,4,0]undec-7-ene (1.5 equiv.) in acetonitrile (30 mL) was 
prepared and stirred for 0.5 h. The ylide mixture was added to the Swern solution and the 
reaction mixture was allowed to stir at room temperature for 12 h. The reaction was 
quenched with brine (50 mL) then concentrated to give an orange residue. This residue 
was extracted with diethyl ether (5 x 50 mL) and the organic layers were combined, dried 
(MgS04) and concentrated to give an orange liquid. Purification was carried out by flash 
column chromatography using diethyl ether / petroleum ether as eluent.
General procedure 4: DIBAL-H reduction to allylic alcohol.61
OR1
DIBAL-H (2.2 equiv.) 
Et2 0, -78 °C to RT OR'
'C 02Et
The a,p-unsaturated ester (1.0 equiv.) was dissolved in diethyl ether (20 mL) and cooled to 
-78 °C. DIBAL-H (1 M in hexane) (2.2 equiv.) was added dropwise and the reaction 
mixture was allowed to warm to room temperature with stirring for 4 h. The reaction was 
cooled to 0 °C before being quenched by the addition of a saturated solution of ammonium 
chloride (20 mL), diluted with diethyl ether (30 mL) and warmed to room temperature with 
vigorous stirring over 1 h producing a white precipitate. The precipitate was filtered 
through a pad of Celite® and washed with diethyl ether (3 x 100 mL). The filtrate was then 
dried (MgS04) and concentrated in vacuo. Purification was carried out by flash column 
chromatography eluting with diethyl ether / petroleum ether.
General procedure 5: Allylic trichloroacetimidate synthesis using NaH and
subsequent metal catalysed rearrangement.64
Catalyst
THF
NaH
CI3CCN
CCI3  CCI3  CCI3
Sodium hydride (60% in mineral oil) (1.2 equiv.) was washed with petroleum ether (40- 
60) ( 3 x 3  mL), suspended in THF (20 mL) and cooled to 0 °C. A solution of the allylic 
alcohol (1.0 equiv.) in THF (6 mL) was then added slowly. After 0.5 h 
trichloroacetonitrile (1.2 equiv.) was added causing the formation of a light yellow colour. 
After 1 h the reaction mixture was warmed to room temperature and filtered through a 
short pad of aluminium oxide (neutral). This was washed with diethyl ether (20 mL) and 
the combined filtrate was concentrated in vacuo to give the desired allylic 
trichloroacetimidate, which was used without further purification. The allylic 
trichloroacetimidate was dissolved in THF (10 mL). Catalyst (10 mol%) was then added 
and the reaction mixture stirred for 24-48 h. Concentration in vacuo followed by 
purification by flash column chromatography eluting with diethyl ether / petroleum ether 
gave all products as brown oils.
General procedure 6: Allylic trichloroacetimidate synthesis and subsequent thermal 
rearrangement.59
OR NaHCI3 CCN
DCM HN>. . 0
A
p-xylene
OR OR
H N ^ O
CCI3
Sodium hydride (60% in mineral oil) (1.2 equiv.) was washed with petroleum ether (40- 
60) ( 3 x 3  mL), suspended in THF (20 mL) and cooled to 0 °C. A solution of the allylic 
alcohol (1.0 equiv.) in THF (6 mL) was then added slowly. After 0.5 h 
trichloroacetonitrile (1.2 equiv.) was added causing the formation of a light yellow colour. 
After 1 h the reaction mixture was warmed to room temperature and filtered through a 
short pad of aluminium oxide (neutral). This was washed with diethyl ether (20 mL) and 
the combined filtrate was concentrated in vacuo to give the desired allylic 
trichloroacetimidate, which was used without further purification. The crude 
trichloroacetimidate was dissolved in /7-xylene (20 mL) and heated to 140 °C for 24 h. The 
reaction mixture was concentrated in vacuo to give a brown oil. Purification by 
chromatography eluting with diethyl ether / petroleum ether gave the target compounds as 
brown oils.
General procedure 7: Allylic trichloroacetimidate synthesis using DBU and
subsequent metal catalysed rearrangement in THF as solvent.57,59
'O O 1)CI3 CCN, DBU DCM
2) Catalyst 
THF, RT
'O O 'O O
H N ^ O
CCI3
(2F,45)-4-Methoxymethoxypent-2-en-l-ol (2 mmol) was dissolved in DCM (10 mL) and 
cooled to 0 °C. l,8-Diazabicyclo[5,4,0]undec-7-ene (1.2 equiv.) and trichloroacetonitrile 
(1.5 equiv.) were then added and the mixture was allowed to warm to room temperature 
and stirred for 2 h. The reaction mixture was then filtered through a dry silica plug and the 
filtrate was concentrated in vacuo to give an orange liquid. The product was used without 
further purification. The allylic trichloroacetimidate was dissolved in THF (10 mL). 
Catalyst (10 mol%) was then added and the reaction mixture was stirred and monitored to 
completion by !H NMR spectroscopy. Concentration in vacuo followed by purification by
flash column chromatography eluting with 20% diethyl ether / petroleum ether gave the
target compounds.
General procedure 8: Allylic trichloroacetimidate synthesis using DBU and
subsequent bis(acetonitrile)palladium(II) chloride catalysed rearrangement in 
varying solvents.57,59
'O O
1)CI3 CCN, DBU 
DCM
2 ) PdCI2 (MeCN) 2  
Solvent
'O O
HN. ,0
+
H N ^ O
CCI3
(2£',4iS)-4-Methoxymethoxypent-2-en-l-ol (0.34 mmol) was dissolved in DCM (10 mL) 
and cooled to 0 °C. l,8-Diazabicyclo[5,4,0]undec-7-ene (1.2 equiv.) and
trichloroacetonitrile (1.5 equiv.) were then added and the mixture was allowed to warm to 
room temperature and stirred for 2 h. The reaction mixture was then filtered through a dry 
silica plug and the filtrate was concentrated in vacuo to give an orange liquid. The product 
was used without further purification. The allylic trichloroacetimidate was dissolved in 
solvent (10 mL). Bis(acetonitrile)palladium(II) chloride (10 mol%) was then added and 
the reaction mixture was stirred and monitored to completion by 'H NMR spectroscopy. 
Concentration in vacuo followed by purification by flash column chromatography eluting 
with 20% diethyl ether / petroleum ether gave the target compounds.
General procedure 9: Synthesis of a-hydroxy methyl esters.96
1) NaN02, H2 S 0 4  
; 2  2 ) MeOH, Toluene, HCI VH
R ^ C 0 2H " R ^ C 0 2Me
L-Amino acid (5 mmol) was dissolved in 2.5 M sulphuric acid (7.5 mmol) and then cooled 
to 0 °C. Sodium nitrite (7.5 mmol) in water (20 mL) was then added dropwise and the 
mixture was allowed to stir at room temperature for 12 h. The reaction mixture was then 
extracted using diethyl ether (3 x 50 mL) and also chloroform (3 x 50 mL). The combined 
organic layers were dried (MgS04) and concentrated in vacuo to give the a-hydroxy acid 
as a white solid. The a-hydroxy acid (5 mmol) was dissolved in toluene (40 mL) and 
methanol (25 mL). Concentrated hydrochloric acid (1 mL) was added and the reaction 
mixture was heated under reflux for 12 h. The reaction mixture was cooled to room
temperature and concentrated in vacuo. The resulting residue was neutralised with 
saturated sodium hydrogen carbonate solution (50 mL) and extracted with ethyl acetate (3 
x 50 mL). The combined organic layers were dried (MgS04) and concentrated. 
Purification by Kugelrohr distillation gave the a-hydroxy esters as colourless oils.
General procedure 10: Preparation of methoxymethyl ethers using Hiinig’s base.60
MOMBr
OH iPr2 NEt, DCM OMOM
R C 02Me R C 02Me
Af,Af-Diisopropylethylamine (1.5 equiv.) and bromomethyl methyl ether (1.5 equiv.) were 
added to a solution of the a-hydroxy ester (5 mmol) in DCM (20 mL). The reaction 
mixture was then heated under reflux for 12 h before being diluted with DCM (50 mL) and 
washed with 2 M hydrochloric acid solution (25 mL). The organic layer was dried 
(MgS04) and concentrated in vacuo. Purification was carried out by flash column 
chromatography using diethyl ether / petroleum ether to give the desired compounds as 
colourless oils.
General procedure 11: Allylic trichloroacetimidate synthesis and subsequent 
rearrangement with bis(acetonitrile)palladium(lI) chloride and p-benzoquinone.
OMOM
1)CI3 CCN, DBU 
DCM
2) PdCI2 (MeCN) 2  
THF
O O
OMOM OMOM
H N ^ O
CCI3
The allylic alcohol (2 mmol) was dissolved in DCM (20 mL) and cooled to 0 °C. 1,8- 
Diazabicyclo[5,4,0]undec-7-ene (0.2 equiv.) and trichloroacetonitrile (1.5 equiv.) were 
then added and the mixture was allowed to warm to room temperature and stirred for 2 h. 
The reaction mixture was then filtered through a dry silica plug and the filtrate was 
concentrated in vacuo to give an orange liquid. The product was used without further 
purification. The allylic trichloroacetimidate was dissolved in THF (10 mL). 
Bis(acetonitrile)palladium(II) chloride (10 mol%) and p-benzoquinone (2.0 equiv.) were 
then added and the reaction mixture was stirred for 24 h. Concentration in vacuo followed
by purification by flash column chromatography eluting with diethyl ether / petroleum
ether gave the target compounds as colourless oils.
General procedure 12: Ruthenium trichloride oxidation to carboxylic acids and 
deprotection to P-hydroxy-a-amino-acids.102
RuCI3 .H2 0, Nal03  ?MOM
CCI4 /MeCN/H20  R/ ^ C 0 2H 6  M HCI, A
OMOM
R^ r uu2n 6 m h c |. a d a ^ c o 2h 
HN^O R T
Y  n h 2
c c i 3
Sodium metaperiodate (4.1 equiv.) was dissolved in water (21 mL) and added to a solution 
of the trichloroacetamide (1 mmol) in carbon tetrachloride (14 mL) and acetonitrile (14 
mL). Ruthenium trichloride hydrate (5 mol%) was added and the mixture was stirred 
vigorously for 6 h before a further portion of sodium metaperiodate (1 equiv.) was added. 
The reaction mixture was then stirred vigorously for 12 h and then extracted with DCM (3 
x 40 mL). The organic layers were combined, dried (MgS04) and concentrated to give a 
viscous oil. The product was used without further purification. The carboxylic acid (1 
mmol) was dissolved in 6 M hydrochloric acid (20 mL) and heated under reflux for 12 h. 
The reaction mixture was then cooled before being extracted with diethyl ether (2 x 10 
mL). The aqueous layer was concentrated to give a brown liquid. Purification was carried 
out using an ion exchange column with Dowex® 50WX8-100 (20 g per mmol of 
substrate), eluting with 25% ammonia solution. Concentration gave the P-hydroxy-a- 
amino-acids as white solids.
Ethyl (2S)-2-te/t-butyldimethylsilyloxypropanoate (122).119
OH TBDMSCI riTDnno
? H imidazole QTBDMS
'x X^‘C02Et j|_|p •^ v C02Et
A mixture of ethyl (S)-lactate 121 (6.2 mL, 55.1 mmol), tert-butyldimethylsilyl chloride 
(9.98 g, 66.1 mmol) and imidazole (5.61 g, 82.6 mmol) in THF (65 mL) were stirred for 12 
h at room temperature forming a white precipitate. The precipitate was filtered and washed 
with ethyl acetate (20 mL). The combined filtrate was concentrated and purified by flash 
column chromatography (5% ethyl acetate / petroleum ether) giving ethyl (2S)-2-tert- 
butyldimethylsilyloxypropanoate 122 (12.7 g, 100%) as a white liquid. [a]D20 -31.1 (c 1.0,
CHC13), (Lit."9 [a]D20 -28.2 (c 0.6, CHC13)); 6H (400 MHz, CDC13) 0.00 (3H, s, SiCH3), 
0.03 (3H, s, SiCH3), 0.89 (9H, s, SiC(CH3)3), 1.26 (3H, t, J  7.2, OCH2Ctf3), 1.38 (3H, d, J
6.8 Hz, 3-H3), 4.16 (2H, m, OC//2CH3) and 4.30 (1H, q, J  6.8, 2-H); m/z (Cl) 233 (M H\ 
100%), 217 (7), 192 (5), 175 (6) and 134 (5).
(2S)-2-<ert-Butyldimethylsilyloxypropan-l-aI (128).119
DIBAL-H (1.1 equiv.)
OTBDMS Et2 0, -78 °C to RT OTBDMS
^ ^ C 0 2Et ^^C H O
The reaction was carried out according to general procedure 2a using ethyl (2S)-2-tert- 
butyldimethylsilyloxypropanoate 122 (13.8 g, 59.5 mmol) giving (2S)-2-tert-
butyldimethylsilyloxypropanal 128 (6.82 g, 61%) which was used without further 
purification. SH (400 MHz, CDC13) 0.00 (3H, s, SiCH3), 0.01 (3H, s, SiCH3), 0.83 (9H, s, 
SiC(CH3)3), 1.18 (3H, d, 7 6.8, 3-H3), 3.99 (1H, q, 7 6.8, 2-H) and 9.51 (1H, m, CHO).
Ethyl (2Zs,4S)-4-te#T-butyIdimethysilyIoxypent-2-enoate (134).120
rvrnnMio triethyl phosphonoacetate, nTRnMQQTBDMS LiC| DBUi MeCN QTBDMS
'^ C H O  ~ / ' ' ' ' ^ " 'C 0 2Et
The reaction was carried out according to general procedure 3a using (2S)-2-tert- 
butyldimethylsilyloxypropan-l-al 128 (6.82 g, 36.3 mmol). Purification was carried out by 
flash column chromatography (5% ethyl acetate / petroleum ether) giving ethyl (2E,4S)-4- 
tert-butyldimethysilyloxypent-2-enoate 134(7.59 g, 81%) as a colourless oil. [a]D21 +4.4 
(ic 1.0, CHC13), (Lit.120 [a]D22 +4.4 (c 1.2, CHC13)); 6H (400 MHz, CDC13) 0.08 (3H, s, 
SiCH3), 0.09 (3H, s, SiCH3), 0.93 (9H, s, SiC(CH3)3), 1.28 (3H, d, 7 6.4, 5-H3), 1.31 (3H, t, 
77.2, OCH2CH3), 4.21 (2H, m, OC//2CH3), 4.47 (1H, m, 4-H), 6.00 (1H, dd, 7 15.6, 2.0, 2-
H) and 6.94 (1H, dd, 7 15.6, 4.0, 3-H); m/z (El) 258.1652 (M+. CI3H260 3Si requires 
258.1651), 243 (9%), 201 (70), 173 (46), 103 (58) and 82 (100).
(2Zs,4S)-4-terf-ButyIdimethysilyloxypent-2-en-l-oI (140).121
OTBDMS
C02Et
DIBAL-H (2.2 equiv.) 
Et2 0, -78 °C to RT OTBDMS
The reaction was carried out according to general procedure 4 using ethyl (2E,4S)-4-tert- 
butyldimethysilyloxypent-2-enoate 134 (0.10 g, 0.4 mmol). Purification was carried out by 
flash column chromatography (50% ethyl acetate / hexane) to give (2E,4S)-4-tert- 
butyldimethysilyloxypent-2-en-l-ol 140 (0.05 g, 52%) as a colourless oil. [a]D23 +5.9 (c 
1.0, CHC13), (Lit.121 [a]D19 +3.7 (c 2.9, CHC13); v mJcrnA (neat) 3343 (OH), 2928 (CH), 
1720, 1252, 1080, 829 and 772; 6H (400 MHz, CDC13) 0.08 (3H, s, SiCH3), 0.09 (3H, s, 
SiCH3), 0.92 (9H, s, SiC(CH3)3), 1.24 (3H, d, J  6.3, 5-H3), 1.43 (1H, br s, OH), 4.16 (2H, 
d, J  6.0, 1-H2), 4.27 (1H, m, 4-H) and 5.72-5.84 (2H, m, 2-H and 3-H); 6C (100 MHz, 
CDC13) -4.4 (CH3), -4.2 (CH3), 18.7 (C), 24.7 (CH3), 26.3 (CH3), 63.6 (CH2), 68.9 (CH), 
127.6 (CH) and 136.8 (CH); m/z (Cl) 217.1626 (MH+. CnH250 2Si requires 217.1624), 175 
(2%), 159(8) and 133(12).
(3/?,4S)-3-(TrichIoromethyIcarbonyIamino)-4-(te/f-butyldimethyIsilyloxy)penta-l-ene 
(153a) and (3S,4S)-3-(trichIoromethylcarbonylamino)-4-(te/t-
butyldimethylsily!oxy)penta-l-ene (153b) from thermal rearrangement.
OTBDMS
H N ^ O  
CCI3
OTBDMS
1)CI3 CCN, NaH, DCM
2) p -xy lene , A
OTBDMS
HN. ^O
The reactions were carried out according to general procedure 6 using (2E,4S)-4-(tert- 
butyldimethylsilyloxy)pent-2-en-l-ol 140 (0.28 g, 1.33 mmol). Purification was carried 
out by flash column chromatography (30% ethyl acetate / petroleum ether) giving the title 
compounds 153a and 153b (0.13 g, 27% over two steps) as a yellow oil, in a ratio of 1 : 1 
(3R : 35). u j c m '1 (neat) 3426 (NH), 2929 (CH), 1721 (CO), 1498, 1255, 837 and 777; 
(3/?,45)-3-(trichloromethylcarbonylamino)-4-(terr-butyldimethylsilyloxy)penta-1 -ene 153a 
(major compound): SH (400 MHz, CDC13) 0.12 (3H, s, SiCH3), 0.14 (3H, s, SiCH3), 0.93 
(9H, s, SiC(CH3)3), 1.19 (3H, d, J  6.4, 5-H3), 4.06 (1H, m, 4-H), 4.29 (1H, m, 3-H), 5.33 
(2H, m, 1-H), 5.86 (1H, m, 2-H) and 7.13 (1H, br d, J  6.4, NH); 6C(100 MHz, CDC13) -4.5 
(CH3), -3.9 (C), -3.5 (CH3), 18.2 (C), 20.6 (CH3), 26.1 (CH3), 59.7 (CH), 69.8 (CH), 119.8
(CH2), 132.0 (CH) and 161.2 (C); (35,45)-3-(trichloromethylcarbonylamino)-4-(tert- 
butyldimethylsilyloxy)penta-l-ene 153b (minor compound): SH (400 MHz, CDC13) 0.09 
(3H, s, SiCH3), 0.12 (3H, s, SiCH3), 0.90 (9H, s, SiC(CH3)3), 1.23 (3H, d, J  6.4, 5-H3), 3.78 
(1H, m, 4-H), 4.31 (1H, m, 3-H), 5.27 (2H, m, 1-H2), 5.79 (1H, m, 2-H) and 7.23 (1H, br s, 
NH); Sc (100 MHz, CDC13) -4.4 (CH3), -3.9 (CH3), -3.5 (C), 21.7 (CH3), 18.4 (C), 26.2 
(CH3), 58.9 (CH), 70.1 (CH), 116.9 (CH2), 135.8 (CH) and 162.8 (C); m/z (Cl) 360.0722 
(MH+. C13H250 2NSi35Cl3 requires 360.0720), 290 (54%), 255 (33), 199 (100), 159 (27) and 
133 (48).
(3/?,4S)-3-(Trichloromethylcarbonylamino)-4-(te/f-butyldimethylsilyloxy)penta-l-ene 
(153a) and (3S,4S)-3-(trichloromethylcarbonyIamino)-4-(tert-
butyldimethylsily!oxy)penta-l-ene (153b) from bis(acetonitrile)palladium(II) chloride 
catalysed aza-Claisen rearrangement.
1)CI3 CCN, NaH, DCM 
OTBDMS 2) PdCI2 (MeCN)2, THF
OTBDMS OTBDMS
CCI3  CCI3
The reactions were carried out according to general procedure 5 using (2E,4S)-4-(tert- 
butyldimethylsilyloxy)pent-2-en-l-ol 140 (0.29 g, 1.32 mmol) then
bis(acetonitrile)palladium(II) chloride (10 mol%) in THF (10 mL). Purification was 
carried out by flash column chromatography (30% ethyl acetate / petroleum ether) giving 
the title compounds 153a and 153b (0.32 g, 68% over two steps) as a yellow oil, in a ratio 
of 2 : 1 (3R : 35). Spectroscopic data as above.
(3/?,4S)-3-(Trichloromethylcarbonylamino)-4-(te/T-butyldimethylsilyloxy)penta-l-ene 
(153a) and (3S,4S)-3-(trichloromethylcarbonyIamino)-4-(te/f-
buty!dimethylsilyIoxy)penta-l-ene (153b) from bis(benzonitrile)palladium(II) 
chloride catalysed aza-Claisen rearrangement.
OTBDMS OTBDMS
1 )CI3 CCN, DBU, DCM 
OTBDMS 2) PdCI2 (PhCN)2, THF
The reactions were carried out according to general procedure 5 using (2£,4S)-4-(tert- 
butyldimethylsilyloxy)pent-2-en-l-ol 140 (0.29 g, 1.33 mmol) then
bis(benzonitrile)palladium(II) chloride (10 mol%) in THF (10 mL). Purification was 
carried out by flash column chromatography (30% ethyl acetate / petroleum ether) giving 
the title compounds 153a and 153b (0.33 g, 68% over two steps) as a yellow oil, in a ratio 
of 2 : 1 (3R : 35). Spectroscopic data as above.
Ethyl (2S)-2-trityloxypropanoate (123).122
OH
TrCI, DBU 
DCM
'COoEt
OTr
^ C 0 2Et
Ethyl (S)-lactate 121 (3.5 g, 29.7 mmol) was added to a solution of triphenylmethyl 
chloride (9.9 g, 35.6 mmol) and l,8-diazabicyclo(5,4,0)undec-7-ene (6.2 mL, 41.5 mmol) 
in DCM (130 mL). The reaction mixture was allowed to stir for 48 h before being 
quenched with water (100 mL). The organic layer was separated and the aqueous layer 
extracted with DCM (3 x 50 mL). The combined organic layers were then dried (MgS04) 
and concentrated. Purification by flash column chromatography (50% ethyl acetate / 
petroleum ether) gave ethyl (2S)-2-trityloxypropionate 123 (10.7 g, 100%) as a white solid. 
[a]D22 -32.4 (c 1.4, CHC13), (Lit.122 [a]D24 -32.4 (c 1.44, CHC13)); 6H (400 MHz, CDC13)
1.07 (3H, t, 77.1, OCH2CH3), 1.38 (3H, d, 76.7, 3-H3), 3.70 (2H, m, OCH2CU3), 4.19 (1H, 
q, 7 6.7, 2-H) and 7.23-7.51 (15H, m, 3 x Ph); m/z (El) 360.1725 (M+. C24H240 3 requires 
360.1725), 283 (21%), 243 (100), 183 (15) and 165 (76).
(2S)-2-Trityloxypropanal (129).122
OTr
^ C 0 2Et
DIBAL-H (1.1 equiv.) 
Et2 0, -78 °C to RT OTr
^C H O
The reaction was carried out according to general procedure 2a using ethyl (25)-2- 
trityloxypropanoate 123 (10.67 g, 29.7 mmol) giving (2S)-2-trityloxypropanal 129 (7.66 g, 
82%) as a white solid, which was used without further purification. SH (400 MHz, CDC13) 
1.33 (3H, d, 7 6.9, 3-H3), 4.03 (1H, qd, 7 6.9, 3.1, 2-H), 7.21-7.54 (15H, m, 3 x Ph) and 
8.71 (1H, d, 7 3.1, CHO).
Ethyl (2E,4S)-4-trityIoxypent-2-enoate (135).
triethyl phosphonoacetate, 
LiCI, DBU, MeCN OTr
'C 02Et
The reaction was carried out according to general procedure 3a using (25)- 
trityloxypropanal 129 (8.99 g, 28.4 mmol). Purification was carried out by flash column 
chromatography (50% ethyl acetate / petroleum ether) giving ethyl (2£,45)-4- 
(trityloxy)pent-2-enoate 135 (8.51 g, 78%) as a white solid, mp 112-114 °C (from EtOAc / 
petroleum ether); [a ]D19 -33.6 (c 1.0, CHC13); u j c m '1 (neat) 2979 (CH), 1714 (CO), 1664 
(C=C), 1448, 1251, 1177, 1058 and 1015; 6H (400 MHz, CDC13) 1.10 (3H, d, 7 6.4, 5-H3), 
1.27 (3H, t, 77.1, OCH2C//3), 4.12 (2H, q, 77.1, OC//2CH3), 4.25 (1H, m, 4-H), 5.48 (1H, 
dd, 7 15.7, 1.1, 2-H), 6.54 (1H, dd, 7 15.7, 6.1, 3-H) and 7.21-7.53 (15H, m, 3 x Ph); 6C 
(100 MHz, CDC13) 14.6 (CH3), 22.5 (CH3), 60.4 (CH2), 70.0 (CH), 87.7 (C), 118.3 (CH), 
127.5 (CH), 128.2 (CH), 129.2 (CH), 145.0 (C), 150.8 (CH) and 166.8 (C); m/z (El) 
386.1880 (M+, C26H260 3 requires 386.1882), 309 (3%), 243 (100), 183 (39) and 165 (37).
(2E,4S)-4-Trityloxypent-2-en-l-ol (141).
OTr
DIBAL-H (2.2 equiv.) 
Et2 0, -78 °C to RT OTr
'C 02Et
The reaction was carried out according to general procedure 4 using ethyl (2E,45)-4- 
(trityloxy)pent-2-enoate 135 (3.0 g, 7.8 mmol). Purification was carried out by flash 
column chromatography (50% ethyl acetate / hexane) to gave (2£ ,45)-4-trityloxypent-2- 
en-l-ol 141 (2.59g, 97%) as a viscous oil. [a]D18 +11.6 (c 1.6, CHC13); u ^ /c m '1 (neat) 
3348 (OH), 2926 (CH), 1596 (C=C), 1447, 1051, 1022 and 966; 6H (400 MHz, CDC13) 
0.69 (1H, t, 76.0, OH), 1.15 (3H, d, 76.4, 5-H3), 3.77 (2H, m, 1-H2), 4.16 (1H, quin., 76.4, 
4-H), 5.24 (1H, dt, 7 15.6, 6.0, 2-H), 5.34 (1H, dd, 7 15.6, 6.4, 3-H) and 7.22-7.54 (15H, m, 
3 x Ph); Sc (100 MHz, CDC13) 23.6 (CH3), 63.3 (CH2), 70.8 (CH), 87.4 (C), 126.8 (CH),
127.2 (CH), 128.1 (CH), 129.4 (CH), 136.2 (CH) and 145.5 (C); m/z (Cl) 327 (MH+ - H20 , 
8%), 243 (100), 183 (80) and 145 (35).
(3/?,4S)-3-(TrichIoromethylcarbonylamino)-4-(trityIoxy)penta-l-ene (154a) and
(3S,4S)-3-(trichloromethylcarbonylamino)-4-(trityloxy)penta-l-ene (154b) from 
thermal rearrangement.
OTr
1)CI3 CCN, NaH, DCM
2) p-xylene, A
OTr
HN. ^O
OTr
HN^ 0
CCI3
The reactions were carried out according to general procedure 6 using (2E,45)-4- 
trityloxypent-2-en-l-ol 141 (0.54 g, 1.58 mmol). Purification was carried out by flash 
column chromatography (30% diethyl ether / petroleum ether) giving the title compounds 
154a and 154b (0.28 g, 36% over two steps) as a yellow oil, in a ratio of 2 : 1 (3R : 3S). 
v mJ c nT1 (neat) 3411 (NH), 3021 (CH), 1713 (CO), 1597 (C=C), 1490, 1447, 1001, 818 
and 698; (3/?,4S)-3-(trichloromethylcarbonylamino)-4-(trityloxy)penta-l-ene 154a (major 
compound): 5H (400 MHz, CDC13) 0.97 (3H, d, J  6.4, 5-H3), 3.41 (1H, qd, J  6.4, 3.1, 4-H),
4.06 (1H, m, 3-H), 5.34 (2H, m, 1-H2), 6.06 (1H, m, 2-H) and 7.12-7.56 (15H, m, 3 x Ph); 
6C (100 MHz, CDC13) 18.1 (CH3), 58.6 (CH), 71.6 (CH), 87.2 (C), 118.9 (CH2), 127.5 
(CH), 128.1 (CH), 128.8 (CH), 132.8 (CH), 144.8 (C), 147.0 (C), 161.0 (C); (3S,4S)-3- 
(trichloromethylcarbonylamino)-4-(trityloxy)penta-l-ene 154b (minor compound): 6H (400 
MHz, CDC13) 0.95 (3H, d, J  6.4, 5-H3), 3.61 (1H, m, 4-H), 3.94 (1H, m, 3-H), 5.16 (2H, m,
1-H2), 6.25 (1H, m, 2-H) and 7.12-7.56 (15H, m, 3 x Ph); m/z (Cl) 490 (MH+, 1%), 452 
(1), 387 (1), 285 (3) and 243 (100).
(3/?,4S)-3-(TrichIoromethyIcarbonylamino)-4-(trityloxy)penta-l-ene (154a) and
(3S,4S)-3-(trichloromethyIcarbonylamino)-4-(trityloxy)penta-l-ene (154b) from
bis(acetonitrile)palladium(Il) chloride catalysed aza-Claisen rearrangement.
OTr
1)CI3 CCN, NaH, DCM
2 ) PdCI2 (MeCN)2, THF
OTr OTr
H N ^ O
CCI3
The reactions were carried out according to general procedure 5 using (2E,4S)-4- 
trityloxypent-2-en-l-ol 141 (1.22 g, 3.6 mmol) and bis(acetonitrile)palladium(II) chloride 
(10 mol%). Purification was carried out by flash column chromatography (30% diethyl
ether / petroleum ether) giving the title compounds 154a and 154b (1.22 g, 70% over two 
steps) as a yellow oil, in a ratio of 3 : 1 (3R : 35). Spectroscopic data as above.
(3/?,4S)-3-(TrichloromethyIcarbonylamino)-4-(trityloxy)penta-l-ene (154a) and
(3S,4S)-3-(trichloromethylcarbonylamino)-4-(trityloxy)penta-l-ene (154b) from 
bis(benzonitrile)palladium(H) chloride catalysed aza-Claisen rearrangement.
OTr
1)CI3 CCN, NaH, DCM
2 ) PdCI2 (PhCN)2, THF
OTr
HI\L /O
OTr
H N ^ O
CCI3
The reactions were carried out according to general procedure 5 using (2E,45)-4- 
trityloxypent-2-en-l-ol 141 (0.55 g, 1.60 mmol) and bis(benzonitrile)palladium(II) 
chloride (10 mol%). Purification was carried out by flash column chromatography (30% 
diethyl ether / petroleum ether) giving the title compounds 154a and 154b (0.34 g, 44% 
over two steps) as a yellow oil, in a ratio of 3 : 1 (3R : 35). Spectroscopic data as above.
Ethyl (25)-2-benzyloxypropanoate (124). 123
nH NaH, BnBr
? H THF 0 °C ? Bn
"^C 0 2Et ^ ^ C 0 2Et
The reaction was carried out according to general procedure 1 using ethyl (5)-lactate 121 
(5.0 mL, 44.5 mmol) giving ethyl (25)-2-benzyloxypropanoate 124 (8.77g, 95%) as a 
colourless oil. [a]D25 -69.3 (c 1.0, CHC13), (Lit.123 [a ]D22 -87.0 (c 2.5, CHC13)); 6H (400 
MHz, CDC13) 1.26 (3H, t, J  7.1, OCH2C//3), 1.42 (3H, d, J  6.8, 3-H3), 4.04 (1H, q, J  6.8, 2- 
H), 4.19 (2H, m, OC//2CH3), 4.42 (1H, d, J  11.6, PhCtfH), 4.68 (1H, d, J 11.6, PhCHtf) 
and 7.21-7.49 (5H, m, Ph); m/z (Cl) 209.1178 (MH+. C12H170 3 requires 209.1178), 179 
(11%), 174(13), 119(7) and 91 (100).
(2S)-2-Benzyloxypropan- l-al (130).
HRn DIBAL-H (1.1 equiv.) OR
? Bn Et20 ,-7 8 °C to R T  QB"
^ C 0 2Et ^ "^CHO
The reaction was carried out according to general procedure 2a using ethyl (25)-2- 
benzyloxypropanoate 124 (3.0 g, 14.4 mmol) giving (25)-2-benzyloxypropan-l-al 130 
(2.37 g, 100%) as a yellow oil, which was used without further purification. SH (400 MHz, 
CDC13) 1.35 (3H, d, J  6.9, 3-H3), 3.89 (1H, qd, /  6.9, 3.2, 2-H), 4.10 (1H, d, J  11.7, 
PhC//H), 4.62 (1H, d, /  11.7, PhCH//), 7.24 (5H, m, Ph) and 9.61 (1H, d, J  3.2, CHO).
Ethyl (2E,4S)-4-benzyloxypent-2-enoate (136).121
triethyl phosphonoacetate,
9 Bn LiCI, DBU, MeCN VBn
^^CHO " / ^ ^ C 0 2Et
The reaction was carried out according to general procedure 3a using (25)-2- 
benzyloxypropanal 130 (2.37 g, 14.4 mmol). Purification by flash column
chromatography (40% ethyl acetate / petroleum ether) gave ethyl (2£,45)-4- 
benzyloxypent-2-enoate 136 (3.14 g, 93%) as an oil. [cx]D23 -50.4 (c 1.0, CHC13); SH (400 
MHz, CDC13) 1.2 (6H, m, OCH2C//3 and 5-H3), 4.10 (1H, m, 4-H), 4.20 (2H, q, J  6.3, 
OC//2CH3), 4.42 (1H, d, J  11.8, PhC//H), 4.56 (1H, d, J  11.8, PhCH//), 6.04 (1H, dd, J 
15.7, 1.3, 2-H), 6.91 (1H, dd, J  15.7, 6.0, 3-H) and 7.29-7.46 (5H, m, Ph); mlz (Cl) 
235.1334 (MH+. C14H]90 3 requires 235.1334), 189 (10%), 145 (5), 107 (12) and 91 (31).
(2E,4S)-4-Benzyloxypent-2-en-l-ol (142).121
OBn
DIBAL-H (2.2 equiv.) 
Et2 0, -78 °C to RT OBn
'C 0 2Et
The reaction was carried out according to general procedure 4 using ethyl (2£,45)-4- 
benzyloxypent-2-enoate 136 (1.99 g, 8.5 mmol). Purification was carried out by flash 
column chromatography (50% ethyl acetate / hexane) to give (2£,45)-4-benzyloxypent-2- 
en-l-ol 142 (0.85 g, 52%). [a]D22 -38.1 (c 1.0, CHC13), (Lit.121 [a]D25 -39.2 (c 1.0, CHC13); 
6h (400 MHz, CDC13) 1.32 (3H, d, J  6.4, 5-H3), 1.39 (1H, br t, J  6.4, OH), 4.00 (1H, quin, 
J 6.4, 4-H), 4.20 (2H, t, J  5.2, 1-H2), 4.42 (1H, d, J  12.0, PhC//H), 4.57 (1H, d, J  12.0, 
PhCH//), 5.6 (1H, dd, J  15.6, 6.4, 3-H), 5.7 (1H, dt, J  15.6, 5.2, 2-H) and 7.15-7.56 (5H, 
m, Ph); m/z (Cl) 175.1121 (MH+ - H20. C12H150  requires 175.1123), 157 (66%), 131 (50), 
91 (51) and 85 (50).
(3/?,4S)-3-(Trichloromethanecarbonylamino)-4-(benzyloxy)penta-l-ene (155a) and
(3S,45)-3-(trichloromethanecarbonylamino)-4-(benzyloxy)penta-l-ene (155b) from 
thermal rearrangement.
OBn
1)CI3 CCN, NaH, DCM
2) p-xylene, A
OBn
HN. /O
OBn
H N ^ O
CCI3
The reactions were carried out according to general procedure 6 using (2£,45)-4- 
benzyloxypent-2-en-l-ol 142 (0.20 g, 1.04 mmol). Purification was carried out by flash 
column chromatography (20% ethyl acetate / hexane) giving the title compounds 155a and 
155b (0.15 g, 44% over two steps) as a brown oil, in a ratio of 2 : 1 (3R : 35). Dmax/cm'1 
(neat) 3415 (NH), 2869 (CH), 1714 (CO), 1598 (C=C), 1497, 1454, 1068, 924 and 818; 
(3/?,45)-3-(trichloromethanecarbonylamino)-4-(benzyloxy)penta-1 -ene 155a (major
compound): 6H (400 MHz, CDC13) 1.22 (3H, d, J  6.4, 5-H3), 3.74 (1H, m, 4-H), 4.36 (1H, 
m, 3-H), 4.67 (2H, s, PhCH2), 5.29 (2H, m, 1-H2), 5.87 (1H, m, 2-H) and 7.24-7.39 (5H, m, 
Ph); 6C (100 MHz, CDC13) 15.8 (CH3), 57.8 (CH), 70.8 (CH2), 75.0 (CH), 92.7 (C), 116.9 
(CH2), 127.7 (CH), 128.0 (CH), 128.6 (CH), 131.7 (CH), 137.8 (C) and 161.0 (C); (35,45)-
3-(trichloromethanecarbonylamino)-4-(benzyloxy)penta-l-ene 155b (minor compound): SH 
(400 MHz, CDC13) 1.24 (1H, d, J  6.4, 5-H3), 3.93 (1H, m, 4-H), 4.29 (1H, m, 3-H), 4.42 
(1H, d, /  11.6, PhCZ/H), 4.66 (1H, d, J  11.6, PhCHH), 5.24 (2 H, m, 1-H2), 5.68 (1H, m, 2- 
H) and 7.24-7.39 (5H, m, Ph); 6C(100 MHz, CDC13) 16.7 (CH3), 58.0 (CH), 71.1 (CH2),
75.3 (CH), 92.9 (C), 119.4 (CH2), 127.9 (CH), 128.0 (CH), 128.3 (CH), 135.0 (CH), 137.9 
(C) and 161.8 (C); mlz (Cl) 338 (M H\ 25%), 302 (22), 218 (15), 181 (70) and 105 (100).
(3/?,45)-3-(Trichloromethanecarbonylamino)-4-(benzyloxy)penta-l-ene (155a) and
(3S,4S)-3-(trichloromethanecarbonylamino)-4-(benzyloxy)penta-l-ene (155b) from 
bis(acetonitrile)palladium(II) chloride catalysed aza-Claisen rearrangement.
OBn
1)CI3 CCN, NaH, DCM
2 ) PdCI2 (MeCN)2, THF
OBn OBn
H N ^ O  H N ^ O
CCI3  CCI3
The reactions were carried out according to general procedure 5 using (2E,45)-4- 
benzyloxypent-2-en-l-ol 142 (0.15 g, 0.8 mmol) and bis(acetonitrile)palladium(II)
chloride (10 mol%). Purification was carried out by flash column chromatography (20% 
ethyl acetate / hexane) giving the title compounds 155a and 155b (0.16 g, 62% over two 
steps) as a brown oil, in a ratio of 3 : 1 (3R : 35). Spectroscopic data as above.
(3/?,4S)-3-(Trichloromethanecarbonylamino)-4-(benzyIoxy)penta-l-ene (155a) and
(3S,4S)-3-(trichloromethanecarbonylamino)-4-(benzyloxy)penta-l-ene (155b) from 
bis(benzonitrile)palladium(II) chloride catalysed aza-Claisen rearrangement.
OBn
1)CI3 CCN, NaH, DCM
2) PdCI2 (PhCN)2, THF
OBn
HN. ^O
OBn
HN^ 0
CCI3
The reactions were carried out according to general procedure 5 using (2E,4S)-4- 
benzyloxypent-2-en-l-ol 142 (0.35 g, 1.04 mmol) and bis(benzonitrile)palladium(II) 
chloride (10 mol%). Purification was carried out by flash column chromatography (20% 
ethyl acetate / hexane) giving the title compounds 155a and 155b (0.20 g, 58% over two 
steps) as a brown oil, in a ratio of 4 : 1 (3R : 35). Spectroscopic data as above.
Ethyl (25)-2-methoxypropanoate (125). 124
™ . NaH, Mel
? H THF 0°C ?
C 0 2Et ^  C0 2Et
The reaction was carried out according to general procedure 1 using ethyl (5)-lactate 121 
(7.7 mL, 67.8 mmol). Purification was carried out by flash column chromatography (50% 
ethyl acetate / petroleum ether) to give ethyl (25)-2-methoxypropanoate 125 (4.29 g, 48%) 
as a pale liquid. [a ]D22 -115.3 (c 1.0, CHC13), (Lit.124 [a]D25 -115.9 (c 1.1, CHC13)); SH (400 
MHz, CDC13) 1.23 (3H, t, y 7.1, OCH2C//3), 1.33 (3H, d, 7 6.8, 3-H3), 3.33 (3H, s, OMe),
3.80 (1H, q, J  6.8, 2-H) and 4.14 (2H, q, J  7.1, OC//2CH3); mlz (Cl) 133.0869 (MH+. 
C6H130 3 requires 133.0865), 128 (3%), 85 (4) and 71 (4).
Ethyl (2/s,4S)-4-methoxypent-2-enoate (137).125
DIBAL-H (2.2 eq) DMSO, (COCI)2> NEt3
OMe Et2 0, -78°C to RT OMe -78°C, then OMe
triethyl phosphonoacetate, C02Et
LiCI, DBU, MeCN
The reactions were carried out according to general procedure 2b and then 3b using ethyl 
(5')-2-methoxypropanoate 125 (5.2 g, 39.4 mmol). Purification by flash column 
chromatography (30% ethyl acetate / petroleum ether) gave ethyl (2E,4S)-4-methoxypent- 
2-enoate 137 (3.61 g, 58% over three steps) as a brown oil. [a ]D22 -34.1 (c 1.0, CHC13); 
i)max/cm-‘ (neat) 2981 (CH), 1716 (CO), 1659 (C=C), 1260, 1176 and 1086; SH(400 MHz, 
CDC13) 1.28 (3H, d, 7 6.4, 5-H3), 1.32 (3H, t, 7 7.2, OCH2C//3), 3.34 (3H, s, OMe), 3.91 
(1H, dq, 7 6.4, 1.8, 4-H), 4.22 (2H, q, 7 7.1, OC//2CH3), 5.98 (1H, dd, 7 15.7, 1.3, 2-H) and 
6.84 (1H, dd, 7 15.7, 6.4, 3-H); 6C(100 MHz, CDC13) 14.6 (CH3), 20.7 (CH3), 57.0 (CH3),
60.8 (CH2), 76.5 (CH), 121.7 (CH), 149.3 (CH) and 166.7 (C); mlz (Cl) 159.1021 (MH+. 
C8H150 3 requires 159.1021), 150 (2%), 138 (9), and 127 (5).
(2E,45)-4-Methoxypent-2-en-l-ol (143).126
OMe
DIBAL-H (2.2 equiv.) 
Et2 0 , -78 °C to RT OMe
'C 02Et
The reaction was carried out according to general procedure 4 using ethyl (2E,4S)-4- 
methoxypent-2-enoate 137 (0.88 g, 5.57 mmol). Purification was carried out by flash 
column chromatography (50% ethyl acetate / petroleum ether) to give (2E,4S)-4- 
methoxypent-2-en-l-ol 143 (0.56 g, 87%) as a yellow liquid. [a]D21 -35.6 (c 1.0, CHC13); 
D j c m '1 (neat) 3363 (OH), 2931 (CH), 1673 (C=C), 1087, 970 and 842; 6H (400 MHz, 
CDC13) 1.18 (3H, d, 7 6.4, 5-H3), 1.50 (1H, br t, 7 5.3, OH), 3.30 (3H, s, OMe), 3.78 (1H, 
quin, 76.4, 4-H), 4.19 (2H, d, 75.3, 1-H2), 5.63 (1H, dd, 7 15.5, 6.4, 3-H) and 5.84 (1H, dt, 
7 15.5 and 5.3, 2-H); 6C(100 MHz, CDC13) 21.4 (CH3), 56.3 (CH3), 63.3 (CH2), 77.6 (CH),
131.3 (CH) and 133.5 (CH); mlz (Cl) 117.0918 (MH+. C6H130 2 requires 117.0916), 99 
(35%), 85 (100) and 79 (3).
(3/?,4S)-3-(TrichloromethylcarbonyIamino)-4-(methoxy)penta-1-ene (156a) and
(3S,4S)-3-(trichloromethylcarbonylamino)-4-(methoxy)penta- 1-ene (156b) from
thermal rearrangement.
OMe
1)CI3 CCN, NaH, DCM
2) p-xylene, A
OMe OMe
H N ^ O
CCI3
The reactions were carried out according to general procedure 6 using (22s,4S)-4- 
methoxypent-2-en-l-ol 143 (0.08 g, 0.65 mmol). Purification was carried out by flash 
column chromatography (30% ethyl acetate / petroleum ether) to give the title compounds 
156a and 156b (0.07 g, 38% over two steps) as a brown oil, in a ratio of 2 : 1 (3R : 3S). 
v mJ c m l (neat) 3339 (NH), 1705 (CO), 1598 (C=C), 1498, 1087, 927 and 817; (3fl,4S)-3- 
(trichloromethylcarbonylamino)-4-(methoxy)penta-1-ene 156a (major compound): 6H (400 
MHz, CDCI3) 1.18 (3H, d, J  6.4, 5-H3), 3.38 (3H, s, OMe), 3.55 (1H, m, 4-H), 4.38 (1H, 
m, 3-H), 5.28 (2H, m, 1-H2), 5.77-5.94 (1H, m, 2-H) and 7.10 (1H, br d, J  6.4, NH); Sc 
(100 MHz, CDCI3) 15.6 (CH3), 57.2 (CH), 58.0 (CH3), 77.9 (CH), 93.2 (C), 119.5 (CH2),
132.0 (CH) and 161.4 (C); (3S,45>3-(trichloromethylcarbonylamino)-4-(methoxy)penta-l- 
ene 156b (minor compound): SH (400 MHz, CDC13) 1.22 (3H, d, J  6.4, 5-H3), 3.37 (3H, s, 
OMe), 3.40 (1H, m, 4-H), 4.42 (1H, m, 3-H), 5.19 (2H, m, 1-H2), 5.72 (1H, m, 2-H) and 
6.96 (1H, br d, J  6.4, NH); Sc (100 MHz, CDC13) 16.5 (CH3), 57.5 (CH), 58.1 (CH3), 77.8
(CH), 93.3 (C), 117.2 (CH2), 134.9 (CH) and 162.1 (C); mlz (Cl) 274 (MH+, 4%), 260 (75), 
226(17), 190(100).
(3/?,4S)-3-(TrichloromethyIcarbonyIamino)-4-(methoxy)penta-l-ene (156a) and
(35,4S)-3-(trichloromethylcarbonylamino)-4-(methoxy)penta-1-ene (156b) from
bis(acetonitrile)palladium(II) chloride catalysed aza-Claisen rearrangement.
OMe
1)CI3 CCN, NaH, DCM
2) PdCI2 (MeCN)2, THF
OMe OMe
H N ^ O
CCI3
The reactions were carried out according to general procedure 5 using {IE,AS)-4- 
methoxypent-2-en-l-ol 143 (0.06 g, 0.52 mmol) and bis(acetonitrile)palladium(II) chloride 
(10 mol%). Purification was carried out by flash column chromatography (30% ethyl
acetate / petroleum ether) to give the title compounds 156a and 156b (0.07 g, 48% over 
two steps) as a brown oil, in a ratio of 7 : 1 (3R : 35). Spectroscopic data as above.
(3/?,45)-3-(Trichloromethylcarbonylamino)-4-(methoxy)penta-l-ene (156a) and
(3S,4S)-3-(trichloromethylcarbonylamino)-4-(methoxy)penta-l-ene (156b) from 
bis(benzonitrile)palladium(II) chloride catalysed aza-Claisen rearrangement.
OMe
1)CI3 CCN, NaH, DCM
2 ) PdCI2 (PhCN)2l THF
OMe
HN. .O
OMe
H N ^ O
CCI3
The reactions were carried out according to general procedure 5 using (2E,4S)-4- 
methoxypent-2-en-l-ol 143 (0.03 g, 0.22 mmol) and bis(benzonitrile)palladium(II) 
chloride (10 mol%). Purification was carried out by flash column chromatography (30% 
ethyl acetate / petroleum ether) to give the title compounds 156a and 156b (0.03 g, 48% 
over two steps) as a brown oil, in a ratio of 6 : 1 (3R : 35). Spectroscopic data as above.
Ethyl (2S)-2-methoxymethoxypropanoate (126).127
OH P g N B  OMQM
7 DCM, 0 °C 7
"^ C 0 2Et ^ ^ C 0 2Et
AyV’-Diisopropylethylamine (12.4 mL, 71.2 mmol) and chloromethyl methyl ether (6.8 
mL, 89.0 mmol) were added dropwise to a solution of ethyl (5)-lactate 121 (7.0 g, 59.3 
mmol) in DCM (70 mL) at 0 °C. The reaction mixture was allowed to stir for 1 h, then 
heated under reflux for 12 h. The reaction mixture was then cooled to room temperature, 
quenched with 2 M hydrochloric acid solution (50 mL) and extracted with DCM (3 x 50 
mL). The combined organic layers were dried (MgS04) and concentrated. Purification 
was carried out by flash column chromatography (40% diethyl ether / petroleum ether) to 
give ethyl (25)-2-methoxymethoxypropanoate 126 (8.7 g, 91%) as a yellow liquid. [a]D23 -
105.7 (c 1.0, CHCI3), (Lit.127 [a]D25 -92.3 (c 1.0, CHC13)); SH (400 MHz, CDC13) 1.29 (3H, 
t, J  7.0, OCH2C //3), 1.43 (3H, d, J  7.0, 3-H3), 3.39 (3H, s, OMe), 4.21 (2H, q, J  7.0, 
OC//2CH3), 4.24 (1H, q, J  7.0, 2-H), 4.69 (1H, d, J  7.0, OC//HO) and 4.72 (1H, d, J 7.0, 
OCH//O); mlz (Cl) 163.0969 (MH+. C7H150 4 requires 163.0970), 131 (100%), 119 (3) and 
85 (4).
(2S)-2-Methoxymethoxypropan-l-ol (132).127
_  ^  DIBAL-H (2.2 equiv.)
9  Et2 0, -78 °C to RT ? M0M
■^COoEt "
The reaction was carried out according to general procedure 2b using ethyl (25)-2- 
methoxymethoxypropanoate 126 (1.0 g, 6.2 mmol). Purification by flash column 
chromatography (90% diethyl ether / petroleum ether) gave (25)-2- 
methoxymethoxypropanol 132 (0.61 g, 82%) as a colourless oil. [a ]D25 +80.0 (c 1.0, 
CHC13); SH (400 MHz, CDCI3) 1.18 (3H, d, J  6.4, 3-H3), 2.60 (1H, br s, OH), 3.43 (3H, s, 
OMe), 3.46 (1H, dd, J  11.8, 7.3, 1-/7H), 3.57 (1H, dd, J  11.8, 2.8, 1-HH), 3.70 (1H, m, 2-
H), 4.71 (1H, d, J  6.9, OC//HO) and 4.76 (1H, d, J  6.9 Hz, OCH//O); mlz (Cl) 121.0866 
(MH+. C5H130 3 requires 121.0865), 119 (8%), 89 (100), and 87 (19).
Ethyl (2E,4S)-4-methoxymethoxypent-2-enoate (138).
DMSO, (COCI)2, NEt3  
OMOM -78 °C, then
> ^ O H
triethyl phosphonoacetate, 
LiCI, DBU, MeCN
OMOM
C 02Et
The reaction was carried out according to general procedure 3b using (25)-2- 
methoxymethoxypropan-l-ol 132 (2.58 g, 21.5 mmol). Purification by flash column 
chromatography (40% diethyl ether / petroleum ether) gave ethyl (2£,45)-4- 
methoxymethoxypent-2-enoate 138 (2.64 g, 65% over two steps) as a brown oil.
[cc]d21-80.0 (c 1.0, CHCI3); v mJ c m l (neat) 2981 (CH), 1720 (CO), 1660 (C=C), 1271, 
1099, 1032 and 920; 6H (400 MHz, CDC13) 1.27 (6H, m, OCH2C/ /3 and 5-H3), 3.37 (3H, s, 
OMe), 4.20 (2H, q, J  7.1, OC//2CH3), 4.35 (1H, quin d, J  6.5, 2.1, 4-H), 4.62 (2H, s, 
OCH20), 5.99 (1H, dd, J  15.7, 2.1, 2-H) and 6.87 (1H, dd, J  15.7, 6.5, 3-H); 6C(100 MHz, 
CDCI3) 14.6 (CH3), 20.9 (CH3), 55.8 (CH3), 60.8 (CH2), 71.4 (CH), 94.8 (CH), 121.4 (CH), 
149.1 (CH) and 166.7 (C); mlz (Cl) 189.1125 (MH+. C9HI70 4 requires 189.1127), 175 
(3%), 159 (42), 143 (49) and 127 (61).
(2Zs,4S)-4-Methoxymethoxypent-2-en-l-ol (144).
OMOM
DIBAL-H (2.2 equiv.) 
Et2 0, -78 °C to RT OMOM
'C 02Et
The reaction was carried out according to general procedure 4 using ethyl (2E,4S)-4- 
methoxymethoxypent-2-enoate 138 (2.56 g, 13.6 mmol). Purification was carried out by 
flash column chromatography (80% diethyl ether / petroleum ether) to give (2E,4S)-4- 
methoxymethoxypent-2-en-l-ol 144 (1.90 g, 96%) as a colourless oil. [a ]D23 -117.9 (c 1.0, 
CHC13); D j c m '1 (neat) 3404 (OH), 2931 (CH), 1446 (C=C), 1373, 1217 and 1026; SH 
(400 MHz, CDCI3) 1.27 (3H, d, J  6.4, 5-H3), 2.21 (H, br s, OH), 3.37 (3H, s, OMe), 4.14 
(2H, dd, J  5.1, 1.6, 1-H2), 4.16 (1H, quin, /  6.4, 4-H), 4.57 (1H, d, J  6.7, OCtfHO), 4.66 
(1H, d, J  6.7, OCH//O), 5.63 (1H, ddt, J  15.0, 6.8, 1.6, 3-H) and 5.81 (1H, dt, J 15.0, 5.1,
2-H); 6C (100 MHz, CDC13) 21.3 (CH3), 55.3 (CH3), 63.0 (CH2), 72.0 (CH), 93.8 (CH2), 
130.9 (CH) and 132.8 (CH); mlz (Cl) 121.0866 (MH+ - H20 . C7H 130 2 requires 121.0865), 
99 (35%), 85 (100) and 79 (3).
(3/?,4S)-3-(TrichloromethyIcarbonyIamino)-4-(methoxymethoxy)penta-l-ene (157a) 
and (3S,4S)-3-(trichloromethylcarbonylamino)-4-(methoxymethoxy)penta-l-ene 
(157b) from thermal rearrangement.
OMOM
1)CI3 CCN, NaH, DCM
2) p-xylene, A
OMOM
HN.
OMOM
H N ^ O
CCI3
The reactions were carried out according to general procedure 6 using (2E,4S)-4- 
methoxymethoxypent-2-en-l-ol 144 (0.08 g, 0.53 mmol). Purification was carried out by 
flash column chromatography (20% diethyl ether / petroleum ether) to give the title 
compounds 157a and 157b (0.03 g, 21% over two steps) as an orange oil, in a ratio of 2 : 1 
(3R ; 3S). u j c m '1 (neat) 3302 (NH), 2935 (CH), 1712 (CO), 1643 (C=C), 1511, 1148, 
1028 and 819; (3/?,4S)-3-(trichloromethylcarbonylamino)-4-(methoxymethoxy)penta-l- 
ene 157a (major compound): §H (400 MHz, CDC13) 1.26 (3H, d, J  6.4, 5-H3), 3.43 (3H, s, 
OMe), 3.88 (1H, qd, J  6.4, 3.0, 4-H), 4.35 (1H, m, 3-H), 4.69 (1H, d, J  6.8, OCHHO) 4.71 
(1H, d, J  6.8, OCH//O), 5.36 (2H, m, 1-H2), 5.89 (1H, m, 2-H) and 7.89 (1H, br d, J  6.4, 
NH); 6C (100 MHz, CDC13) 18.4 (CH3), 56.2 (CH), 58.1 (CH3), 77.7 (CH), 92.1 (C), 97.0
(CH2), 119.6 (CH2), 131.8 (CH) and 161.7 (C); ^^^^-(trichlorom ethylcarbonylam ino)- 
4-(methoxymethoxy)penta-1-ene 157b (minor compound): SH (400 MHz, CDC13) 1.24 
(3H, d, J  6.4, 5-H3), 3.39 (3H, s, OMe), 3.93 (1H, qd, J  6.4, 3.0, 4-H), 4.43 (1H, m, 3-H), 
4.63 (1H, d, J  6.8, OCtfHO) 4.79 (1H, d, J  6.8 Hz, 0C H //0), 5.27 (2H, m, 1-H2), 5.89 
(1H, m, 2-H) and 7.10 (1H, br d, J  6.4, NH); 6C(100 MHz, CDC13) 17.8 (CH3), 56.1 (CH),
58.2 (CH3), 74.1 (CH), 94.3 (C), 95.3 (CH2), 117.3 (CH2), 135.3 (CH) and 161.7 (C); mlz
(Cl) 290.0127 (MH+. C9H150 3N35C13 requires 290.0118), 258 (81%), 246 (22), 214 (37) and 
196 (72).
(3/?,4S)-3-(TrichloromethyIcarbonylamino)-4-(methoxymethoxy)penta-l-ene (157a) 
and (3S,4S)-3-(trichloromethylcarbonyIamino)-4-(methoxymethoxy)penta-l-ene 
(157b) from bis(acetonitrile)palladium(II) chloride catalysed aza-Claisen 
rearrangement.
OMOM
1)CI3 CCN, NaH, DCM
2 ) PdCI2 (MeCN)2, THF
OMOM
HN. ^O
OMOM
H N ^ O
CCI3
The reactions were carried out according to general procedure 5 using (2£’,45)-4- 
methoxymethoxypent-2-en-l-ol 144 (0.44 g, 3.7 mmol) and bis(acetonitrile)palladium(II) 
chloride (10 mol%). Purification was carried out by flash column chromatography (20% 
diethyl ether / petroleum ether) to give the title compounds 157a and 157b (0.68 g, 64% 
over two steps) as an orange oil, in a 10 : 1 (3R : 3S) ratio. Spectroscopic data as above.
(3/?,4S)-3-(TrichloromethyIcarbonylamino)-4-(methoxymethoxy)penta-l-ene (157a) 
and (3S,4S)-3-(trichloromethylcarbonylamino)-4-(methoxymethoxy)penta-l-ene 
(157b) from bis(benzonitrile)palladium(II) chloride catalysed aza-Claisen 
rearrangement.
OMOM
1)CI3 CCN, NaH, DCM
2) PdCI2 (PhCN)2, THF
OMOM
HN. ^.O
OMOM
H N ^O
CCI3
The reactions were carried out according to general procedure 5 using (2E,4S)-4- 
methoxymethoxypent-2-en-l-ol 144 (0.06 g, 0.42 mmol) and
bis(benzonitrile)palladium(II) chloride (10 mol%). Purification was carried out by flash 
column chromatography (20% diethyl ether / petroleum ether) to give the title compounds 
157a and 157b (0.10 g, 57% over two steps) as an orange oil, in a ratio of 9 : 1 (3R : 35). 
Spectroscopic data as above.
(3/?,4S)-3-(Trichloromethylcarbonylamino)-4-(methoxymethoxy)penta-l-ene (157a) 
and (35,45)-3-(trichloromethylcarbonylamino)-4-(methoxymethoxy)penta-l-ene 
(157b) from thermal rearrangement with K2C 03.
OMOM
1)CI3CCN, DBU, DCM
2) p-xylene, K2CO3, A
OMOM
HN. ^O
OMOM
H N ^ O
CCI3
(2£',45)-4-Methoxymethoxypent-2-en-l-ol 144 (0.10 g, 0.69 mmol) was dissolved in DCM 
(10 mL) and cooled to 0 °C. l,8-Diazabicyclo[5,4,0]undec-7-ene (0.10 g, 0.69 mmol) and 
trichloroacetonitrile (0.1 mL, 1.03 mmol) were then added and the mixture was allowed to 
warm to room temperature and stirred for 2 h. The reaction mixture was then filtered 
through a dry silica plug and the filtrate was concentrated in vacuo to give an orange 
liquid. The product was used without further purification. The allylic trichloroacetimidate 
and potassium carbonate (0.20 g) were dissolved in p-xylene (10 mL) and heated under 
reflux for 72 h. The mixture was then concentrated to give a brown liquid. Purification 
was carried out by flash column chromatography (20% diethyl ether / petroleum ether) to 
give the title compounds 157a and 157b (0.18 g, 91% over two steps) as an orange oil, in a 
2 : 1 (3R : 35) ratio. Spectroscopic data as described above.
Ethyl (2S)-2-methoxyethoxymethoxypropanoate (127).128
OH NaH, MEMCI OMEM
THF 0 °C t
" ^ C 0 2Et ^ ^ C 0 2Et
The reaction was carried out according to general procedure 1 using ethyl (5)-lactate 121 
(4.8 mL, 42.4 mmol). Purification was carried out by flash column chromatography (20% 
diethyl ether / petroleum ether) to give ethyl (25)-2-methoxyethoxymethoxypropionate 127 
(8.73 g, 100%) as a colourless oil. [a]D23 -62.7 (c 2.0, CHC13), (Lit.128 [a]D20 -66.7 (c 1.2, 
CHCI3)); 6„ (400 MHz, CDCI3) 1.29 (3H, t, J  7.1, OCH2CH3), 1.43 (3H, d, J  6.8, 3-H3), 
3.40 (3H, s, OMe), 3.54 (2H, m, 0 C //2CH20), 3.75 (2H, m, 0CH2C//20), 4.18 (2H, q, J
7.1, OCH2C//3), 4.25 (1H, q, J  6.8, 2-H), 4.80 (2H, s, 0CH20); mlz (Cl) 207.1232 (MH+. 
C9H180 3 requires 207.1232), 203 (30%), 179 (3), 131 (100) and 89 (80).
(2S)-2-Methoxyethoxymethoxypropan-l-al (131).
DIBAL-H (1.1 equiv.)
OMEM Et2 0, -78 °C to RT OMEM
^ C 0 2Et ^^C H O
The reaction was carried out according to general procedure 2a using ethyl (2S)-2- 
methoxyethoxymethoxypropanoate 127 (5.0 g, 24.3 mmol) giving (25)-2-
methoxyethoxymethoxypropan-l-al 131 (3.93 g, 100%) as a yellow oil, which was used 
without further purification. SH (400 MHz, CDC13) 1.32 (3H, d, J  7.1, 3-H3), 3.38 (3H, s, 
OMe), 3.48-3.90 (4H, m, OCH2CH20), 4.1 (1H, qd, J  7.1, 1.9, 2-H), 4.81 (2H, s, OCH20) 
and 9.62 (1H, d, 71.9, CHO).
Ethyl (2i?,4S)-4-methoxyethoxymethoxypent-2-enoate (139).
triethyl phosphonoacetate,
OMEM LiCI, DBU, MeCN OMEM
'CHO C 02Et
The reaction was carried out according to general procedure 3a using (2S)-2- 
methoxyethoxymethoxypropan-l-al 131 (4.20 g, 25.9 mmol). Purification was carried out 
by flash column chromatography (30% ethyl acetate / petroleum ether) giving ethyl 
(2£',4S)-4-methoxyethoxymethoxypent-2-enoate 139 (1.69 g, 28%) as a yellow liquid. 
[a]D21 -53.5 (c 1.0, CHC13); D j c m '1 (neat) 2983 (CH), 1748 (CO), 1656 (C=C), 1180, 
1029 and 750; 6H (400 MHz, CDC13) 1.28 (6H, m, OCH2CH3 and 5-H3), 3.39 (3H, s, 
OMe), 3.54-3.78 (4H, m, 0CH2CH20), 4.15 (2H, q, J  7.2, OCH2CU3), 4.42 (1H, qd, J  6.8,
1.6 Hz, 4-H), 4.70 (1H, d, J  6.8, OCHRO), 4.73 (1H, d, J  6.8, OCH//0), 5.99 (1H, dd, J  
15.6, 1.6, 2-H), 6.84 (1H, dd, J  15.6, 6.8, 3-H); Sc (100 MHz, CDC13) 14.4 (CH3), 20.7 
(CH3), 59.2 (CH2), 66.7 (CH), 67.1 (CH2), 71.2 (CH3), 71.9 (CH2), 93.6 (CH2), 121.2 (CH),
149.0 (CH) and 166.6 (C); mlz (Cl) 233.1390 (MH+. CnH2]0 5 requires 233.1389), 203 
(10%), 157 (19), 127 (64) and 89 (100).
(2£',4S)-4-Methoxyethoxymethoxypent-2-en-l-ol (145).
OMEM
DIBAL-H (2.2 equiv.) 
Et2 0, -78 °C to RT OMEM
'C 02Et
The reaction was carried out according to general procedure 4 using ethyl (2E,4S)-4- 
methoxyethoxymethoxypent-2-enoate 139 (1.04 g, 4.48 mmol). Purification was carried 
out by flash column chromatography (90% ethyl acetate / petroleum ether) giving (2E,4S)~
4-methoxyethoxymethoxypent-2-en-l-ol 145 (0.76 g, 89%) as a yellow liquid. [a ]D24 -73.0 
(c 2.1, CHC13); v j c m 1 (neat) 3418 (OH), 2928 (CH), 1290, 1247, 1036, 778 and 734; SH 
(400 MHz, CDCI3) 1.21 (3H, d, J  6.4, 5-H3), 1.63 (1H, br s, OH), 3.44 (3H, s, OMe), 3.51 
(2H, m, OGtf2CH20), 3.60 (2H, m, 0CH2C//20), 4.16 (2H, dd, J  6.5, 1.2, 1-H2), 4.23 (1H, 
q, J  6.4, 4-H), 4.70 (1H, d, J  7.0, OC//HO), 4.77 (1H, d, J  7.0, OCH//O), 5.61 (1H, m, 3-
H) and 5.85 (1H, m, 2-H); Sc (100 MHz, CDC13) 21.6 (CH3), 59.4 (CH3), 63.2 (CH2), 67.1 
(CH2), 72.2 (CH2), 73.0 (CH), 93.6 (CH2), 131.1 (CH) and 133.3 (CH); mlz (Cl) 158 (MH+ 
- CH3 and H20 , 7%), 129 (12), 123 (7) and 89 (100).
(3/?,4S)-3-(Trichloromethylcarbonylamino)-4-(methoxyethoxymethoxy)penta-1-ene 
(158a) and (35,45)-3-(Trichloromethylcarbonylamino)-4-
(methoxyethoxymethoxy)penta-1-ene (158b) from thermal rearrangement.
OMEM
1)CI3 CCN, NaH, DCM
2) p-xylene, A
OMEM
HN.
OMEM
H N ^ O
CCI3
The reactions were carried out according to general procedure 6 using (2£,45)-4- 
methoxyethoxymethoxypent-2-en-l-ol 145 (0.29 g, 1.50 mmol). Purification was carried 
out by flash column chromatography (30% ethyl acetate / petroleum ether) giving the title 
compounds 158a and 158b (0.19 g, 37% over two steps) as a yellow oil, in a ratio of 2 : 1 
(3R : 35). v mJ c m '  (neat) 3289 (NH), 2930 (CH), 1708 (C=0), 1601 (C=C), 1514, 1034 
and 820; (3/?,45)-3-(trichloromethylcarbonylamino)-4-(methoxyethoxymethoxy)penta-1 - 
ene 158a (major compound): SH (400 MHz, CDC13) 1.27 (3H, d, J  6.4, 5-H3), 3.39 (3H, s, 
OMe), 3.56-3.78 (4H, m, 0CH2CH20), 3.91 (1H, qd, J  6.4, 2.8, 4-H), 4.41 (1H, m, 3-H),
4.80 (1H, d, J  7.2, OC/7HO), 4.82 (1H, d, J  7.2, OCHHO), 5.35 (2H, m, 1-H2), 5.90 (1H, 
m, 2-H) and 7.73 (1H, br d, J  6.4, NH); 6C(100 MHz, CDC13) 18.0 (CH3), 58.3 (CH), 59.4
(CH), 68.0 (CH2), 72.0 (CH2), 77.4 (CH3), 93.8 (C), 95.7 (CH2), 119.6 (CH2), 131.9 (CH) 
and 162.2 (C); (3S,4S)-3-(trichloromethylcarbonylamino)-4-
(methoxyethoxymethoxy)penta-1-ene 158b (minor compound): SH (400 MHz, CDC13) 1.29 
(3H, d, J  6.4, 5-H3), 3.41 (3H, s, OMe), 3.56-3.78 (4H, m, OCH2CH20), 4.03 (1H, qd, J  
6.4, 2.4, 4-H), 4.27 (1H, m, 3-H), 4.72 (1H, d, J 12 , OCHHO), 4.74 (1H, d, J 12, 
OCH//0), 5.26 (2H, m, 1-H2), 5.70 (1H, m, 2-H) and 7.15 (1H, br d, J  6.4, NH); mlz (Cl) 
334 (MH+, 5%), 306 (6), 260 (95), 258 (100), 214 (22) and 162 (40).
(3/?,4S)-3-(Trichloromethylcarbonylamino)-4-(methoxyethoxymethoxy)penta-l-ene 
(158a) and (3S,4S)-3-(trichIoromethylcarbonylamino)-4-
(methoxyethoxymethoxy)penta-1-ene (158b) from bis(acetonitrile)palladium(II) 
chloride catalysed aza-Claisen rearrangement.
1)CI3 CCN, NaH, DCM 
OMEM 2) PdCI2 (MeCN)2, THF
OMEM OMEM
CCI3  CCI3
The reactions were carried out according to general procedure 5 using {2E,4S)-A- 
methoxyethoxymethoxypent-2-en-l-ol 145 (0.52 g, 2.7 mmol) and
bis(acetonitrile)palladium(II) chloride (10 mol%). Purification was carried out by flash 
column chromatography (30% ethyl acetate / petroleum ether) giving the title compounds 
158a and 158b (0.54 g, 60% over two steps) as a yellow oil, in a ratio of 8 : 1 (3R : 3S). 
Spectroscopic data as above.
(3/?,4S)-3-(Trichloromethylcarbonylamino)-4-(methoxyethoxymethoxy)penta-l-ene 
(158a) and (3S,4S)-3-(trichloromethyIcarbonylamino)-4-
(methoxyethoxymethoxy)penta-l-ene (158b) from bis(benzonitrile)palladium(II) 
chloride catalysed aza-Claisen rearrangement.
OMEM
1)CI3 CCN, NaH, DCM
2) PdCI2 (PhCN)2, THF
OMEM
HN.
OMEM
H N ^ O
CCI3
The reactions were carried out according to general procedures 5 using (2E,AS)-A- 
methoxyethoxymethoxypent-2-en-l-ol 145 (0.30 g, 1.55 mmol) and
bis(benzonitrile)palladium(II) chloride (10 mol%). Purification was carried out by flash 
column chromatography (30% ethyl acetate / petroleum ether) giving the title compounds 
158a and 158b (0.27 g, 52% over two steps) as a yellow oil, in a ratio of 8 : 1 (3R : 3S). 
Spectroscopic data as above.
(4/f,5S)-4-Vinyl-5-methyl-oxazolidin-2-one (160a) and (4S,5S)-4-vinyl-5-methyl- 
oxazolidin-2-one (160b).
OTBDMS OTBDMS QH OH
A mixture of (3/?,4S)-3-(trichloromethylcarbonylamino)-4-(tert-
butyldimethylsilyloxy)penta-1-ene 153a and (35,45)-3-(trichloromethylcarbonylamino)-4- 
(terf-butyldimethylsilyloxy)penta-1-ene 153b (0.11 g, 0.3 mmol) and tetra-rc-
butylammonium fluoride (1.0 M solution in THF) (0.32 mL, 0.32 mmol) in THF (5 mL) 
was allowed to stir at room temperature for 0.5 h. The reaction mixture was then 
concentrated and the resulting residue was taken up in ethyl acetate (20 mL), washed with 
water (10 mL), dried (MgS04) and concentrated in vacuo. Purification by flash column 
chromatography (70% ethyl acetate / petroleum ether) gave a yellow oil. The oil was 
added to a solution of potassium hydroxide (0.12 g, 2.22 mmol) in isopropanol (5 mL) and 
the reaction mixture was allowed to stir at room temperature for 12 h. The mixture was 
then concentrated and the resulting residue was dissolved in water (10 mL) and extracted 
with ethyl acetate (5 x 10 mL). The organic layers were combined, dried (MgS04) and 
concentrated in vacuo to give the title compounds 160a and 160b (16 mg, 41% over two 
steps) as a colourless oil, in a ratio of 2 : 1 (4R : 45). 'umax/cm'1 (neat) 3280 (NH), 2984 
(CH), 1733 (CO), 1645 (C=C), 1383, 1227 and 1056; (4fl,5S)-4-vinyl-5-methyl- 
oxazolidin-2-one 160a (major compound): §H (400 MHz, CDC13) 1.34 (3H, d, J  6.5, 5- 
CH3), 4.33 (1H, t, J  6.1, 4-H), 4.82 (1H, dq, J  7.9, 6.5, 5-H), 5.30 (2H, m, 4-CH=CH2) and 
5.78 (1H, m, 4-C//=CH2); 6c (100 MHz, CDC13) 16.4 (CH3), 58.8 (CH), 76.7 (CH), 119.6 
(CH2), 133.4 (CH) and 160.1 (C); (45,55)-4-vinyl-5-methyl-oxazolidin-2-one 160b (minor 
compound): 6H (400 MHz, CDC13) 1.40 (3H, d, J  6.2, 5-CH3), 3.90 (1H, t, J  7.2, 4-H), 4.33 
(1H, qd, J  7.9, 6.2, 5-H), 5.24 (2H, m, 4-CH=CH2) and 5.78 (1H, m, 4-C//=CH2); 6C(100 
MHz, CDC13) 19.3 (CH3), 63.3 (CH), 79.2 (CH), 119.3 (CH2), 135.7 (CH) and 160.0 (C); 
mlz (Cl) 128.0711 (MH+. C6HI0O2Nrequires 128.0712), 126 (2%), 112 (1) and 84 (1).
(3/?,4S)-3-(TrichIoromethyIcarbonylamino)-4-(methoxymethoxy)penta-l-ene (157a) 
and (3S,4S)-3-(trichloromethylcarbonylamino)-4-(methoxymethoxy)penta-l-ene 
(157b) from palladium (II) chloride catalysed aza-Claisen rearrangement.
'O O 1)CI3 CCN, dbu  DCM
2 ) PdCI2, THF
RT
'O O 'O O
HI\L ..O H N ^ O
CCI3
The reactions were carried out according to general procedure 7 for 120 h using (2E,4S)-4- 
methoxymethoxypent-2-en-l-ol 144 (100 mg, 0.69 mmol) then palladium(II) chloride (12 
mg, 10 mol%) to give (3/?,45)-3-(trichloromethylcarbonylamino)-4- 
(methoxymethoxy)penta-1-ene 157a and (35,45)-3-(trichloromethylcarbonylamino)-4- 
(methoxymethoxy)penta-1-ene 157b (90 mg, 45% over two steps) as a brown oil, in a 11 : 
1 (3R : 3S) ratio. Spectroscopic data as described above.
(3/?,4S)-3-(TrichloromethyIcarbonyIamino)-4-(methoxymethoxy)penta-l-ene (157a) 
and (3S,4S)-3-(trichloromethylcarbonylamino)-4-(methoxymethoxy)penta-l-ene 
(157b) from palladium (II) bromide catalysed aza-Claisen rearrangement.
1)CI3 CCN, DBU 
U V DCM
2 ) PdBr2l THF 
RT
'O O
HI\L
'O O
H N ^ O
CCI3
The reaction was carried out according to general procedure 7 for 72 h using (2£',45')-4- 
methoxymethoxypent-2-en-l-ol 144 (100 mg, 0.69 mmol) then palladium(II) bromide (18 
mg, 10 mol%) to give (3/?,4S)-3-(trichloromethylcarbonylamino)-4- 
(methoxymethoxy)penta-1-ene 157a and (35,45)-3-(trichloromethylcarbonylamino)-4- 
(methoxymethoxy)penta-1-ene 157b (87 mg, 44% over two steps) as a brown oil, in a 9 : 1 
(3R : 35) ratio. Spectroscopic data as described above.
(3/?,4S)-3-(TrichloromethyIcarbonylamino)-4-(methoxymethoxy)penta-l-ene (157a) 
and (3S,4S)-3-(trichloromethylcarbonylamino)-4-(methoxymethoxy)penta-l-ene 
(157b) from palladium(II) acetate catalysed aza-Claisen rearrangement.
"O O 1)CI3 CCN, DBU DCM
2 ) PdOAc2, THF
RT
'O O
HN. HN^ 0
CCI3
The reactions were carried out according to general procedure 7 for 96 h using (2E,4S)-4- 
methoxymethoxypent-2-en-l-ol 144 (72 mg, 0.49 mmol) then palladium(II) acetate (18 
mg, 10 mol%) to give (3/?,45)-3-(trichloromethylcarbonylamino)-4- 
(methoxymethoxy)penta-1-ene 157a and (35,45)-3-(trichloromethylcarbonylamino)-4- 
(methoxymethoxy)penta-1-ene 157b (25 mg, 18% over two steps) as a brown oil, in a 9 : 1 
(3R : 3S) ratio. Spectroscopic data as described above.
(3/?,4S)-3-(TrichloromethyIcarbonyIamino)-4-(methoxymethoxy)penta-l-ene (157a) 
and (3S,4S)-3-(trichIoromethylcarbonylamino)-4-(methoxymethoxy)penta-1-ene
(157b) from hydrogen tetrachloroaurate(m) hydrate catalysed aza-Claisen 
rearrangement.
'O O 1 )CI3 CCN, DBU DCM
2) HAuCI4 .2H20
THF, RT
'O O 'O O
HN. /O H N ^O
CCI3
The reactions were carried out according to general procedure 7 for 48 h using (2E,4S)-4- 
methoxymethoxypent-2-en-l-ol 144 (100 mg, 0.69 mmol) then hydrogen
tetrachloroaurate(III) hydrate (24 mg, 10 mol%) to give (3/?,45)-3-
(trichloromethylcarbonylamino)-4-(methoxymethoxy)penta-1-ene 157a and (35,45)-3- 
(trichloromethylcarbonylamino)-4-(methoxymethoxy)penta-1-ene 157b (98 mg, 49% over 
two steps) as a brown oil, in a 6 : 1 (3R : 35) ratio. Spectroscopic data as described above.
(3/?,4S)-3-(TrichloromethylcarbonyIamino)-4-(methoxymethoxy)penta-l-ene (157a) 
and (3S,45)-3-(trichloromethylcarbonylamino)-4-(methoxymethoxy)penta-l-ene 
(157b) from platinium(II) chloride catalysed aza-Claisen rearrangement.
'O O 1 )CI3 CCN, DBU DCM
2 ) PtCI2  
THF, RT
'O ' O '
HN. H N ^ O
CCI3
The reactions were carried out according to general procedure 7 for 144 h using (2£,45)-4- 
methoxymethoxypent-2-en-l-ol 144 (50 mg, 0.34 mmol) then platinium chloride (9 mg, 10 
mol%) to give (3/?,45)-3-(trichloromethylcarbonylamino)-4-(methoxymethoxy)penta-l- 
ene 157a and (35,45)-3-(trichloromethylcarbonylamino)-4-(methoxymethoxy)penta-1-ene 
157b (49 mg, 49% over two steps) as a brown oil, in a 10 : 1 (3R : 35) ratio. Spectroscopic 
data as described above.
2.0 Further Evidence for the Directing Effect and Enhancement of 
Stereoselectivity
(l/?,2/?)-N-(2-hydroxy-l-methyl-2-phenylethyl)-N-methylhexanamide (164).68
M e Hexanoic anhydride M e
Ph' Y X ' m  ---------------------------  Phv %
OH Me OH Me
Hexanoic anhydride (6.0 mL, 25.9 mmol) was added dropwise over several minutes to a 
solution of (l/?,2/?)-(-)-pseudoephedrine 163 (4.0 g, 24.2 mmol) in THF (60 mL). The 
reaction mixture was stirred at room temperature for 0.5 h before the excess anhydride was 
quenched by the addition of a saturated solution of aqueous sodium bicarbonate solution 
(50 mL). The reaction mixture was then extracted with ethyl acetate (3 x 50 mL). The 
organic layers were then combined, dried (MgS04) and concentrated in vacuo. Purification 
by flash column chromatography (50% ethyl acetate / petroleum ether) gave ( lR,2R)-N-(2- 
hydroxy-l-methyl-2-phenylethyl)-./V-methylhexanamide 164 (6.4 g, 100%). [a]D21 -87.2 (c 
1.0, CHC13); &H (400 MHz, CDCI3) 0.81 (3H, t, 7 7.0, 6’-H3), 0.91 (1H, d, 7 6.7, OH), 1.01 
(2H, d, 7 7.0, I-CH3), 1.24 (4H, m, 4 ’-H2, 5’-H2), 1.43 (2H, m, 3’-H2), 2.14 (2H, dt, 7 15.5, 
7.8, 2’-H2), 2.71 (3H, s, NCH3), 4.31 (1H, m, 1-H), 4.41 (1H, m, 2-H) and 7.08-7.35 (5H, 
m, Ph); §c (100 MHz, CDC13) 13.9 (CH3), 14.5 (CH3), 15.3 (CH3), 22.5 (CH2), 24.7 (CH2), 
31.5 (CH2), 34.4 (CH2), 58.3 (CH), 75.5 (CH), 126.3 (CH), 127.6 (CH), 128.3 (CH), 142.5 
(C) and 175.7 (C); mlz (Cl) 264.1965 (MH+. C16H26N 02 requires 264.1964), 256 (5%), 186 
(2) and 156 (4).
(1/?, 2R, 29R)-N- (2-hydroxy- l-methyl-2-phenylethyl)-2’^ V-dimethylhexanamide (165).68
Me O 
OH Me
A solution of lithium chloride (3.3 g, 77.6 mmol) and diisopropylamine (4.4 mL, 31.7 
mmol) in THF (25 mL) was cooled to -78 °C before «-butyllithium (2.4 M in hexane, 12.3 
mL, 29.5 mmol) was added. The solution was warmed briefly to 0 °C, then was cooled to - 
78 °C and stirred for 0.5 h. A solution of (li?,2/?)-A-(2-hydroxy-l-methyl-2-phenylethyl)- 
A-methylhexanamide 164 (3.4 g, 12.9 mmol) in THF (35 mL), cooled to 0 °C, was 
transferred to the reaction flask and the resulting solution was stirred at -78 °C for 1 h, 0 °C
LDA (2.0 equiv.) 
LiCI.Mel
Me O 
OH Me
for 0.25 h and at room temperature for 5 min. The reaction mixture was then cooled to 0 
°C and methyl iodide (2.95 mL, 19.4 mmol) was added. After 1 h, the reaction was 
quenched with a saturated solution of aqueous ammonium chloride solution (50 mL). The 
two phases were separated and the aqueous phase was extracted with ethyl acetate (3 x 50 
mL). The organic layers were combined, dried (MgS04) and concentrated. Purification by 
flash column chromatography (50% ethyl acetate / petroleum ether) gave (1R,2R,2’R)-N- 
(2-hydroxy-l-methyl-2-phenylethyl)-2’,A-dimethylhexanamide 165 (3.54 g, 99%). [a]D21 -
122.6 (c 1.0, CHC13); i)max/crn-] (neat) 3377 (OH), 2931 (CH), 1613 (CO), 1454, 1407, 1109 
and 1050; ( l/?,2/?,2’/?)-A-(2-hydroxy-l-methyl-2-phenylethyl)-2’,A-dimethylhexanamide 
165 exists as a 3 : 1 mixture of rotomers, signals for the major rotamer are: 6H (400 MHz, 
CDCI3) 0.91 (3H, t, 77.2, 6’-H3), 1.04 (3H, d, J  6.8, 2’-CH3), 1.12 (1H, d ,77.2 , OH), 1.16- 
1.42 (8H, m, 4 ’-H2, 5’-H2, 1-CH3), 1.68 (1H, m, 3’-HH), 2.59 (1H, sex, J  6.8, 2’-H), 
2.81 (3H, s, N-CH3), 4.31 (1H, m, 1-H), 4.67 (1H, t, J  7.2, 2-H) and 7.25-7.57 (5H, m, Ph); 
6C (100 MHz, CDCI3) 14.0 (CH3), 14.4 (CH3), 17.4 (CH3), 17.7 (CH3), 22.7 (CH2), 29.6 
(CH2), 33.7 (CH2), 36.0 (CH), 58.1 (CH), 76.5 (CH3), 126.2 (CH), 127.4 (CH), 128.2 (CH),
142.6 (C) and 179.1 (C); mlz (Cl) 278.2119 (MH+. C17H28N 02 requires 278.2120), 169 
(25%) and 106 (8).
(2/?)-2-Methylhexan-l-ol (166). 129
Me O
P h . X X  ^  ^  UH2 NBH3
i I I ' / . . O H
OH Me
«-Butyllithium (2.4 M in hexane, 20 mL, 47.3 mmol) was added to a solution of di­
isopropylamine (7.2 mL, 50.9 mmol) in THF at -78 °C. The resulting solution was stirred 
at -78 °C for 10 min, then warmed to 0 °C for 10 min. Borane-ammonia complex (90%,
1.67 g, 48.51 mmol) was added in one portion and the suspension was cooled to -78 °C 
before a solution of (l/?,2/?,2’/?)-A-(2-hydroxy-l-methyl-2-phenylethyl)-2’,A- 
dimethylhexanamide 165 (3.36 g, 48.5 mmol) in THF (35 mL) was added dropwise. The 
reaction mixture was warmed to room temperature and stirred for 2 h. The reaction 
mixture was then cooled to 0 °C before 2 M hydrochloric acid (120 mL) was carefully 
added and allowed to stir for 0.5 h. The organic layer was then separated followed by 
extraction of the aqueous layer with ether (4 x 45 mL). The combined organic layers were 
washed sequentially with 2 M hydrochloric acid (20 mL), 1 M sodium hydroxide solution 
(20 mL) and brine (20 mL). The diethyl ether extracts were dried (MgS04) and 
concentrated. Purification by flash column chromatography (40% diethyl ether /
petroleum ether) gave (2/?)-2-methylhexan-l-ol 166 (0.86 g, 62%) as a colourless liquid. 
[a ]D21 +12.8 (c 1.0, CHC13) (Lit.129 [a]D21 +12.8 (c 1.5, CHC13); SH (400 MHz, CDC13) 0.89- 
0.99 (6H, m, 2-CH3, 6-H3), 1.09-1.48 (7H, m, 3-H2, 4-H2, 5-H2, OH), 1.63 (1H, m, 2-H), 
3.44 (1H, dd, J  10.4, 6.4, l-HR) and 3.54 (1H, dd, J  10.4, 6.4, 1-Htf); 6C (100 MHz, 
CDCI3) 14.1 (CH3), 16.6 (CH3), 23.0 (CH2), 29.2 (CH2), 32.9 (CH2), 35.8 (CH) and 68.5 
(CH2); mlz (Cl) 85 (MH+ - CH2OH, 100%), 79 (67) and 73 (19).
Ethyl (2£',4/?)-4-methyloctan-2-enoate (167).
DMSO, (COCI)2l NEt3  
-78 °C, then
triethyl phosphonoacetate, / ^s'-Ss' / ~v C0 2Et
LiCI, DBU, MeCN
The reactions were carried out according to general procedure 3b using (2R)-2- 
methylhexan-l-ol 166 (0.1 g, 0.9 mmol). Purification by flash column chromatography 
(30% ether / petroleum ether) gave ethyl (2£,4/?)-4-methyloctan-2-enoate 167 (0.05 g, 
34%) as a colourless oil. [a]D23 -30.8 (c 1.0, CHC13); u ^ /c m '1 (neat) 2959 (CH), 1717 
(CO), 1651 (C=C), 1263 and 1177; SH (400 MHz, CDC13) 0.81 (3H, t, J  6.8, OCH2C //3),
0.97 (3H, d, J  6.8, 4-CH3), 1.16-1.38 (9H, m, 5-H2, 6-H2, 7-H2, 8-H3), 2.21 (1H, m, 4-H),
4.11 (2H, q, J  6.8, OC//2CH3), 5.70 (1H, dd, J  16.0, 1.2, 2-H) and 6.79 (1H, dd, J 16.0, 7.6,
3-H); 6C (100 MHz, CDC13) 13.0 (CH3), 13.3 (CH3), 18.4 (CH3), 21.7 (CH2), 28.4 (CH2),
34.7 (CH2), 35.5 (CH), 59.1 (CH), 118.5 (CH), 153.8 (CH) and 166.0 (C); mlz (El) 
184.1464 (MH+. CnH20O2 requires 184.1463), 169 (1%), 155 (1), 142 (11), 84 (65) and 82 
( 100).
(2E,4/?)-4-Methyloctan-2-en-l-ol (168).
DIBAL-H (2.2 equiv.) 
Et2 0, -78 °C to RT
>‘C 02Et
The reaction was carried out according to general procedure 4 using ethyl (2Zs,4/?)-4- 
methyloctan-2-enoate 167 (0.4 g, 2.2 mmol). Purification by flash column 
chromatography (30% diethyl ether / petroleum ether) gave (2£',4/?)-4-methyloctan-2-en-l- 
ol 168 (0.14 g, 45%) as a clear liquid. [a ]D19 -15.7 (c 1.0, CHC13); ,umax/cnT1 (neat) 3296 
(OH), 2921 (CH), 1675 (C=C), 1455, 1380 and 969; 6H (400 MHz, CDC13) 0.84-0.95 (5H, 
m, 7-H2, 8-H3), 0.99 (3H, d, J  6.4, 4-CH3), 1.22-1.56 (4H, m, 5-H2, 6-H2), 2.14 (1H, quin, J
6.4, 4-H), 3.49 (1H, m, OH), 4.12 (2H, m, 1-H2) and 5.60 (2H, m, 2-H, 3-H); 6C(100 MHz, 
CDC13) 14.3 (CH3), 20.4 (CH3), 22.8 (CH2), 29.5 (CH2), 36.3 (CH), 36.6 (CH2), 64.0 
(CH2), 127.0 (CH) and 139.4 (CH); mlz (Cl): 125 (MH+- H20 , 100%), 99 (10) and 83 (11).
(35,4/?)-3-(Trichloromethylcarbonylamino)-4-methyIocta- 1-ene (170a) and (3R,4R)-3- 
(trichloromethylcarbonylamino)-4-methylocta-l-ene (170b).
1)CI3 CCN, NaH, DCM
2 ) PdCI2 (MeCN)2, THF
OH HN^ 0
CCI3
The reactions were carried out according to general procedure 5 using (2E,4/?)-4- 
methyloctan-2-en-l-ol 168 (0.16 g, 1.1 mmol) then bis(acetonitrile)palladium(II) chloride 
(10 mol%). Purification by chromatography (50% diethyl ether / petroleum ether) gave the 
target compounds 170a and 170b (0.19 g, 59%) as a colourless oil, in a ratio of 1 : 2 (3R : 
3S). v mJ c m '  (neat) 3330 (NH), 2959 (CH), 1694 (CO), 1513 and 817; (3/?,4/?)-3- 
(trichloromethylcarbonylamino)-4-methylocta-1-ene 170a (major isomer): SH (400 MHz, 
CDC13) 0.81-1.02 (6H, m, 4-CH3, 8-H3), 1.21-1.46 (6H, m, 5-H2, 6-H2, 7-H2), 2.05 (1H, m, 
4-H), 4.42 (1H, m, 3-H), 5.26 (2H, m, 1-H2), 5.82 (1H, m, 2-H) and 6.63 (1H, br s, NH); 
(35,4i?)-3-(trichloromethylcarbonylamino)-4-methylocta- 1-ene 170b (minor isomer): 6H 
(400 MHz, CDC13) 0.81-1.02 (6H, m, 4-CH3, 8-H3), 1.21-1.46 (6H, m, 5-H2, 6-H2, 7-H2), 
1.91 (1H, m, 4-H), 4.48 (1H, m, 3-H), 5.18 (2H, m, 1-H2), 5.82 (1H, m, 2-H) and 6.48 (1H, 
br s, NH); mlz (Cl) 286 (M H\ 26%), 216 (12), 167 (6), 125 (12) and 104 (5).
(3/?,45)-3-(TrichloromethyIcarbonylamino)-4-hydroxypenta-l-ene (159a) and (35,45)-
3-(trichloromethyIcarbonylamino)-4-hydroxypenta-l-ene. (159b)
OH OH
OTBDMS ') DBU- CI3 CCN 
ii) TBAF
0 ^ 1  /km m\ HNV O + H N .^ .0OH 111) PdCI2 (MeCN) 2  v
CCI3
(2£',45)-4-(te?t-Butylldimethylsilyloxy)-pent-2-en-l-ol 140 (0.8 g, 3.7 mmol) was 
dissolved in DCM (20 mL) and cooled to 0 °C. l,8-Diazabicyclo[5,4,0]undec-7-ene (0.6 
mL, 4.4 mmol) and trichloroacetonitrile (0.6 mL, 5.6 mmol) were then added and the 
mixture was allowed to warm to room temperature and stirred for 2 h. The reaction
mixture was then filtered through a dry silica plug and the filtrate was concentrated in 
vacuo to give an orange liquid. The product was used without further purification. The 
allylic trichloroacetimidate and tetra-rc-butylammonium fluoride (TBAF) (1M soln in THF) 
(6.7 mL, 6.7 mmol) in THF (20 mL) was allowed to stir at room temperature for 24 h. The 
reaction mixture was concentrated and the resulting residue was taken up in ethyl acetate 
(30 mL), washed with water (25 mL), dried (MgS04) and concentrated in vacuo. The 
product was used without further purification. The allylic trichloroacetimidate was 
dissolved in THF (10 mL). Bis(acetonitrile)palladium(II) chloride (10 mol%) was then 
added and the reaction mixture stirred for 24 h. Concentration in vacuo followed by 
purification by flash column chromatography (40% ethyl acetate / petroleum ether) gave 
(3/?,45)-3-(trichloromethylcarbonylamino)-4-hydroxypenta-l-ene 159a and (3S,4S)-3- 
(trichloromethylcarbonylamino)-4-hydroxypenta-1-ene 159b (0.28 g, 31% over three 
steps) as a yellow oil, in a ratio of 4 : 1 (3R,3S). u ^ c m '1 (neat): 3403 (OH and NH), 2979 
(CH), 1693 (CO), 1644 (C=C), 1513, 1131, 929 and 822; (3/?,4S)-3-(trichloK>methyl 
carbonylamino)-4-hydroxypenta-1-ene 159a: &H (400 MHz, CDC13) 1.27 (3H, d, J  6.4, 5- 
H3), 1.97 (1H, br d, J  5.6, OH), 4.05 (1H, m, 4-H), 4.38 (1H, m, 3-H), 5.39 (2H, m, 1-H2), 
5.90 (1H, m, 2-H) and 7.24 (1H, br d, J  6.4, NH); Sc (100 MHz, CDC13) 20.0 (CH3), 58.6 
(CH), 68.9 (CH), 92.7 (C), 119.6 (CH2), 131.1 (CH) and 161.4 (C); (3S,4S)-3- 
(trichloromethylcarbonylamino)-4-hydroxypenta-1-ene 159b: SH (400 MHz, CDC13) 1.29 
(3H, d, J  6.4, 5-H3), 2.04 (1H, br s, OH), 4.05 (1H, m, 4-H), 4.38 (1H, m, 3-H), 5.33 (2H, 
m, 1-H2), 5.90 (1H, m, 2-H) and 7.13 (1H, br d, J  6.4, NH); Sc (100 MHz, CDC13) 20.0 
(CH3), 58.2 (CH), 68.6 (CH), 92.7 (C), 117.4 (CH2), 134.7 (CH) and 162.0 (C); mlz (Cl) 
245.9852 (MH+. C7Hn0 2N35Cl3 requires 245.9855), 228 (10%), 212 (7) and 172 (4).
Ethyl (2S)-2-(propyIoxy-2-ene)propanoate (175).130
The reaction was carried out according to general procedure 1 using ethyl (^-lactate 121 
(10.0 g, 84.8 mmol). Purification by flash column chromatography (40% diethyl ether / 
petroleum ether) gave ethyl (2,S)-2-(propyloxy-2-ene)propanoate 175 (13.4 g, 100%) as a 
yellow liquid. [a]D25 -67.8 (c 2.0, MeOH) (Lit.130 [a]D25 -70.7 (c 2.7, MeOH)); SH (400 
MHz, CDC13) 1.31 (3H, t, J  7.2, OCH2C//3), 1.44 (3H, d, J  6.8, 3-H3), 3.96 (1H, ddt, J
12.8, 6.8, 1.2, OCHRCHCH2), 4.02 (1H, q, J  6.8, 2-H), 4.16 (1H, ddt, J  12.8, 5.6 and 1.2, 
OCHHCHCH2), 4.23 (2H, m, OC7/2CH3), 5.20-5.34 (2H, m, OCH2CUCH2) and 5.89-5.99
(1H, m, OCH2C//CH3); 6C (100 MHz, CDC13) 14.3 (CH3), 18.7 (CH3), 60.8 (CH2), 71.1 
(CH2), 74.1 (CH), 117.7 (CH2), 134.2 (CH) and 173.3 (C); mlz (Cl) 159.1018 (MH+. 
C8H150 3 requires 159.1021), 157 (2%) and 119 (2).
Ethyl (25)-2-propyIoxypropanoate (176).131
H2 > Pd/C " ^ ^ 0
^ C 0 2Et Et0H ^ C 0 2Et
Ethyl (25)-2-(propyloxy-2-ene)propanoate 175 (12.9 g, 81.6 mmol) was dissolved in 
ethanol (50 mL) before palladium (10% on carbon) (50 mg) was added. The reaction 
vessel was flushed with hydrogen then allowed to stir under an atmosphere of hydrogen for 
72 h. The reaction mixture was filtered through a short pad of Celite®, which was then 
washed with chloroform. The combined filtrates were concentrated and purified by flash 
chromatography (15% diethyl ether / petroleum ether) to give ethyl (2S)-2- 
propyloxypropanoate 176 (9.21 g, 71% yield) as a yellow liquid. [a]D25 -98.3 (neat), 
(Lit.131 [a]D20 -100.9 (neat)); 6H (400 MHz, CDC13) 0.95 (3H, t, 7 7.2, OCH2CH2C//3), 1.31 
(3H, t, J  7.2, OCH2C//3), 1.42 (3H, d, J  6.8, 3-H3), 1.64 (2H, sex, J  7.2, OCH2C//2CH3), 
3.34 (1H, dt, J  8.8, 7.2, OCT/HCH2CH3), 3.54 (1H, dt, J  8.8, 7.2, OCHHCH2CH3) 3.96 
(1H, q, J  6.8, 2-H) and 4.22 (2H, m, OC/72CH3); 6C (100 MHz, CDC13) 10.5 (CH3), 14.3 
(CH3), 18.7 (CH3), 23.0 (CH2), 60.7 (CH2), 72.0 (CH2), 75.0 (CH) and 173.6 (C); mlz (Cl) 
161.1176 (MH+. C8H]70 3 requires 161.1178), 228 (10%), 212 (7) and 172 (4).
(25)-2-Propyloxypropan-l-ol (177). 132
DIBAL-H (2.2 equiv.)
9  Et2 0, -78 °C to RT 9
'C 02Me
The reaction was carried out according to general procedure 2b using ethyl (25)-2- 
propyloxypropanoate 176 (5.0 g, 31.3 mmol). Purification was carried out by flash column 
chromatography (50% diethyl ether / petroleum ether) to give (25)-2-propyloxypropan-1 -ol 
177 (1.83 g, 51%) as clear liquid. [a]D24 +17.8° (c 1.0, CHC13), (Lit.132 [a]D20 +26.1 (neat); 
dH (400 MHz, CDC13) 0.94 (3H, t, J  7.6, OCH2CH2C //3), 1.12 (3H, d, J  6.0, 3-H3), 1.61 
(2H, m, OCH2CH2CH2), 2.08 (1H, br s, OH), 3.34 (1H, dt, J  8.8, 6.8, OCHHCH2CH2) and 
3.41-3.61 (4H, m, 1-H2, 2-H and OCH//CH2CH3); 6C(100 MHz, CDC13) 10.6 (CH3), 15.9
(CH3), 23.3 (CH2), 66.4 (CH2), 70.5 (CH2) and 75.7 (CH); mlz (Cl) 119.1074 (MH+. 
C6H150 2 requires 119.1072), 113 (3%) and 85 (4).
Ethyl (2E,45)-4-propyIoxypent-2-enoate (178).
DMSO, (COCI)2, NEt3  
-78 °C, then
triethyl phosphonoacetate, C 02Et
LiCI, DBU, MeCN
The reactions were carried out according to general procedure 3b using (25)- 
propyloxypropan-l-ol 177 (1.8 g, 15.3 mmol). Purification was carried out by flash 
column chromatography (40% diethyl ether / petroleum ether) to give ethyl (2£,45)-4- 
propyloxypent-2-enoate 178 (1.15 g, 41% over two steps). [a]D24 -10.0 (c 1.0, CHC13); 
u j c m '1 (neat): 2977 (CH), 1719 (CO), 1658 (C=C), 1271, 1180, 1097 and 982; SH (400 
MHz, CDC13) 0.94 (3H, t, 7 7.0, OCH2CH2C//3), 1.30 (3H, d, 7 6.4, 5-H3), 1.32 (3H, t, 7
7.2, OCH2C//3), 1.61 (2H, sex, 7 7.0, OCH2C//2CH3), 3.34 (1H, dt, 7 8.8, 7.0, 
OC#HCH2CH3), 3.41 (1H, dt, 7 8.8, 7.0, OCH//CH2CH3), 4.01 (1H, quin d, 7 6.4, 1.2, 4- 
H), 4.22 (2H, q, 7 7.2, OC//2CH3), 5.99 (1H, dd, 7 15.6, 1.2, 2-H) and 6.87 (1H, dd, 7 15.6,
6.4, 3-H); Sc (100 MHz, CDC13) 10.6 (CH3), 14.3 (CH3), 20.7 (CH3), 23.1 (CH2), 60.4 
(CH2), 70.8 (CH2), 74.6 (CH), 120.8 (CH), 149.8 (CH) and 166.5 (C); mlz (Cl) 187.1336 
(MH+. C10H18O3 requires 187.1334), 186 (1%), 127 (12) and 117 (1).
(2E,45)-4-Propyloxypent-2-en-l-oI (179).
DIBAL-H (2.2 equiv.) 
Et2 0 , -78 °C to RT
'C 02Et
The reaction was carried out according to general procedure 4 using ethyl (2£,45)-4- 
propyloxypent-2-enoate 178 (1.1 g, 5.8 mmol). Purification was carried out by flash 
column chromatography (50% diethyl ether / petroleum ether) to give (2£,45)-4- 
propyloxypent-2-en-l-ol 179 (0.55 g, 66%) as a clear liquid. [a]D24 -11.0 (c 1.0, CHC13); 
u j c m '1 (neat): 3367 (OH), 2970 (CH), 1653 (C=C), 1558, 1541, 1456, 1086 and 971; &H 
(400 MHz, CDC13) 0.93 (3H, t, 7 7.2, CH2CH2C//3), 1.26 (3H, d, 7 6.4, 5-H3), 1.41 (1H, t, 7
6.4, OH), 1.60 (2H, sex, 7 7.2, CH2C//2CH3), 3.30 (1H, dt, 7 8.8, 7.2, C//HCH2CH3), 3.42 
(1H, dt, 7 8.8, 7.2, CH//CH2CH3), 3.88 (1H, quin, 7 6.4, 4-H), 4.18 (2H, m, 1-H2), 5.66 
(1H, ddt, 7 15.2, 6.4, 1.2, 3-H) and 5.81 (1H, dt, 7 15.2, 5.6, 2-H); Sc (100 MHz,
CDC13) 10.6 (CH3), 21.3 (CH3), 23.1 (CH2), 63.1 (CH2), 70.1 (CH2), 75.5 (CH), 130.2 (CH) 
and 134.0 (CH); m/z (Cl) 145.1223 (MH+. C8H170 2 requires 145.1229), 127 (44%) and 85 
( 100).
(3/?,45)-TrichIoromethyIcarbonylamino-4-propyIoxypenta-l-ene (187a) and (35,45)- 
trichloromethyIcarbonylamino-4-propyloxypenta-l-ene (187b).
'O
1 )CI3 CCN, dbu , dcm
2 ) PdCI2 (MeCN)2, THF
'O
HN.
'O
H N ^ O
CCI3
The reactions were carried out according to general procedure 7 using (2£,45)-4- 
propyloxypent-2-en-l-ol 179 (0.2 g, 1.4 mmol) and bis(acetonitrile)palladium(Il) chloride 
(10 mol%). Purification was carried out by flash column chromatography (30% diethyl 
ether / petroleum ether) to give the title compounds 187a and 187b (0.25 g, 77%) as a 
brown oil in a ratio of 5 : 1 (37?,35). (neat): 3331 (NH), 2931 (CH), 1715 (CO),
1652 (C=C), 1518, 1114 and 822; (3/?,45)-trichloromethylcarbonylamino-4-
propyloxypenta-1 -ene 187a: SH (400 MHz, CDC13) 0.96 (3H, t, J  7.7, CH2CH2CH3), 1.18 
(3H, d, J  6.4, 5-H3), 1.54-1.65 (2H, m, CH2C7/2CH3), 3.29 (1H, dt, J 8.8, 6.4, 
C/7HCH2CH3), 3.62-3.67 (2H, m, 4-H and CHHCH2CH3), 4.32-4.39 (1H, m, 3-H), 5.31- 
5.36 (2H, m, 1-H2) and 5.82-5.91 (1H, m, 2-H); 6C(100 MHz, CDC13) 10.8 (CH3), 16.0 
(CH3), 23.1 (CH2), 57.9 (CH), 70.8 (CH2), 75.8 (CH), 92.5 (C), 119.2 (CH2), 131.8 (CH) 
and 161.0 (C); (35,45)-trichloromethylcarbonylamino-4-propyloxypenta-l-ene 187b: 6H 
(400 MHz, CDC13) 0.93 (3H, t, J  7.6, CH2CH2C//3), 1.21 (3H, d, J  6.4, 5-H3), 1.57-1.66 
(2H, m, CH2CH2CH3), 3.34 (1H, dt, J 8.8, 6.8, C//HCH2CH3), 3.54-3.60 (2H, m, 4-H and 
CH//CH2CH3), 4.32-4.39 (1H, m, 3-H), 5.23-5.28 (2H, m, 1-H2) and 5.87-5.95 (1H, m, 2- 
H); 6C(100 MHz, CDC13) 10.7 (CH3), 17.0 (CH3), 23.1 (CH2), 58.1 (CH), 71.1 (CH2), 75.8 
(CH), 88.4 (C), 116.9 (CH2), 135.1 (CH) and 161.4 (C); m/z (Cl) 288.0328 (MH+. 
C10H17O2N35Cl3 requires 288.0325), 254 (20%) and 218 (100).
4-Methoxybutanoic acid (181).133
(!r°
y-Butyrolactone 180 (10.0 g, 116.3 mmol) was added dropwise to a solution of sodium (8.0 
g, 348.8 mmol) in methanol at 0 °C. The reaction mixture was then heated under reflux for 
48 h, cooled and concentrated. The resulting white residue was acidified to pH 2 with 2 M 
hydrochloric acid solution and extracted with ethyl acetate (3 x 50 mL). The combined 
organic layers were dried (MgS04) and concentrated to give 4-methoxybutanoic acid 181 
(7.0 g, 51%) as a clear oil. 6H (400 MHz, CDC13) 1.90 (2H, m, 3-H2), 2.48 (2H, t, J  7.2, 2- 
H2), 3.36 (3H, s, OMe) and 3.45 (2H, t, J  6.0, 4-H2); Sc (100 MHz, CDC13) 24.6 (CH3),
30.8 (CH2), 58.6 (CH3), 71.5 (CH2) and 178.9 (C); m/z (Cl) 119.0710 (MH+. C5Hn0 3 
requires 119.0708), 101 (38%) and 87 (21).
(l/?,2/?)-AA-(2-hydroxy-l-methyl-2-phenylethyl)-4’-methyloxy-A^-methylbutyramide 
(182).
i. MeOCOCI, NEt3  Me O
THF , P h . X , , A  ,OMey  N v
iL Me OH Me
PhV % H  
OH Me
4-Methoxybutanoic acid 181 (2.36 g, 20.0 mmol) was dissolved in THF (50 mL) and 
cooled to 0°C. Triethylamine (3.1 mL, 22.0 mmol) and methyl chloroformate (1.7 mL,
22.0 mmol) were then added producing a white precipitate. This suspension was stirred 
for 1 h before a solution of (l/?,2R)-(-)-pseudoephedrine (3.63 g, 22.0 mmol) in THF (20 
mL) was added and the mixture was allowed to stir at room temperature for 12 h. The 
reaction was quenched with brine (50 mL), concentrated and then extracted with ethyl 
acetate (3 x 50 mL). The combined organic layers were dried (MgS04) and concentrated 
in vacuo to give a clear liquid. Purification was carried out by flash column 
chromatography (50% ethyl acetate / petroleum ether) to give (l/?,2^)-A^-(2-hydroxy-l- 
methyl-2-phenylethyl)-4’-methyloxy-7V-methylbutyramide 182 (5.1 g, 97%) as a clear 
liquid. [a]D21 -91.8 (c 1.0, CHC13); v mJ c m '  (neat) 3390 (OH), 2932 (CH), 1623 (CO), 
1453 (C=C), 1118, 756 and 703; (l/?,2/?)-Af-(2-hydroxy-l-methyl-2-phenylethyl)-4’- 
methyloxy-Af-methylbutyramide 182 exists as a 3 : 1 mixture of rotomers, signals for the
Na
MeOH
major rotamer are: SH (400 MHz, CDC13) 1.12 (3H, d, J  6.8, 1-CH3), 1.92 (2H, m, 3’-H2), 
2.40 (2H, m, 2’-H2), 2.85 (3H, s, NMe), 3.34 (3H, s, OMe), 3.43 (2H, t, J  6.0, 4’-H2), 4.27 
(1H, br s, 2-OH), 4.47 (1H, m, 1-H), 4.56-4.63 (1H, m, 2-H) and 7.33-4.40 (5H, m, Ph); 6C 
(100 MHz, CDC13) 14.5 (CH3), 25.1 (CH2), 30.9 (CH2), 58.6 (CH3), 71.8 (CH2), 76.6 
(CH3), 126.4 (CH), 127.0 (CH), 127.7 (CH), 128.4 (CH), 128.7 (CH), 142.3 (C) and 175.1 
(C); m/z (Cl) 266.1755 (MH+. C ^ H ^ N  requires 266.1756), 248 (3%) and 234 (2).
(l/?,2/?,2,/?)-A^-(2-Hydroxy-l-methyl-2-phenylethyl)-4’-methoxy-2, V^- 
diinethylbutyramide (183).
Me O
OMe
i. LDA, LiCI, THF
ii. Mel
OH Me
Me O
" ’v S
OH Me
OMe
A solution of lithium chloride (0.09 g, 2.15 mmol) and diisopropylamine (0.11 mL, 0.81 
mmol) in THF (5 mL) was cooled to -78 °C before «-butyllithium (2.5 M in hexane, 0.3 
mL, 0.75 mmol) was added. The solution was warmed briefly to 0 °C, then was cooled to 
-78 °C and stirred for 0.5 hr. A solution of (l/?,2tf)-A-(2-hydroxy-l-methyl-2- 
phenylethyl)-4’-methyloxy-A-methylbutyramide 182 (95 mg, 0.35 mmol) in THF (10 mL), 
cooled to 0 °C, was transferred to the reaction flask and the resulting solution was stirred at 
-78 °C for 1 hr, 0 °C for 0.25 hr and at room temperature for 5 min. The reaction mixture 
was then cooled to 0 °C, where upon methyl iodide (0.08 mL, 0.54 mmol) was added. 
After 3 h the reaction was quenched with saturated aqueous ammonium chloride solution 
(20 mL). The aqueous layer was separated and extracted with ethyl acetate (3 x 20 mL). 
The combined organic layers were dried (MgS04) and concentrated to give a yellow liquid. 
Purification by chromatography (50 % ethyl acetate / petroleum ether) gave (l/?,2/?,27?)- 
A-(2-Hydroxy-l-methyl-2-phenylethyl)-4’-methoxy-2’,A-dimethylbutyramide 183 (0.1 g, 
65%) as a yellow liquid. [a]D23 -96.2 (c 1.0, CHC13); 'Umax/cm'1 (neat) 3364 (OH), 2973 
(CH), 1612 (CO) 1451, 1111, 750 and 700; (1/?,2/^2’/?)-A-(2-Hydroxy-1-methy 1-2- 
phenylethyl)-4’-methoxy-2’,A-dimethylbutyramide 183 exists as a 3:1 mixture of 
rotamers, signals for major rotamer are: SH (400 MHz, CDC13) 1.06 (3H, d, J  6.8, 1-CH3),
1.13 (3H, d, J 6.8, 2’-CH3), 1.62 (1H, m, 3’-HH), 1.89-2.05 (2H, m, 2’-H and 3’-HH), 2.87 
(3H, s, NMe), 3.31 (3H, s, OMe), 3.38 (2H, m, 4’-H2), 4.45 (1H, br s, OH), 4.55-4.64 (2H, 
m, 1-H and 2-H) and 7.35 (5H, m, Ph); Sc (100 MHz, CDC13) 14.4 (CH3), 17.7 (CH3), 33.4 
(CH), 34.1 (CH2), 58.6 (CH3), 70.6 (CH2), 76.3 (CH3), 126.3 (CH), 126.5 (CH), 127.0
(CH), 127.6 (CH), 128.7 (CH), 142.4 (C) and 178.7 (C); m/z (Cl) 280.1911 (MH+.
C16H260 6N requires 280.1913), 262 (16%) and 248 (11).
Ethyl (2Zs,4S)-4-methyl-6-methoxyhex-2-enoate (185).
i. LiAIH(OEt) 3
Me O Hexane-THF HWE
n '  ' y  "  — — — -----------------------
° H Me ii. TFA.1MHCI 0
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'C 02Et
Lithium aluminium hydride (0.22 g, 5.86 mmol) was suspended in anhydrous hexanes (20 
mL) and cooled to 0 °C. Anhydrous ethyl acetate (0.85 mL. 8.70 mmol) was added 
drop wise over 0.5 h and the solution was allowed to stir for a further 1 h before being 
cooled to -78 °C. (l/?,2^,2’/?)-A-(2-Hydroxy-l-methyl-2-phenylethyl)-4’-methoxy-2’,A- 
dimethylbutyramide 183 (0.71 g, 2.55 mmol) in THF (15 mL) was added to the 
LiAlH(OEt)3 solution with the evolution of H2 gas. The reaction mixture was then allowed 
to stir for 0.25 h at -78 °C, then at 0 °C for 5 h. The reaction was quenched with a solution 
of trifluoroacetic acid (1.9 mL, 25.5 mmol) in aqueous 1 M hydrochloric acid solution (10 
mL). Separation of the organic layer was followed by extraction of the aqueous layer with 
diethyl ether (3 x 20 mL). The combined organic layers were then neutralized to pH 7 
with sodium hydrogen carbonate solution (30 mL). The aqueous layer was extracted with 
diethyl ether (2 x 20 mL) and the combined organic layers were dried (MgS04). The 
aldehyde was used without further purification. A solution of lithium chloride (0.16 mg,
3.8 mmol), triethyl phosphonoacetate (0.76 mL, 3.8 mmol) and 1,8- 
diazabicyclo[5,4,0]undec-7-ene (0.57 mL, 3.8 mmol) in acetonitrile (10 mL) was prepared 
and stirred for 0.5 h. The ylide mixture was added to the aldehyde solution and the 
reaction mixture was allowed to stir at room temperature 12 h. The reaction was quenched 
with brine (50 mL) then concentrated to give an orange residue. This residue was 
extracted with diethyl ether (5 x 50 mL) and the organic layers were combined, dried 
(MgS04) and concentrated to give an orange liquid. Purification by flash column 
chromatography (50% diethyl ether / petroleum ether) gave ethyl (2E,4S)-4-methyl-6- 
methoxyhex-2-enoate 185 (0.1 mL, 21% over two steps) as a colourless oil. [a]D22 -27.5 (c
1.0, CHC13); v mJ c m l (neat) 2931 (CH), 1719 (CO), 1651 (C=C), 1270, 1179 and 1120; 6H 
(400 MHz, CDCI3) 1.09 (3H, d, J  6.8, 4-CH3), 1.31 (3H, t, J  7.2, OCU2CH3), 1.66 (2H, q, J
6.8, 5-H2), 2.50 (1H, m, 4-H), 3.33 (3H, s, OMe), 3.35-3.41 (2H, m, 6-H2), 4.20 (2H, q, J
7.2, OC//2CH3), 5.81 (1H, dd, J  15.6, 1.2, 2-H) and 6.87 (1H, dd, J  15.6, 8.0, 3-H); Sc (100 
MHz, CDCI3) 14.3 (CH3), 19.4 (CH3), 33.3 (CH), 35.7 (CH2), 58.6 (CH3), 60.2 (CH3), 70.3
(CH2), 120.0 (CH), 153.8 (CH) and 166.8 (C); m/z (Cl) 187.1329 (MH+. C10H19O3 requires
187.1334), 232 (2%) and 187 (100).
(2Zs,4S)-4-Methyl-6-methoxyhex-2-en-l-ol (186).
'O'
DIBAL-H (2 .2  equiv .) 
Et2 0 ,  -78  °C  to  RT 'O'
'C 0 2Et
The reaction was carried out according to general procedure 4 using ethyl (2E,4S)-4- 
methyl-6-methoxyhex-2-enoate 185 (0.8 g, 0.4 mmol). Purification was carried out by 
flash column chromatography (50% diethyl ether / petroleum ether) to give (2E,4S)-4- 
methyl-6-methoxyhex-2-en-l-ol 186 (0.5 g, 87%) as a colourless oil. [a]D21 -22.7 (c 1.0, 
CHC13); v mJ c m l (neat): 3382 (OH), 2929 (CH), 1456 (C=C), 1116, 972 and 669; SH (400 
MHz, CDCI3) 1.03 (3H, d, J  6.8, 4-CH3), 1.36 (1H, br s, OH), 1.59 (2H, q, /  6.4, 5-H2), 
2.32 (1H, m, 4-H), 3.34 (3H, s, OMe), 3.39 (2H, t, J  6.4, 6-H2), 4.12 (2H, m, 1-H2) and 
5.56-5.68 (2H, m, 2-Hand 3-H); 6C(100 MHz, CDC13) 20.4 (CH3), 33.2 (CH), 36.4 (CH2),
58.6 (CH3), 63.8 (CH2), 70.8 (CH2), 127.6 (CH) and 138.2 (CH); m/z (Cl) 127.1125 (MH+- 
H20. C8H150  requires 127.1123), 95 (19%) and 85 (3).
(3/?,4/?)-(Trichloromethylcarbonylamino)-4-methyl-6-methoxyhexa-l-ene (188a) and 
(35,4/?)-3-(trichloromethylcarbonylamino)-4-methyl-6-methoxyhexa-l-ene (188b).
' O '
1 )C I 3 CCN, d b u ,  d c m
2) PdC I2 (M eC N )2, THF
' O ' ' O '
H N . ^ O H N ^O
CCI3
The reactions were carried out according to general procedure 7 using (2£',45,)-4-methyl-6- 
methoxyhex-2-en-l-ol 186 (0.05 g, 0.4 mmol) and bis(acetonitrile)palladium(II) chloride 
(10 mol%). Purification by flash column chromatography (30% diethyl ether / petroleum 
ether) gave (3/?,4/?)-(trichloromethylcarbonylamino)-4-methyl-6-methoxyhexa-l-ene 188a 
and (35,4/?)-3-(trichloromethylcarbonylamino)-4-methyl-6-methoxyhexa-l-ene 188b (0.06 
mg, 60% over two steps) as a brown oil, in a ratio of 1 : 2 (3R : 3S). (Found: C, 41.7; H, 
5.6; N, 4.7, C10H16O2NCl3 requires C, 41.6; H, 5.6; N, 4.9%); v mJ c m ] (neat): 3331 (NH), 
2931 (CH), 1715 (CO), 1652 (C=C), 1518, 1114 and 822; (3R,4R)~
(trichloromethylcarbonylamino)-4-methyl-6-methoxyhexa-l-ene 188a: 6H (400 MHz,
CDC13) 1.00 (3H, d, 7 6.8, 4-CH3), 1.66 (2H, m, 5-H2), 1.97 (1H, m, 4-H), 3.37 (3H, s, 
OMe), 3.45 (2H, m, 6-H2), 4.39 (1H, m, 3-H), 5.26 (2H, m, 1-H2), 5.81 (1H, m, 2-H) and
7.67 (1H, br d, 7 7.2, NH); (C); 6C (100 MHz, CDC13) 17.5 (CH3), 32.6 (CH2), 35.3 (CH),
57.2 (CH3), 58.8 (CH), 71.2 (CH), 93.3 (C), 117.0 (CH), 134.3 (CH) and 161.4 (C); 
(3S,4/?)-3-(trichloromethylcarbonylamino)-4-methyl-6-methoxyhexa-l-ene 188b: &H (400 
MHz, CDC13) 1.02 (3H, d, 7 6.8, 4-CH3), 1.66 (2H, m, 5-H2), 2.05 (1H, m, 4-H), 3.36 (3H, 
s, OMe), 3.51 (2H, m, 6-H2), 4.39 (1H, m, 3-H), 5.22 (2H, m, 1-H2), 5.79 (1H, m, 2-H) and 
7.76 (1H, br d, 7 6.0, NH); 6C(100 MHz, CDC13) 16.3 (CH3), 31.2 (CH2), 34.6 (CH), 57.7 
(CH3), 58.9 (CH), 69.5 (CH), 93.3 (C), 116.0 (CH), 135.9 (CH) and 161.7; m/z (Cl) 290 
(MH+, 89%), 254 (20), 220 (36), 218 (100) and 184 (8).
Ethyl (2S)-2-(methylsuIfanylmethoxy)propanoate (190).
9H ^s'^ci
C° 2Et Et3 N, AgN02  C0 2Et
A solution of ethyl (S)-lactate 121 (0.50 g, 4.24 mmol) and chloromethylmethyl sulfide 
(0.43, 5.09 mmol) in THF (15 mL) was added to a solution of silver nitrate (0.79 mg, 4.66 
mmol) and triethylamine (0.71 mL, 5.09 mmol) in THF (10 mL). The reaction mixture 
was allowed to stir at room temperature for 4 h before being heated to 80 °C and stirred for 
5 days. The mixture was then filtered through Celite® then washed with saturated 
ammonium chloride solution (20 mL), saturated sodium hydrogen carbonate solution (20 
mL) and water (20 mL). The organic layer was then dried (MgS04) and concentrated to 
give a brown liquid. Purification was carried out by flash column chromatography (30% 
diethyl ether / petroleum ether) to give ethyl (2S)-2-(methylsulfanylmethoxy)propanoate 
190 (0.16 g, 21%). [a]D21 -166.0 (c 1.0, CHC13); u j c m '1 (neat) 2984 (CH), 1746 (CO), 
1201, 1109, 1063 and 1024; SH (400 MHz, CDC13) 1.31 (3H, t, 77.2, OCH2C//3), 1.44 (3H, 
d, 7 7.0, 3-H3), 2.18 (3H, s, SMe), 4.22 (2H, qd, 7 7.2, 1.2, OC//2CH3), 4.37 (1H, q, 7 7.0,
2-H), 4.66 (1H, d, 7 11.6, OCtfHS) and 4.79 (1H, d, 7 11.6, OCH//S); &c (100 MHz, 
CDC13) 14.0 (CH3), 14.2 (CH3), 18.4 (CH3), 61.0 (CH2), 71.2 (CH), 74.3 (CH2) and 172.9 
(C); m/z (Cl) 179.0740 (MH+. C7H]50 3S requires 179.0742) 163 (3%), 147 (3), 131 (61), 
119 (4) and 102 (8).
(2S)-2-MethyIsuIfanyImethoxypropan-l-oI (191).
DIBAL-H (2.2 equiv.) 
'O Et2 0, -78 °C to RT
^ C 0 2Et
The reaction was carried out according to general procedure 2b using ethyl (2S)-2- 
(methylsulfanylmethoxy)propanoate 190 (1.58 g, 8.87 mmol). Purification by flash 
column chromatography (40% diethyl ether / petroleum) gave (2S)-2- 
methylsulfanylmethoxypropan-l-ol 191 (0.75 g, 82%) as colourless oil. [a]D19 +146.9 (c
1.0, CHC13); v mJ c m '  (neat) 3418 (OH), 2922 (CH), 1436, 1301, 1060 and 681; 6H (400 
MHz, CDCI3) 1.16 (3H, d, 76.4, 3-H3), 2.13 (1H, m, OH), 2.20 (3H, s, SMe), 3.52 (1H, dd, 
7 11.6 and 6.8, 1-//H), 3.64 (1H, dd, 7 11.6 and 3.2, 1-Htf), 3.90 (1H, m, 2-H), 4.65 (1H, 
d, 7 11.2, OC7/HS) and 4.77 (1H, d, 7 11.2, OCH//S); 6C(100 MHz, CDC13) 14.0 (CH3), 
15.9 (CH3), 66.2 (CH2), 73.3 (CH2) and 74.0 (CH); m/z (Cl) 137.0517 (MH+. C5H130 2S 
requires 137.0636) 118 (12%), 105 (22), 89 (100) and 75 (35).
Ethyl (2E,4S)-4-methylsulfanylmethoxypent-2-enoate (192).
DMSO, (COCI)2l NEt3  
-78 °C, then
.OH
triethyl phosphonoacetate, C 02Et
LiCI, DBU, MeCN
The reactions were carried out according to general procedure 3b using (2S)-2- 
methylsulfanylmethoxypropan-l-ol 191 (0.55 g, 5.28 mmol). Purification was carried out 
by flash column chromatography (30% diethyl ether / petroleum ether) to give ethyl 
(2E,45)-4-methylsulfanylmethoxypent-2-enoate 192 (0.4 g, 37%) as colourless oil. [a]D21 - 
232.4 (c 1.0, CHCI3); u j c m '1 (neat) 2980 (CH), 1716 (CO), 1659 (C=C), 1300, 1266, 
1180 and 1051; SH (400 MHz, CDC13) 1.29 (6H, m, OCH2C7/3 and 5-H3), 2.17 (3H, s, 
SMe), 4.22 (2H, q, 7 6.8, OC7/2CH3), 4.48 (1H, quin d, 76.2, 1.2, 4-H), 4.55 (1H, d, 7 11.6, 
OCHHS), 4.70 (1H, d, 7 11.6, OCHHS), 6.01 (1H, dd, 7 15.6, 1.2, 2-H) and 6.84 (1H, dd, 7 
15.6, 6.2, 3-H); 6C(100 MHz, CDC13) 13.8 (CH3), 14.3 (CH3), 20.3 (CH3), 60.5 (CH2), 70.9 
(CH), 72.8 (CH2), 121.6 (CH), 148.4 (CH) and 166.3 (C); m/z (Cl) 205.0896 (MH+. 
C9H170 3S requires 205.0898) 175 (10%), 157 (100) and 127 (35).
(2Z?,4S)-Methylsulfanylmethoxypent-2-en- l-ol (193).
'O
DIBAL-H (2.2 equiv.) 
Et2 0, -78 °C to RT ' 0
'C 02Et
The reaction was carried out according to general procedure 4 using (2£,4S)-4- 
methylsulfanylmethoxypent-2-enoate 192 (0.34 g, 1.79 mmol). Purification was carried 
out by flash column chromatography using (50% diethyl ether / petroleum ether) to give 
(2£^,45)-methylsulfanylmethoxypent-2-en-l-ol 193 (0.22 mg, 75%) as a colourless oil. 
[a]D21 -250.3 (c 1.0, CHC13); u j c m ’1 (neat) 3403 (OH), 2975 (CH), 1671 (C=C), 1433, 
1374, 1300 and 1057; 6H (400 MHz, CDC13) 1.29 (3H, d, 7 6.4, 5-H3), 1.47 (1H, br s, OH), 
2.18 (3H, s, SMe), 4.19 (2H, dd, 7 5.2, 1.6, 1-H2), 4.33 (1H, m, 4-H), 4.55 (1H, d, 7 11.6, 
OC7/HS), 4.67 (1H, d, 7 11.6, OCH//S), 5.63 (1H, ddt, 7 15.6, 7.6 and 1.6, 3-H) and 5.86 
(1H, dtd, 7 15.6, 5.2, 0.8, 2-H); 6C(100 MHz, CDC13) 13.8 (CH3), 21.1 (CH3), 62.9 (CH2),
72.0 (CH2), 72.1 (CH), 131.7 (CH) and 132.3 (CH); m/z (Cl) 145.0685 (MH+ - H20. 
C7H13OS requires 145.0688) 145 (38%), 133 (100), 115 (32) and 85 (67).
(3/?,4S)-3-(TrichIoromethyIcarbonylamino)-4-(methoxymethoxy)penta-l-ene (157a) 
and (3S,4S)-3-(trichloromethylcarbonylamino)-4-(methoxymethoxy)penta-l-ene 
(157b) from bis(acetonitrile)palladium(Il) chloride in diethyl ether as solvent.
‘O O 1)CI3 CCN, d b u  PCM
2) PdCI2 (MeCN) 2
Et2 0, RT
'O O "O O
HN. /O + H N ^ O
CCI3
The reaction was carried out according to general procedure 8 for 24 h using (2E,4S)-4- 
methoxymethoxypent-2-en-l-ol 144 (50 mg, 0.34 mmol) then
bis(acetonitrile)palladium(II) chloride (8 mg, 10 mol%) in diethyl ether (10 mL) to give 
(3/?,45)-3-(trichloromethylcarbonylamino)-4-(methoxymethoxy)penta- 1-ene 157a and
(3S,4S)-3-(trichloromethylcarbonylamino)-4-(methoxymethoxy)penta-l-ene 157b (47 mg, 
47% over two steps) as a brown oil, in a 12 : 1 (3R : 3S) ratio. Spectroscopic data as 
described above.
(3/?,4S)-3-(Trichloromethylcarbonylamino)-4-(methoxymethoxy)penta-l-ene (157a) 
and (3S,4S)-3-(trichloromethylcarbonylamino)-4-(methoxymethoxy)penta-l-ene 
(157b) from bis(acetonitrile)paIladium(II) chloride in acetonitrile as solvent.
'O O 1 )CI3 CCN, dbu  PCM
2 ) PdCI2 (MeCN) 2
MeCN, RT
'O O 'O O
HN. + H N y 0
CCI3
The reaction was carried out according to general procedure 8 for 24 h using (2£,45)-4- 
methoxymethoxypent-2-en-l-ol 144 (100 mg, 0.69 mmol) then
bis(acetonitrile)palladium(II) chloride (18 mg, 10 mol%) in acetonitrile (10 mL) to give 
(3/?,45)-3-(trichloromethylcarbonylamino)-4-(methoxymethoxy)penta-1 -ene 157a and
(35,4S)-3-(trichloromethylcarbonylamino)-4-(methoxymethoxy)penta-l-ene 157b (64 mg, 
32% over two steps) as a brown oil, in a 9 : 1 (3R : 35) ratio. Spectroscopic data as 
described above.
(3J?,4S)-3-(Trichloromethylcarbonylamino)-4-(methoxymethoxy)penta-l-ene (157a) 
and (3S,4S)-3-(trichloromethylcarbonylamino)-4-(methoxymethoxy)penta-l-ene 
(157b) from bis(acetonitrile)palladium(II) chloride in DCM as solvent.
'O O 1)CI3 CCN, dbu  DCM
2) PdCI2 (MeCN) 2
DCM, RT
'O O 'O O
HN. + H N ^ O
CCI3
The reaction was carried out according to general procedure 8 for 24 h using (2£,,45)-4- 
methoxymethoxypent-2-en-l-ol 144 (50 mg, 0.34 mmol) then
bis(acetonitrile)palladium(II) chloride (8 mg, 10 mol%) in DCM (10 mL) to give (3/?,45)-
3-(trichloromethylcarbonylamino)-4-(methoxymethoxy)penta-l-ene 157a and (35,45)-3- 
(trichloromethylcarbonylamino)-4-(methoxymethoxy)penta-l-ene 157b (47 mg, 49% over 
two steps) as a brown oil, in a 12 : 1 (3R : 35) ratio. Spectroscopic data as described 
above.
(3/?,4S)-3-(TrichloromethyIcarbonylamino)-4-(methoxymethoxy)penta-l-ene (157a) 
and (3S,4S)-3-(trichloromethylcarbonylamino)-4-(methoxymethoxy)penta-l-ene 
(157b) from bis(acetonitrile)palladium(II) chloride in toluene as solvent.
'O O 1)CI3 CCN, d b u  DCM
2 ) PdCI2 (MeCN) 2  
Toluene, RT
'O O 'O O
HN. H N y 0
CCI3
The reaction was carried out according to general procedure 8 for 24 h using (2£,45)-4- 
methoxymethoxypent-2-en-l-ol 144 (50 mg, 0.34 mmol) then
bis(acetonitrile)palladium(II) chloride (8 mg, 10 mol%) in toluene (10 mL) to give 
(3/?,45)-3-(trichloromethylcarbonylamino)-4-(methoxymethoxy)penta-1 -ene 157a and
(35,45)-3-(trichloromethylcarbonylamino)-4-(methoxymethoxy)penta-l-ene 157b (56 mg, 
56% over two steps) as a brown oil, in a 15 : 1 (3R : 35) ratio. Spectroscopic data as 
described above.
(3/?,45)-3-(TrichloromethylcarbonyIamino)-4-(methoxymethoxy)penta-l-ene (157a) 
and (3S,4S)-3-(trichloromethyIcarbonyIamino)-4-(methoxymethoxy)penta-l-ene 
(157b) from bis(acetonitrile)palladium(II) chloride in l-n-butyl-3-methylimidazolium 
tetrafluoroborate as solvent.
'O O 1)CI3 CCN, d b u  DCM
2) PdCI2 (MeCN) 2  
(BMI) BF4i RT
'O O 'O O
HN. ^.0 + H N ^ O
CCI3
The reaction was carried out according to general procedure 8 for 148 h using (2£,4S)-4- 
methoxymethoxypent-2-en-l-ol 144 (100 mg, 0.69 mmol) then
bis(acetonitrile)palladium(II) chloride (18 mg, 10 mol%) in l-«-butyl-3- 
methylimidazolium tetrafluoroborate (3 mL) to give (37?,45)-3- 
(trichloromethylcarbonylamino)-4-(methoxymethoxy)penta-l-ene 157a and (35,45)-3- 
(trichloromethylcarbonylamino)-4-(methoxymethoxy)penta-l-ene 157b (74 mg, 37% over 
two steps) as a brown oil, in a 5 : 1 (3R : 35) ratio. Spectroscopic data as described above.
3.0 Application of Ether Directed, Pd(II)-Catalysed aza-Claisen 
Rearrangement for Natural Product Synthesis.
(2S,3S)-2-Amino-3-hydroxybutanoic acid (249).103
OMOM RuCI3  H2 0, Nal03  
CCI4 /MeCN/H20
OMOM
c o 2h 6  M HCI, A
OH
hnY °
CCI3
C 02H 
NH2
The reactions were carried out according to general procedure 12 using (3/?,4S)-3- 
(trichloromethylcarbonylamino)-4-(methoxymethoxy)pent-l-ene 157a (0.7 g, 2.4 mmol) to 
give (2S,3S)-2-amino-3-hydroxybutanoic acid 249 (0.19 mg, 67% over two steps). [a]D21 
+8.0 (c 1.0, H20); Lit.103 [a]D22 +8.6 (c 0.1, H20); 6H (400 MHz, D20 ) 1.17 (3H, d, J  6.8,
4-H3), 3.98 (1H, d, J  3.6, 2-H) and 4.24 (1H, qd, J  6.8, 3.6, 3-H); 6C(100 MHz, D20) 16.1 
(CH3); 59.6 (CH), 65.3 (CH) and 171.9 (C); m/z (Cl) 119.0539 (MH+. C4H90 3N requires 
119.0582), 117 (11%), 85 (4), 81 (74) and 79 (100).
Methyl (2S)-2-hydroxy-3-methylbutanoate (220). 134
1) NaN02) H2 S 0 4  
r 2  2) MeOH, Toluene, HCI 9H
0O2H C 02Me
The reaction was carried out according to general procedure 9 using L-valine 218 (7.0 g,
59.8 mmol). Purification by Krugelrohr distillation gave methyl (25)-2-hydroxy-3- 
methylbutanoate 220 (1.96 g, 25%). [a]D21 +24.3 (c 1.0, CHC13); Lit.134 [a]D25 +23.1 (c 2.5, 
CHC13); 5h (400 MHz, CDC13) 0.87 (3H, d, J  6.8, 3-CH3), 1.03 (3H, d, J  6.8, 4-H3), 2.02 
(1H, sept of d, J  6.8, 3.6, 3-H), 2.66 (1H, d, J  6.4, OH), 3.80 (3H, s, OMe), 4.05 (1H, dd, J
6.4, 3.6, 2-H); 6C(100 MHz, CDC13) 16.0 (CH3), 18.8 (CH3), 32.1 (CH), 52.4 (CH3), 75.0
(CH), 175.4 (C); m/z (Cl) 133.0872 (MH+. C6H130 3 requires 133.0865), 105 (8%) and 73 
(7).
Methyl (25)-2-methoxymethoxy-3-methylbutanoate (226).
OH 'Pr2 NEt, MOMBr OMOM
- DCM 7
C 02Me --------------------- ► ^ r ^ C 0 2Me
The reaction was carried out according to general procedure 10 using methyl (2S)-2- 
hydroxy-3-methylbutanoate 220 (1.96 g, 14.9 mmol). Purification was carried out by flash 
column chromatography (30% diethyl ether / petroleum ether) to give methyl (2S)-2- 
methoxymethoxy-3-methyl-butanoate 226 (1.33 g, 60%). [a]D20 -76.0 (c 1.0, CHC13); 
u j c m 1 (neat) 2965 (CH), 1748 (CO), 1201, 1152, 1041 and 916; 6H (400 MHz, CDC13) 
0.97 (3H, d, 7 6.8, 3-CH3), 0.99 (3H, d, 7 6.8, 4-H3), 2.04-2.15 (1H, m, 3-H), 3.39 (3H, s, 
OMe), 3.75 (3H, s, OMe), 3.89 (1H, d, 7 5.6, 2-H), 4.66 (1H, d, 7 7.2,, OCHHO) and 4.68 
(1H, d, 7 7.2, OCHHO); 6C(100 MHz, CDC13) 17.7 (CH3), 18.8 (CH3), 31.5 (CH), 51.7 
(CH3), 56.1 (CH3), 80.7 (CH), 96.5 (CH2) and 172.9 (C); m/z (Cl) 177.1126 (MH+. C8Hn0 4 
requires 177.1127), 145 (100%), 117 (34) and 79 (38).
(2S)-2-Methoxymethoxy-3-methylbutan- l-ol (229).
OMOM DIBAL-H (2.2 equiv.) 0M0M
Et2 0, -78 °C to RT nH
C 02Me
The reaction was carried out according to general procedure 2b using methyl (2S)-2- 
methoxymethoxy-3-methylbutanoate 226 (0.5 g, 3.2 mmol). Purification was carried out 
by flash column chromatography (50% diethyl ether / petroleum ether) to give (2S)- 
methoxymethoxy-3-methylbutan-l-ol 229 (0.3 g, 62%) as a yellow liquid. [a]D19 +80.3 (c
1.0, CHC13); v mJ c m l (neat) 3423 (OH), 2957 (CH), 1152, 1095, 1026 and 916; 6„ (400 
MHz, CDC13) 0.94 (3H, d, J  6.8, 3-CH3), 0.95 (3H, d, J  6.8, 4-H3), 1.78-1.90 (1H, m, 3-H), 
3.17 (1H, dd, J  9.2, 3.2, OH), 3.29 (1H, m, 2-H), 3.45 (3H, s, OMe), 3.61 (1H, m, 1-HH), 
3.61 (1H, ddd, J  12.0, 9.2, 2.4, 1-Htf), 4.66 (1H, d, 7 6.8, OCHHO) and 4.76 (1H, d, 7 6.8, 
OCHT/O); Sc (100 MHz, CDC13) 18.2 (CH3), 18.9 (CH3), 30.3 (CH), 55.7 (CH3), 63.9 
(CH2), 88.2 (CH) and 97.8 (CH2); m/z (Cl) 149.1174 (MH+. C7H170 3 requires 149.1178), 
117 (100%), 87 (20) and 71 (18).
Ethyl (2£',4/?)-4-methoxymethoxy-5-methylhex-2-enoate (232).
OMOM Swern-HWE
OH ___________
OMOM
The reactions were carried out according to general procedure 3b using (2S)- 
methoxymethoxy-3-methylbutan-l-ol 229 (1.0 g, 6.13 mmol). Purification was carried out 
by flash column chromatography (10% diethyl ether / petroleum ether) to give ethyl 
(2£',4/?)-4-methoxymethoxy-5-methylhex-2-enoate 232 (1.0 g, 79% over two steps) as a 
yellow liquid. [a ]D19 -96.2 (c 1.0, CHC13); v mJ c m 1 (neat) 2965 (CH), 1718 (CO), 1656 
(C=C), 1249, 1153, 1029, 986 and 920; 6H (400 MHz, CDC13) 0.93 (3H, d, 7 6.8, 5-CH3), 
0.98 (3H, d, 7 6.8, 6-H3), 1.31 (3H, t, 7 7.2, OCH2CH3), 1.82-1.93 (1H, m, 5-H), 3.38 (3H, 
s, OMe), 3.95 (1H, m, 4-H), 4.18 (2H, q, 7 7.2, OC7/2CH3), 4.58 (1H, d, 7 6.8, OCHHO), 
4.63 (1H, d, 7 6.8, OCH//0), 5.98 (1H, dd, 7 15.6, 1.2, 2-H) and 6.82 (1H, dd, 7 15.6, 6.8,
3-H); 6C (100 MHz, CDC13) 14.2 (CH3), 18.2 (CH3), 18.3 (CH3), 32.6 (CH3), 55.7 (CH),
60.5 (CH2), 80.2 (CH3), 94.7 (CH2), 123.0 (CH), 146.5 (CH) and 166.2 (C); m/z (Cl) 
217.1441 (MH+. CnH210 4requires 217.1440), 187 (17%), 155 (100) and 127 (5).
(2£',4/?)-4-Methoxymethoxy-5-methylhex-2-en-l-ol (235).
OMOM
C 02Et
DIBAL-H (2.2 equiv.) 
Et02, -78 °C to RT
OMOM
The reaction was carried out according to general procedure 4 using ethyl (2E,4/?)-4- 
methoxymethoxy-5-methylhex-2-enoate 232 (1.0 g, 4.6 mmol). Purification was carried 
out by flash column chromatography (50% diethyl ether / petroleum ether) to give 
(2£,4i?)-4-methoxymethoxy-5-methylhex-2-en-l-ol 235 (0.6 g, 77%) as a yellow liquid. 
[a]D20 -124.3 (c 1.0, CHC13); u j c m '1 (neat) 3386 (OH), 2958 (CH), 1469, 1152, 1089, 
1030, 973 and 920; 6H (400 MHz, CDC13) 0.89 (3H, d, 7 6.8, 5-CH3), 0.96 (3H, d, 7 6.8, 6- 
H3), 1.71 (1H, sept, 7 6.8, 5-H), 1.86 (1H, m, OH), 3.37 (3H, s, OMe), 3.73 (1H, dd, 7 7.6,
6.8, 4-H), 4.16 (2H, dd, 7 5.6, 4.4, 1-H2), 4.51 (1H, d, 7 6.8, OCtfHO), 4.69 (1H, d, 7 6.8, 
OCH//0), 5.54 (1H, ddt, 7 15.6, 7.6, 1.6, 3-H) and 5.79 (1H, dt, 7 15.6, 5.6, 2-H); 6C(100 
MHz, CDC13) 18.5 (CH3), 18.6 (CH3), 32.7 (CH), 55.5 (CH), 62.9 (CH2), 81.5 (CH3), 93.7 
(CH2), 129.6 (CH) and 133.3 (CH); m/z (Cl) 145.1227 (MH+ - CH20 . C8H]70 2 requires 
145.1229), 125 (8%), 113 (38), 95 (100) and 85 (11).
(35,45)-3-(Trichloromethylcarbonylamino)-4-(methoxymethoxy)-5-methyIhexa-l-ene 
(241b) and (2Is,4S)-l-(trichloromethylcarbonylamino)-4-(methoxymethoxy)-5- 
methylhexa-2-ene (241c).
OMOM
1)CI3 CCN, DBU 
DCM
2 ) PdCI2 (MeCN) 2  
THF
OMOM OMOM
° Y nh
CCI3
The reactions were carried out according to general procedures 7 using (2E,4R)~ 
methoxymethoxy-5-methylhex-2-en-l-ol 235 (0.6 g, 3.5 mmol) then
bis(acetonitrile)palladium(II) chloride (10 mol%). Purification by flash column 
chromatography (15% diethyl ether/ petroleum ether) gave (3S,4S)-3- 
(trichloromethylcarbonylamino)-4-(methoxymethoxy)-5-methylhexa-1 -ene 241b and 
(2£’,45)-l-(trichloromethylcarbonylamino)-4-(methoxymethoxy)-5-methylhexa-2-ene 241c 
(0.65 g, 58% combined yield, over two steps) in a 1 : 2 ratio respectively. (2E,4S)-1- 
(Trichloromethylcarbonylamide)-4-(methoxymethoxy)-5-methylhexa-2-ene 241c: [a]D18 -
89.7 (c 1.0, CHCI3); u j c m '1 (neat) 3422 (OH), 2853 (CH), 1655, 1037, 992 and 793; SH 
(400 MHz, CDCI3) 0.90 (3H, d, 7 6.8, 5-CH3), 0.97 (3H, d, 7 6.8, 6-H3), 1.74-1.84 (1H, m,
5-H), 3.38 (3H, s, OMe), 3.76 (1H, t, 7 6.8, 4-H), 4.08 (2H, d, 7 6.8, 1-H2), 4.53 (1H, d, 7
6.8, OCT/HO), 4.69 (1H, d, 7 6.8, OCHHO), 5.64 (1H, dd, 7 15.6, 6.8, 3-H) and 5.79 (1H, 
m, 2-H); Sc (100 MHz, CDC13) 17.3 (CH3), 17.5 (CH3), 31.6 (CH), 43.3 (CH2), 54.5 (CH3),
76.2 (C), 79.7 (CH), 92.9 (CH2), 128.5 (CH), 132.3 (CH) and 161.8 (C); m/z (Cl) 276 
(MH+ - CH3OCH2, 11%), 240 (11), 204 (5) and 168 (6); (3S,4S)-3-
(trichloromethylcarbonylamino)-4-(methoxymethoxy)-5-methylhexa-1 -ene 241b: [a]D25 
+61.8 (c 1.0, CHCI3); v mJ c m l (neat) 3422 (NH), 2862 (CH), 1680, 1041 and 995; SH (400 
MHz, CDCI3) 0.98 (3H, d, 7 6.8, 5-CH3), 1.00 (3H, d, 7 6.8, 6-H3), 1.77-1.86 (1H, m, 5-H),
3.13 (1H, dd, 7 10.0, 1.6, 4-H), 3.44 (3H, s, OMe), 4.56 (1H, m, 3-H), 4.62 (1H, d, 7 6.4, 
OCHHO), 4.79 (1H, d, 7 6.4, OCH//O), 5.31 (1H, d, 7 10.0, 1-HR), 5.36 (1H, d, 7 17.2, 1- 
UH) 5.80 (1H, ddd, 7 17.2, 10.0, 6.8, 2-H) and 8.49 (1H, br d, 7 6.8, NH); Sc (100 MHz, 
CDCI3) 18.9 (CH3), 19.6 (CH3), 31.0 (CH), 54.7 (CH), 55.8 (CH), 90.9 (CH3), 93.0 (C),
99.3 (CH2), 118.8 (CH2), 131.5 (CH) and 161.5 (C), m/z (Cl) 276 (MH+- CH3OCH2, 12%), 
240 (5), 204 (3) and 168 (2).
Methyl (2S)-2-hydroxy-4-methylpentanoate (221).134
1 ) NaN02, H2 S 0 4
2) MeOH, Toluene, HCINH2  o \  kJQn u  T n i i i a n o  um  I OH
C 02H ^  v  C 02Me
The reactions were carried out according to general procedure 9 using L-leucine 219 (7.0 g, 
53 mmol). Purification by Krugelrohr distillation gave methyl (25)-hydroxy-4-methyl- 
pentanoate 221 (2.6 g, 33%) as a clear liquid. [a]D20 +3.9 (c 1.0, CHC13); Lit.134 [a]D21 +2.2 
(c 1.0, CHC13); SH (400 MHz, CDCI3) 0.95 (3H, d, J  6.8, 5-H3), 0.94 (3H, d, J  6.8, 4-CH3), 
1.54-1.60 (2H, m, 3-H2), 1.83 (1H, m, 4-H), 2.63 (1H, d, J  6.0, OH), 3.79 (3H, s, OMe) 
and 4.19 (1H, td, J  7.6, 6.0, 2-H); 6C (100 MHz, CDC13) 21.6 (CH3), 23.3 (CH), 24.4 
(CH3), 43.5 (CH2), 52.5 (CH3), 69.1 (CH) and 176.4 (C); m/z (Cl) 147.1023 (MH+. 
C7H150 3 requires 147.1021), 143 (8%) and 119 (11).
Methyl (25)-methoxymethoxy-4-methyIpentanoate (227).
0H b^ ,  I OMOMMOMBr, DCM
C 02Me ^  C 02Me
The reaction was carried out according to general procedure 10 using methyl (25)- 
hydroxy-4-methylpentanoate 221 (2.2 g, 15.1 mmol). Purification was carried out by flash 
column chromatography (50% diethyl ether / petroleum ether) to give methyl (25)- 
methoxymethoxy-4-methylpentanoate 227 (2.0 g, 71%) as an orange liquid. [a]D20 -66.0 (c
1.0, CHCI3); v mJ c m l (neat) 2956 (CH), 1750 (CO), 1203, 1158, 1026 and 917; 6H (400 
MHz, CDCI3) 0.95 (3H, d, J  6.4, 5-H3), 0.96 (3H, d, J  6.4, 4-CH3), 1.50-1.57 (1H, m, 3- 
CHR), 1.67-1.76 (1H, m, 3-CHH), 1.78-1.87 (1H, m, 4-H), 3.40 (3H, s, OMe), 3.75 (3H, s, 
OMe), 4.16 (1H, dd, J  9.2, 4.4, 2-H), 4.66 (1H, d, J  6.8, OCHHO) and 4.69 (1H, d, J  6.8, 
OCHtfO); 6C (100 MHz, CDC13) 21.5 (CH3), 23.2 (CH), 24.4 (CH3), 41.8 (CH2), 51.9 
(CH3), 56.1 (CH3), 74.3 (CH), 96.4 (CH2) and 173.7 (C); m/z (Cl) 191.1289 (MH+. C9H190 4 
requires 191.1283) and 159 (100%).
(25)-2-Methoxymethoxy-4-methylpentan-l-ol (230).
DIBAL-H (2.2 equiv.)
QMOM Et2 0, -78 °C to RT I OMOM
C 02Me "
The reaction was carried out according to general procedure 2b using methyl (2S)- 
methoxymethoxy-4-methylpentanoate 227 (2.45 g, 12.90 mmol). Purification was carried 
out by flash column chromatography (60% diethyl ether / petroleum ether) to gave (25)-2- 
methoxymethoxy-4-methylpentan-l-ol 230 (1.78 g, 86%) as a yellow liquid. [a]D19 +57.1 
(c 1.0, CHC13); u j c m ’1 (neat) 3402 (OH), 2951 (CH), 1469, 1099, 1029 and 917; 6H (400 
MHz, CDCI3) 0.90 (3H, d, J  6.8, 5-H3), 0.92 (3H, d, J  6.8, 4-CH3), 1.20 (1H, ddd, J  14.0,
8.4, 5.2, 3-HH), 1.47 (1H, ddd, J  14.0, 8.4, 5.6, 3-Htf), 1.68-1.77 (1H, m, 4-H), 3.26 (1H, 
dd, J  9.2, 3.6, OH), 3.44 (3H, s, OMe), 3.47 (1H, m, 2-H), 3.55-3.65 (2H, m, 1-H2), 4.68 
(1H, d, J  6.8, OCHHO) and 4.73 (1H, d, J  6.8, OCHHO); Sc (100 MHz, CDC13) 22.2 
(CH3), 23.2 (CH), 24.4 (CH3), 40.7 (CH2), 55.7 (CH), 66.2 (CH2), 81.0 (CH3) and 97.1 
(CH2); m/z (Cl) 163.1333 (MH+. C8H190 3 requires 163.1334), 131 (100%), 101 (29) and 83 
(21).
Ethyl (2E,4/?)-4-methoxymethoxy-6-methylhepta-2-enoate (233).
C 02Et
The reactions were carried out according to general procedure 3b using (25)- 
methoxymethoxy-4-methylpentan-l-ol 230 (1.79 g, 10.98 mmol). Purification was carried 
out by flash column chromatography (30% diethyl ether / petroleum ether) to give ethyl 
(2E,4/?)-4-methoxymethoxy-6-methylhept-2-enoate 233 (2.01 g, 83% over two steps) as a 
yellow liquid. [a]D21 -125.6 (c 1.0, CHC13); v mJ c m l (neat) 2954 (CH), 1718 (CO), 1659 
(C=C), 1266, 1161, 984 and 919; 6H (400 MHz, CDC13) 0.94 (3H, d, J  6.4, 6-CH3), 0.95 
(3H, d, J  6.4, 7-H3), 1.30 (3H, t, J  7.2, OCH2CH3), 1.34 (1H, m, 5-CHH), 1.58 (1H, ddd, J
14.0, 8.4, 6.0, 5-CHH), 1.73-1.84 (1H, m, 6-H), 3.39 (3H, s, OMe), 4.20 (2H, q, J  7.2, 
OCH2CH3), 4.27 (1H, m, 4-H), 4.57 (1H, d, J  6.8, OCHHO), 4.64 (1H, d, J  6.8, OCHHO), 
5.97 (1H, dd, J  15.6, 1.2, 2-H) and 6.81 (1H, dd, J  15.6, 6.8, 3-H); 6C(100 MHz, CDC13)
14.3 (CH3), 22.1 (CH3), 23.1 (CH3), 24.3 (CH), 44.2 (CH2), 55.7 (CH), 60.5 (CH2), 73.6 
(CH3), 94.6 (CH2), 121.7 (CH), 148.2 (CH) and 166.3 (C); m/z (Cl) 231.1594 (MH+. 
C12H230 4 requires 231.1596), 201 (63%), 169 (100) and 129 (6).
OMOM 
,OH
DMSO, (COCI)2, NEt3  
-78 °C, then
triethyl phosphonoacetate, 
LiCI, DBU, MeCN
OMOM
(2Z?,4/?)-4-Methoxymethoxy-6-methyIhept-2-en-l-oI (236).
OMOM
DIBAL-H (2.2 equiv.) 
Et2 0, -78 °C to RT OMOM
'C 02Et
The reaction was carried out according to general procedure 4 using ethyl (2E,4R)-4- 
methoxymethoxy-6-methylhept-2-enoate 233 (2.1 g, 9.13 mmol). Purification was carried 
out by flash column chromatography (60% diethyl ether / petroleum ether) to give 
(2£,4fi)-4-methoxymethoxy-6-methylhept-2-en-l-ol 236 (1.48 g, 87%) as a yellow liquid. 
[a]D19 -126.4 (c 1.0, CHC13); u max/cm'1 (neat) 3332 (OH), 2952 (CH), 1560, 1092, 1029, 
971 and 916; 6H (400 MHz, CDC13) 0.92 (3H, d, J  6.4, 6-CH3), 0.94 (3H, d, J  6.4, 7-H3),
1.12 (1H, m, OH), 1.29 (1H, m, 5-HH), 1.56 (1H, m, 5-HH), 1.69-1.81 (1H, m, 6-H), 3.38 
(3H, s, OMe), 4.12 (1H, m, 4-H), 4.15 (2H, ddd, J  6.4, 5.2, 1.2, 1-H2), 4.52 (1H, d, J  6.8, 
OCT/HO), 4.71 (1H, d, J  6.8, OCH//O), 5.55 (1H, ddt, J  15.6, 8.0, 1.2, 3-H) and 5.79 (1H, 
dt, J  15.6, 5.2, 2-H); 6C(100 MHz, CDC13) 22.3 (CH3), 23.0 (CH3), 24.3 (CH), 44.8 (CH2),
55.5 (CH), 63.0 (CH2), 74.4 (CH3), 93.6 (CH2), 131.8 (CH) and 131.9 (CH); m/z (Cl) 143 
(MH+- CH20 , 19%), 127 (100), 109 (92) and 85 (42).
(3/?,45)-3-(Trichloromethylcarbonylamino)-4-(methoxymethoxy)-6-methylhept-l-ene 
(242a), (35,45)-3-(TrichloromethylcarbonyIamino)-4-(methoxymethoxy)-6-
methylhept-l-ene (242b) and (2Zs,4S)-l-(trichloromethylcarbonylamino)-4- 
(methoxymethoxy)-6-methylhept-2-ene (242c).
OMOM
1)CI3 CCN, DBU 
DCM
2) PdCI2 (MeCN) 2
THF
OMOM OMOM OMOM
The reactions were carried out according to general procedure 7 using (2E,4R)~ 
methoxymethoxy-6-methylhept-2-en-l-ol 236 (1.48 g, 7.87 mmol) then
bis(acetonitrile)palladium(II) chloride (10 mol%). Purification by flash column 
chromatography (20% diethyl ether / petroleum ether) gave (2E,4S)-1- 
(trichloromethylcarbonylamino)-4-(methoxymethoxy)-6-methylhepta-2-ene 242c. Further 
elution (25% diethyl ether / petroleum ether) gave (3R,4S)-3-
(trichloromethylcarbonylamino)-4-(methoxymethoxy)-6-methylhept- 1-ene 242a followed 
by (30% diethyl ether / petroleum ether) (35,45)-3-(trichloromethylcarbonylamino)-4-
(methoxymethoxy)-6-methylhept-l-ene 242b (1.56 g, 60% combined yield, over two 
steps) in a 14 : 1 : 1 ratio, as a brown oil. (2£',45,)-l-(trichloromethylcarbonylamino)-4- 
(methoxymethoxy)-6-methylhepta-2-ene 242c: [a]D20 -91.1 (c 1.0, CHC13); 'umax/cm'1 (neat) 
2594 (CH), 1769 (CO), 1468, 1154, 1096 and 1035; SH (400 MHz, CDC13) 0.92 (3H, d, 7
6.4, 6-CH3), 0.93 (3H, d, 7 6.4, 7-H3), 1.25 (1H, ddd, 7 13.6, 8.2, 5.6, 5-HH), 1.51 (1H, m,
5-HH), 1.70-1.81 ( lH ,m ,6-H), 3.37 (lH ,s, OMe), 4.05 (2H, d ,7  6.8, 1-H2),4.11 (lH ,m ,
4-H), 4.51 (1H, d, 7 6.8, OCMiO), 4.68 (1H, d, 7 6.8, OCHHO), 5.62 (1H, dd, 7 15.2, 7.6, 
3-H) and 5.81 (1H, dt, 7 15.2, 6.8, 2-H); 6C(100 MHz, CDC13) 22.2 (CH3), 23.0 (CH), 24.2 
(CH3), 44.3 (CH2), 44.6 (CH2), 55.5 (CH3), 73.9 (CH), 93.8 (CH2), 96.2 (C), 128.3 (CH),
135.2 (CH) and 161.9 (C); m/z (Cl) 288 (MH+- CH3OCH2, 32%), 254 (10) and 218 (7); 
(3/?,4S)-3-(trichloromethylcarbonylamino)-4-(methoxymethoxy)-6-methylhept-l-ene 
242a: [a]D19 +37.0 (c 1.0, CHC13); v mJ c m '  (neat) 3263 (NH), 2951 (CH), 1713 (CO), 
1625 (C=C), 1517, 1032, 823 and 680; 6H (400 MHz, CDC13) 0.90 (3H, d, 7 6.4, 6-CH3), 
0.94 (3H, d, 7 6.4, 7-H3), 1.25 (1H, ddd, 7 12.8, 9.2, 4.4, 5-HR), 1.53 (1H, ddd, 7 12.8, 9.2,
6.4, 5-Htf), 1.68-1.80 (1H, m, 6-H), 3.44 (1H, s, OMe), 3.66 (1H, ddd, 7 9.2, 4.4, 1.6, 4- 
H), 4.37 (1H, m, 3-H), 4.66 (1H, d, 7 6.8, OC//HO), 4.75 (1H, d, 7 6.8, OCHHO), 5.31 
(2H, d, 7 1.6, 1-Mi), 5.35 (1H, m, 1-Mi), 5.78-5.91 (1H, m, 2-H) and 8.36 (1H, br d, 7
6.8, NH); 6C(100 MHz, CDC13) 22.2 (CH), 23.2 (CH3), 24.4 (CH3), 42.0 (CH2), 56.0 (CH),
56.9 (CH), 82.2 (CH3), 93.0 (C), 98.2 (CH2), 118.9 (CH2), 131.7 (CH) and 161.5 (C); m/z
(Cl) 332.0578 (MH+. C12H210 3N35C13 requires 332.0587), 300 (42%), 262 (100), 238 (18), 
202 (21) and 167 (49). Unable to isolate (35,45)-3-(trichloromethylcarbonylamino)-4- 
(methoxymethoxy)-6-methylhept-l-ene 242b for characterisation.
(3/?,4S)-3-(Trichloromethylcarbonylamino)-4-(methoxymethoxy)-6-methylhept-l-ene 
(242a) and (35,45)-3-(Trichloromethylcarbonylamino)-4-(methoxymethoxy)-6- 
methylhept-l-ene (242b).
OMOM
1 )CI3 CCN, DBU 
DCM
2) PdCI2 (MeCN) 2  
THF
O O
OMOM
HNL ^ O +
OMOM
H N ^ O
CCI3
The reactions were carried out according to general procedure 11 using (2E,AR)~ 
methoxymethoxy-6-methylhept-2-en-l-ol 236 (0.1 g, 0.53 mmol). Purification was carried
out by flash column chromatography (10% diethyl ether / petroleum ether) to give (3/?,4*S)-
3-(trichloromethylcarbonylamino)-4-(methoxymethoxy)-6-methylhept- 1-ene 242a and 
(35',41S)-3-(trichloromethylcarbonylamino)-4-(methoxymethoxy)-6-methylhept-l-ene 242b 
(0.13 g, 73% combined yield, over two steps) in a 14 : 1 ratio (3R,35), as a brown oil. 
Spectroscopic data as above.
(2S,3S)-2-Amino-3-hydroxy-5-methyl hexanoic acid (250).104
OMOM
hnY °
CCI3
RUCI3  H2 0, Nal03  
CCI4 /MeCN/H20
OMOM 
C02H
H N ^ O
CCI3
6  M HCI 
A
OH
C02H 
NH2
The reactions were carried out according to general procedure 12 using (3/?,45')-3- 
(trichloromethylcarbonylamino)-4-(methoxymethoxy)-6-methyl-hept-1-ene 242a (0.7 g, 
2.1 mmol) to give (25,,3,S)-2-amino-3-hydroxy-5-methyl hexanoic acid 250 (0.16 g, 48%). 
[a]D20 +13.7 (c 1.0, 1 M HCI); Lit.104 [a]D25 +14.6 (c 1.0, 1 M HCI); v mJ c m l (neat) 3033 
(OH and NH), 2960 (CH), 1617 (CO), 1405, 1339, 1136 and 1053; 6H (400 MHz, D20) 
0.82 (3H, d, J  6.8, 6-H3), 0.86 (3H, d, J  6.8, 5-CH3), 1.11 (1H, ddd, J  14.0, 10.0, 2.8, 4- 
HH), 1.43 (1H, ddd, J  14.0, 10.0, 4.4, 4-HH), 1.63-1.71 (3H, m, 5-H), 3.75 (3H, m, 2-H) 
and 4.12 (1H, m, 3-H); 6C(100 MHz, D20 ) 20.3 (CH3) 22.7 (CH3), 23.9 (CH), 39.6 (CH2),
59.8 (CH), 67.5 (CH), and 171.7 (C); m/z (Cl) 145 (M+ - NH2, 20%), 131 (50), 117 (49) 
and 113 (100).
(2S)-Acetoxysuccinic anhydride (223).135
Acetic anhydride 
VH acetyl chloride
h o 2c ^ ^ c02H  ------------------------
L-Malic acid 222 (10.0 g, 74.6 mmol) was added to a solution of acetic anhydride (10.5 
mL, 111.9 mmol) and acetyl chloride (10.2 mL, 141.8 mmol), which had been cooled to 0 
°C. The reaction mixture was allowed to stir at 0 °C for 5 minutes then for 1.5 h at 50 °C. 
The reaction mixture was cooled to room temperature and excess acetic anhydride and 
acetyl chloride were distilled off under reduced pressure at 50 °C to give (2S)- 
acetoxysuccinic anhydride 223 (11.7 g, 100%). mp 55-57 °C; Lit.135 mp 56-58 °C; &H (400
MHz, CDClj) 2.19 (3H, s, CH3), 3.00 (1H, dd, J  19.2, 6.4, CHH), 3.35 (1H, dd, J  19.2,9.2, 
CHH) and 5.52 (1H, dd, J  9.2, 6.4, CH); 5C (100 MHz, CDC13) 20.2 (CH3), 53.1 (CH2),
67.6 (CH), 166.3 (C), 167.8 (C) and 169.7 (C); m/z (Cl) 159.0292 (MH*. C6H7Os requires 
159.0293), 131 (3%), 113 (6) and 99 (37).
(2S)-2-Hydroxy-4-oxo-4-phenylbutanoic acid (224).135
t 4
o
Anhydrous aluminium chloride (1.3 g, 9.5 mmol) was added to a solution of (25)- 
acetoxysuccinic anhydride 223 (0.5 g, 3.2 mmol) in anhydrous benzene (8 mL) which had 
been cooled to 0 °C. The reaction mixture was then was heated under reflux with vigorous 
stirring for 4 h then poured into a mixture of crushed ice (10 g) and conc. hydrochloric acid 
(10 mL). The mixture was stirred for 2 h and then extracted with ethyl acetate (3 x 15 
mL). The combined organic layers were dried (MgS04) and concentrated in vacuo. 
Purification was carried out by recrystallisation from ethyl acetate / petroleum ether to give 
(25)-2-hydroxy-4-oxo-4-phenylbutanoic acid 224 (0.33 g, 55%) as white crystals, mp 139- 
141 °C; Lit.135 mp 142-144 °C; SH (400 MHz, CDC13) 3.53 (2H, dd, J  18.4, 6.4, 3-H2), 3.86 
(1H, br s, OH), 4.72 (1H, dd, J  6.4, 4.4, 2-H), 7.49 (2H, m, Ph), 7.63 (1H, m, Ph) and 7.98 
(2H, m, Ph); 6C(100 MHz, CDC13) 41.7 (CH2), 66.9 (CH), 128.4 (CH), 128.9 (CH), 134.4 
(CH), 135.6 (C), 174.4 (C) and 199.3 (C); m/z (El) 194 (M+, 2%), 176 (8), 149 (8), 131 (4) 
and 105 (100).
Methyl-(25)-2-hydroxy-4-phenylbutanoate (225).136
O OH 1) H2, Pd/C
^  J i  X  40 psi, 35 °C
c o 2h _______________
2) MeOH, 
toluene, A
(25)-2-Hydroxy-4-oxo-4-phenylbutanoic acid 224 (7.3 g, 37.6 mmol) was dissolved in 
acetic acid (100 mL) with heating. 10% Palladium on carbon (0.75 g) was added and the 
reaction mixture was shaken at 35 °C and under 40 psi of pressure of H2 for 48 h. The 
reaction mixture was filtered through Celite® and concentrated to give a white solid. This 
solid carboxylic acid was dissolved in toluene (40 mL) and methanol (20 mL) before
C 02Me
concentrated hydrochloric acid (4 mL) was added and the reaction mixture was heated 
under reflux for 12 h. The reaction mixture was concentrated, then the resulting residue 
was dissolved in sodium hydrogen carbonate solution (50 mL) and extracted into ethyl 
acetate (3 x 50 mL). The combined organic layers were dried (MgS04) and concentrated 
in vacuo. Purification was carried out by flash column chromatography (30% ethyl acetate 
/ petroleum ether) to give methyl (25)-2-hydroxy-4-phenylbutanoate 225 (3.4 g, 46% over 
two steps) as a liquid. [a]D19 +23.7 (c 1.0, CHC13); Lit.136 [cx]D25 +30.9 (c 2.1, CHC13); 6H 
(400 MHz, CDC13) 1.94 (1H, m, 3-HH), 2.11 (1H, m, 3-HH), 2.77 (2H, m, 4-H2), 2.82 (1H, 
d, J  5.2, OH), 3.78 (1H, s, OMe), 4.20 (1H, ddd, J  9.2, 5.2, 4.4, 2-H), 7.21 (5H, m, Ph); 
m/z (Cl) 194.0941 (MH+. CnH140 3 requires 194.0943), 176 (7%), 163 (4), 135 (6), 117 
(20), 105 (60) and 90 (100).
Methyl (2S)-2-methoxymethoxy-4-phenyIbutanoate (228).
OH Hiinig's base OMOM
MOMBr, DCM
C 02Me ______________ ^  , '/ ^ ^ C 0 2Me
The reaction was carried out according to general procedure 10 using methyl (2S)-2- 
hydroxy-4-phenylbutanoate 225 (3.3 g, 17.1 mmol). Purification was carried out by flash 
column chromatography (30% diethyl ether / petroleum ether) to give methyl (2S)-2- 
methoxymethoxy-4-phenylbutanoate 228 (3.2 g, 86%) as an oil. [a]D18 -28.6 (c 1.0, 
CHC13); v mJ c m A (neat) 2949 (CH), 1749 (CO), 1655 (C=C), 1644 and 1028; 6H (400 
MHz, CDC13) 2.10 (2H, td, J  8.4, 6.4, 3-H2), 2.68-2.84 (2H, m, 4-H2), 3.42 (3H, s, OMe), 
3.74 (3H, s, OMe), 4.15 (1H, t, J  6.4, 2-H), 4.68 (1H, d, J  6.8, OC//HO), 4.72 (1H, d, J
6.8, OCHf/O) and 7.18-7.31 (5H, m, Ph); Sc (100 MHz, CDC13) 31.4 (CH2), 34.5 (CH2),
52.0 (CH3), 56.2 (CH), 75.1 (CH3), 96.5 (CH2), 126.1 (CH), 128.5 (CH), 141.0 (C) and
173.0 (C); m/z (Cl) 207.1015 (MH+- CH3OH. C]2H150 3 requires 207.1021), 189 (89%), 147 
(52) and 105 (23).
(25)-2-Methoxymethoxy-4-phenylbutan-l-ol (231).
OMOM DIBAL-H (2.2 equiv.) OMOM
Et2 0, -78 °C to RT
C 02Me
The reaction was carried out according to general procedure 2b using methyl (2S)-2- 
methoxymethoxy-4-phenylbutanoate 228 (2.99 g, 13.46 mmol). Purification was carried 
out by flash column chromatography (50% diethyl ether / petroleum ether) to give (2S)-2- 
methoxymethoxy-4-phenylbutan-l-ol 231 (2.24 g, 79%). [a]D18 +47.5 (c 1.0, CHC13); 
(Found: C, 68.4; H, 8.6. C12H180 3 requires C, 68.5; H, 8.6%); Dtnax/cm'1 (neat) 3421 (OH), 
2934 (CH), 1146, 1101, 1024 and 916; 6H (400 MHz, CDC13) 1.82-1.92 (2H, m, 3-H2), 
2.64-2.83 (2H, m, 4-H2), 3.48 (3H, s, OMe), 3.56-3.64 (3H, m, 2-H and 1-H2), 4.69 (1H, d, 
J  6.8, 0C H //0), 4.79 (1H, d, J  6.8, OC//HO), 7.20-7.35 (5H, m, Ph); 6C (100 MHz, 
CDC13) 31.7 (CH2), 33.3 (CH2), 55.7 (CH2), 65.8 (CH2), 81.9 (CH3), 97.2 (CH2), 126.0 
(CH), 128.4 (CH), 128.5 (CH) and 141.6 (C); m/z (Cl) 211 (MH+, 7%), 179 (92), 161 
(100), 131 (55) and 105(17).
Ethyl (2E,45)-4-methoxymethoxy-6-phenyl-2-hexa-2-enoate (234).
OMOM DMSO, (COCI)2, NEt3  OMOM
r nw '78 C, then “
OH  ►
triethyl phosphonoacetate,
LiCI, DBU, MeCN
The reactions were carried out according to general procedure 3b using (2S)-2- 
methoxymethoxy-4-phenylbutan-l-ol 231 (2.16 g, 10.28 mmol). Purification was carried 
out by flash column chromatography (50% diethyl ether / petroleum ether) to give ethyl 
(2£',45)-4-methoxymethoxy-6-phenyl-2-hexanoate 234 (1.57 g, 55%). [a ]D19 -52.0 (c 1.0, 
CHC13); (Found: C, 68.8; H, 8.0. C16H220 4 requires C, 69.0; H, 8.0%); 'umax/cm'1 (neat) 
2944 (CH), 1717 (CO), 1658 (C=C), 1265, 1147 and 1020; SH (400 MHz, CDC13) 1.31 
(3H, t, J  7.2, OCH2CH3), 1.86-2.02 (2H, m, 5-H2), 2.67-2.82 (2H, m, 6-H2), 3.41 (3H, s, 
OMe), 4.21 (2H, q, J  7.2, OC//2CH3), 4.25 (1H, m, 4-H), 4.62 (1H, d, J  6.8, OCtfHO), 
4.67 (1H, d, J  6.8, OCHT/O), 6.01 (1H, dd, J  15.6, 1.6, 2-H), 6.86 (1H, dd, J  15.6, 6.0, 3- 
H) and 7.18-7.32 (5H, m, Ph); 6C(100 MHz, CDC13) 14.3 (CH3), 31.4 (CH2), 36.6 (CH2),
55.8 (CH), 60.6 (CH2), 74.9 (CH3), 94.8 (CH2), 122.2 (CH), 126.0 (CH), 128.4 (CH), 128.5 
(CH), 141.5 (C), 147.6 (CH) and 166.2 (C); m/z (Cl) 279 (MH+, 52%), 247 (50), 217 
(100), 216 (7) and 173 (6).
(22s ,4S)-Methoxymethoxy-6-phenylhex-2-en- l-ol (237).
OMOM
C02Et
DIBAL-H (2.2 equiv.) 
Et20, -78 °C to RT OMOM
The reaction was carried out according to general procedure 4 using ethyl (2Zs,45)-4- 
methoxymethoxy-6-phenyl-2-hexanoate 234 (1.28 g, 4.60 mmol). Purification was carried 
out by flash column chromatography (50% diethyl ether / petroleum ether) to give (2E,4S)~ 
methoxymethoxy-6-phenyl-hex-2-en-l-ol 237 (0.87 g, 78%). [cx]D16 +93.7 (c 1.0, CHC13); 
(Found: C, 71.0; H, 8.6. C14H2o03 requires C, 71.2; H, 8.6%); Dma,/cm'‘ (neat) 3408 (OH), 
2927 (CH), 1603 (C=C), 1146, 1093, 1028, 972, 917 and 699; 6H (400 MHz, CDC13) 1.41 
(1H, br s, OH), 1.80-2.03 (2H, m, 5-H2), 2.63-2.81 (2H, m, 6-H2), 3.40 (3H, s, OMe), 4.09 
(1H, q, 7 7.2, 4-H), 4.17 (2H, dd, J  5.2, 1.6, 1-H2), 4.57 (1H, d, J  6.8, OC/2HO), 4.72 (1H, 
d, J  6.8, OCHHO), 5.61 (1H, ddt, J  15.6, 7.2, 1.6, 3-H), 5.84 (1H, dt, J  15.6, 5.2, 2-H) and 
7.17-7.32 (5H, m, Ph); Sc (100 MHz, CDC13) 31.7 (CH2), 37.2 (CH2), 55.6 (CH), 62.9 
(CH2), 75.9 (CH3), 93.9 (CH2), 125.9 (CH), 128.4 (CH), 128.4 (CH), 131.2 (CH), 132.4
(CH) and 142.0 (C); m/z (Cl) 219 (MH+ - H20 , 12%), 199 (15), 175 (96), 157 (100) and 
131 (86).
(3/?,4S)-3-(TrichloromethyIcarbonylamino)-4-(methoxymethoxy)-6-phenylhexa-l-ene 
(243a), (3S,4S)-3-(TrichloromethyIcarbonylamino)-4-(methoxymethoxy)-6-
phenylhexa-1-ene (243b) and (2£',4S)-l-(trichloromethylcarbonylamino)-4- 
(methoxymethoxy)-6-phenylhexa-2-ene (243c).
1)CI3CCN,DBU 9mom 9mom 9mom
oh DCM
2) PdCI2(MeCN)2 2 H N ^ O + 2 HNn^ , 0 + 2 O ^ N H
™ F CCI3 CCI3 CCI3
The reactions were carried out according to general procedure 7 using (2Zs,4/?)- 
methoxymethoxy-6-phenylhex-2-en-l-ol 237 (0.99 g, 2.60 mmol) then
bis(acetonitrile)palladium(II) chloride (10 mol%). Purification was carried out by flash 
column chromatography (10% diethyl ether / petroleum ether) to give (2fs,4S)-l- 
(trichloromethylcarbonylamino)-4-(methoxymethoxy)-6-phenylhexa-2-ene 243c. Further 
elution (15% diethyl ether / petroleum ether) gave (3^,4»S)-3-
(trichloromethylcarbonylamino)-4-(methoxymethoxy)-6-phenylhexa-l -ene 243a followed
by (20% diethyl ether / petroleum ether) (3iS,4S)-3-(trichloromethylcarbonylamino)-4- 
(methoxymethoxy)-6-phenylhexa-1-ene 243b (0.64 g, 65% combined yield, over two 
steps) in a 9 : 1 : 4 ratio, as a brown oil. (2£,4/?)-l-(trichloromethylcarbonylamino)-4- 
(methoxymethoxy)-6-phenylhexa-2-ene 243c: [a]D20 -82.1 (c 1.0, CDC13); u ^ /c m '1 (neat) 
3085 (NH), 2947 (CH), 1718 (CO), 1656 (C=C), 1496, 1148, 1098, 1030 and 970; 6H (400 
MHz, CDC13) 1.83-2.04 (2H, m, 5-H2), 2.73-2.83 (2H, m, 6-H2), 3.43 (3H, s, OMe), 4.10 
(3H, m, 4-H and 1-H2), 4.61 (1H, d, J  6.8, OCtfHO), 4.74 (1H, d, J  6.8, OCH//O), 5.72 
(1H, dd, J  15.2, 7.2, 3-H), 5.86 (1H, dt, J  15.2, 6.4, 2-H), 7.23-7.35 (5H, m, Ph); 6C(100 
MHz, CDCI3) 31.6 (CH2), 37.1 (CH2), 44.3 (CH2), 55.6 (CH), 75.4 (CH3), 94.1 (CH2), 94.2 
(C), 126.0 (CH), 128.4 (CH), 128.5 (CH), 128.8 (CH), 134.7 (CH), 141.8 (C) and 163.1 
(C); m/z (Cl) 321 (MH+ - CH3CH20 , 6%), 284 (11), 225 (12), 193 (62) and 157 (100). 
(3JR,45)-3-(Trichloromethylcarbonylamino)-4-(methoxymethoxy)-6-phenylhexa-l-ene 
243a: [a ]D18 +58.8 (c 1.0, CHC13); (Found: C, 50.5; H, 5.3; N, 3.7. C16H20Cl3NO3 requires 
C, 50.5; H, 5.3, N, 3.7%); v mJ c m A (neat) 3277 (NH), 2939 (CH), 1713 (CO), 1514, 1141, 
1031 and 821; &H (400 MHz, CDC13) 1.81-1.91 (1H, m, 5-tfH), 1.95 (1H, m, 5-HH), 2.63- 
2.71 (1H, m, 6-HH), 2.79-2.86 (1H, m, 6-Htf), 3.48 (3H, s, OMe), 3.59 (1H, ddd, J  8.6, 
4.4, 2.0, 4-H), 4.43 (1H, br t, J  8.6, 3-H), 4.65 (1H, d, J  6.8, OC//HO), 4.81 (1H, d, J  6.8, 
OCH//O), 5.34 (1H, m, 1-tfH), 5.38 (1H, m, l-HR), 5.89 (1H, ddd, J 11.2, 10.4, 8.6, 2-H), 
7.19-7.39 (5H, m, Ph), 8.37 (1H, br d, J  8.6, NH); 6C(100 MHz, CDC13) 31.9 (CH2), 34.8 
(CH2), 56.0 (CH), 56.9 (CH), 83.5 (CH3), 93.0 (C), 98.4 (CH2), 119.2 (CH2), 126.2 (CH),
128.4 (CH), 128.6 (CH), 131.5 (CH), 141.0 (C), 161.5 (C); m/z (Cl) 380 (MH+, 100%), 
310 (63), 286 (12), 244 (16), 187 (66) and 157 (58). Unable to isolate (3S,4S)-3- 
(trichloromethylcarbonylamino)-4-(methoxymethoxy)-6-phenylhexa-1 -ene 243b for 
characterisation.
(3/?,4S)-3-(Trichloromethylcarbonylamino)-4-(methoxymethoxy)-6-phenylhexa-l-ene 
(243a) and (3S,4S)-3-(TrichIoromethylcarbonyIamino)-4-(methoxymethoxy)-6- 
phenylhexa-1-ene (243b).
OMOM OMOM1) CI3 CCN, DBU 
DCMOMOM
2 ) PdCI2 (MeCN) 2  
THF
The reactions were carried out according to general procedure 11 using (2E,AR)~ 
methoxymethoxy-6-phenylhex-2-en-l-ol 237 (0.1 g, 0.42 mmol). Purification was carried
out by flash column chromatography (10% diethyl ether / petroleum ether) to give (3R,4S)~ 
3-(trichloromethylcarbonylamino)-4-(methoxymethoxy)-6-phenylhexa-1 -ene 243a and 
(35,45,)-3-(trichloromethylcarbonylamino)-4-(methoxymethoxy)-6-phenylhexa-1 -ene 243b 
(0.11 g, 69% combined yield, over two steps) in a 9 : 1 ratio (3R,35), as a brown oil. 
Spectroscopic data as above.
(2S,3S)-2-Amino-3-hydroxy-5-phenyIpentanoic acid (252).
? M0M RuCI3 .H2 0, ? M0M 6  M HCI
Nal03  r^ V ^ V C02H A
H N ^ O  "  H N ^ O  "  ft J  NHoY  CCI4 /MeCN/ N M 2
CCI3  H20  CCIg
The reactions were carried out according to general procedures 12 using (3R,4S)-3- 
(trichloromethylcarbonylamino)-4-(methoxymethoxy)-6-phenylhexa-1-ene 243a (0.77 g, 
0.20 mmol) and gave (25,35)-2-amino-3-hydroxy-5-phenylpentanoic acid 252 (0.03 g, 
48% over two steps) as a brown solid. [a]D19 +14.7 (c 0.4, 2 M HCI); Dmax/cm'1 (neat) 3388 
(NH, OH), 2913 (CH), 1729 (CO), 1495, 1218 and 1036; 6H (400 MHz, D20) 1.73-1.83 
(2H, m, 4-CH2), 2.53-2.63 (1H, m, 5-//H), 2.74 (1H, ddd, J  14.0, 8.8, 5.2, 5-Htf), 3.89 
(1H, d, J  3.6, 2-H), 3.93 (1H, dt, J 8.8, 3.6, 3-H) and 7.09-7.26 (5H, m, Ph); 6C(100 MHz, 
D20) 31.2 (CH2), 33.2 (CH2), 58.1 (CH), 68.6 (CH), 126.2 (CH), 128.5 (CH), 128.7 (CH), 
141.3(C) and 169.9 (C); m/z (Cl) 210 (MH+, 12%), 175 (100), 144 (28) and 113 (34).
(2/?)-3-(te/f-ButyldimethylsiIyloxy)-l,2-epoxypropane (267).137
TBDM SCI 
Ov  imidazole
---------------- - |^>^/OTBDMS
A mixture of (S)-glycidol 266 (5.0 g, 65.4 mmol), tert-butyldimethylsilyl chloride (14.8 g,
98.1 mmol) and imidazole (6.7 g, 98.1 mmol) in THF (70 mL) were stirred for 12 h at 
room temperature forming a white precipitate. The precipitate was filtered and washed 
with diethyl ether (50 mL). The combined filtrate was concentrated and purified by flash 
column chromatography (10% diethyl ether / petroleum ether) to give (2R)-3-(tert- 
butyldimethylsilyloxy)-1,2-epoxypropane 267 (10.8 g, 88%) as a clear white liquid. [a]D24 
+2.7 (c 1.0, CHCI3); u j c m ’1 (neat): 2929 (CH), 1472, 1255, 1098 and 838; bH (400 MHz, 
CDCI3) 0.09 (3H, s, SiCH3), 0.10 (3H, s, SiCH3), 0.92 (9H, s, SiC(CH3)3), 2.66 (1H, dd, J  
4.6, 2.4, 3-HH), 2.79 (1H, dd, J  5.2, 4.6, 3-HH), 3.12 (1H, m, 2-H), 3.68 (1H, dd, J  11.8,
4.8, 1-HH), 3.87 (1H, dd, J  11.8, 3.2, 1-Htf); 5C(100 MHz, CDC13) -5.3 (CH3), -5.4 (CH3),
19.0 (C), 26.0 (CHj), 45.0 (CH2), 52.5 (CH) and 63.9 (CH2); m h  (Cl) 189.1307 (MH+. 
C,H210 2Si requires 189.1311), 145 (5%), 131 (6), 113 (4) and 73 (25).
(2J?)-l-(tert-ButyldimethyIsilyloxy)butan-2-ol (268).'“
MeMgBr
q  CuBr.SMe2 OH
[>^OTBDMS —  -  \ s^ C^OTBDMS
Methylmagnesium bromide (3 M in diethyl ether) (28.7 mL, 86.2 mmol) was added 
dropwise to a solution of copper(I) bromide-dimethyl sulfide complex (0.60 g, 2.9 mmol) 
in THF (50 mL) at -78 °C and the white suspension was stirred for 0.5 h. (2R)-3-(tert- 
Butyldimethylsilyloxy)- 1,2-epoxypropane 267 (10.8 g, 57.5 mmol) in THF (50 mL) was 
then added and the reaction mixture was warmed to 0 °C and stirred for 2 h. The reaction 
was quenched by the addition of a saturated ammonium chloride solution (50 mL) and 
extracted with ethyl acetate (3 x 50 mL). The organic layers were combined, dried 
(MgS04) and concentrated in vacuo. Purification was carried out by flash column 
chromatography (20% diethyl ether / petroleum ether) to give {2R)-\-(tert- 
butyldimethylsilyloxy)butan-2-ol 268 (10.5 g, 90%) as a clear liquid. [a ]D21 -61.0 (c 1.0, 
CHC13); &H (400 MHz, CDCI3) 0.09 (6H, s, Si(CH3)2), 0.92 (9H, s, SiC(CH3)3), 0.98 (3H, t, 
7 7.2, 4-H3), 1.47 (2H, m, 3-H2), 2.39 (1H, br s, OH), 3.41 (1H, dd, 7 9.8, 7.6, 1 -HR), 3.57 
(1H, m, 2-H) and 3.65 (1H, dd, 7 9.8, 3.2, 1-HH)\ bc (100 MHz, CDC13) -5.5 (CH3), 10.2 
(CH3), 18.5 (C), 26.0 (CH2), 26.1 (CH3), 67.1 (CH2) and 73.4 (CH); m/z (Cl) 205 (M H\ 
37%), 198 (100), 187 (10) and 172 (25).
(2/?)-l-(tert-ButyldimethylsilyIoxy)-2-(methoxymethoxy)butane (269).
MOMBr
OH 'Pr2NEt O O
\^J\^OTBDMS -----------  \^A^OTBDM S
DCM
The reaction was carried out according to general procedure 10 using {2R)-\-{tert- 
butyldimethylsilyloxy)butan-2-ol 268 (9.41 g, 46.1 mmol). Purification was carried out by 
flash column chromatography (20% diethyl ether / petroleum ether) to give {2R)-\-{tert- 
butyldimethylsilyloxy)-2-(methoxymethoxy)butane 269 (3.2 g, 86%) as a clear oil. [a]D20 
+54.3 (c 1.0, CHCI3); D j c m '1 (NaCl): 2930 (CH), 1464, 1255, 1107, 838 and 777; 6H 
(400 MHz, CDCI3) 0.10 (6H, s, Si(CH3)2), 0.91 (9H, s, SiC(CH3)3), 0.96 (3H, t, 7 7.2, 4- 
H3), 1.55 (2H, m, 3-H2), 3.41 (3H, s, OMe), 3.57 (3H, m, 1-H2 and 2-H), 4.68 (1H, d, 7 6.8, 
OCHHO) and 4.80 (1H, d, 7 6.8, OCH//O); bc (100 MHz, CDC13) -5.2 (CH3), 10.0 (CH3),
18.5 (C), 24.7 (CH2), 26.1 (CH3), 55.6 (CH3), 65.7 (CH2), 79.7 (CH) and 96.4 (CH2); mlz
(Cl) 217.1616 (M+- CH30 , CuH250 2Sirequires 217.1624), 171 (33%) and 73 (25).
(2/?)-2-(Methoxymethoxy)butan-l-ol (264).
TBAF, THF 
0°C
OTBDMS
Tetra-rc-butylammonium fluoride (1.0 M solution in THF) (45.4 mL, 45.4 mmol) was 
added to a solution of (2R)~ 1 -(ter/-butyldimethylsilyloxy)-2-(methoxymethoxy)butane 269 
(9.4 g, 37.9 mmol) in THF (90 mL) at 0 °C. The reaction mixture was warmed to room 
temperature, stirred for 12 h and then concentrated. The resulting residue was taken up in 
ethyl acetate (20 mL), washed with water (10 mL), dried (MgS04) and concentrated in 
vacuo. Purification by flash column chromatography (40% diethyl ether / petroleum ether) 
gave (2#)-2-(methoxymethoxy)butan-l-ol 264 (3.0 g, 59%) as yellow oil. [a]D22 -60.5 (c
1.0, CHC13); u j c m '1 (neat): 3442 (OH), 2936 (CH), 1465, 1135, 1033 and 918; 6H (400 
MHz, CDC13) 0.95 (3H, t, J  7.6, 4-H3), 1.54 (2H, m, 3-H2), 3.08 (1H, br s, OH), 3.44 (3H, 
s, OMe), 3.46-3.63 (3H, m, 1-H2 and 2-H), 4.71 (1H, d, J  7.0, OC//HO) and 4.76 (1H, d, J
7.0, OCH//0); 6C (100 MHz, CDC13) 10.1 (CH3), 24.7 (CH2), 55.8 (CH), 65.5 (CH2), 83.6 
(CH) and 97.1 (CH2); mlz (Cl) 135.1016 (MH+. C6H]50 3requires 135.1021), 121 (3%), 103 
(100) 89 (13) and 73 (29).
Ethyl (2E,45)-4-(methoxymethoxy)hex-2-enoate (270).
DMSO, (COCI)2, NEt3  
-78 °C, then
triethyl phosphonoacetate, 
LiCI, DBU, MeCN
C 02Et
The reactions were carried out according to general procedure 3b using (2R)-2- 
(methoxymethoxy)butan-l-ol 264 (1.43 g, 10.7 mmol). Purification by flash column 
chromatography (50% ether / petroleum ether) gave ethyl (2E,4S)-4- 
(methoxymethoxy)hex-2-enoate 270 (1.9 g, 86%) as a yellow liquid. [a]D23 +104.8 (c 1.0, 
CHC13); (Found: C, 59.3; H, 9.1. C10H18O4 requires C, 59.4; H, 9.0%); u max/cm'1 (neat): 
2937 (CH), 1722 (CO), 1660 (C=C), 1273, 1178 and 1034; 6H (400 MHz, CDC13) 0.96 
(3H, t, J  7.2, 6-H3), 1.30 (3H, t, J  7.2, OCH2CH3), 1.65 (2H, m, 5-H2), 3.39 (3H, s, OMe), 
4.14 (1H, ddd, J  12.8, 6.0, 1.2, 4-H), 4.21 (2H, q, J  7.2, OCH2CH3), 4.60 (1H, d, J 6.8,
OCflHO), 4.65 (1H, d, J  6.8, OCHHO), 5.99 (1H, dd, J  16.0, 1.2, 2-H) and 6.82 (1H, dd, J
16.0, 6.0, 3-H); 6C(100 MHz, CDC13) 9.7 (CH3), 14.4 (CH3), 27.9 (CH), 55.8 (CH3), 60.6 
(CH2), 76.6 (CH), 94.8 (CH2), 122.2 (CH), 147.9 (CH) and 166.4 (C); mlz (Cl) 203.1281 
(MH+. C10H19O4requires 203.1283), 173 (43%), 171 (25), 141 (100) and 113 (2).
(2Zs,4S)-4-(Methoxymethoxy)hex-2-en-l-ol (271).
DIBAL-H (2.2 equiv.) 
Et2 0, -78 °C to RT
C 02Et
The reaction was carried out according to general procedure 4 using ethyl {2E,4S)-4- 
(methoxymethoxy)hex-2-enoate 270 (1.85 g, 9.16 mmol). Purification by flash column 
chromatography (50% ether / petroleum ether) gave (2£,4S)-4-(methoxymethoxy)hex-2- 
en-l-ol 271 (1.4 g, 95%) as a yellow liquid. [a ]DM -146.5 (c 1.0, CHC13); (Found: C, 59.7; 
H, 10.2. C8H160 3 requires C, 60.0; H, 10.1%); v mJ c m l (neat): 3708 (OH), 2935 (CH), 
1673 (C=C), 1158, 1097 and 1034; SH (400 MHz, CDC13) 0.94 (3H, t, J 1.2, 6-H3), 1.60 
(2H, m, 5-H2), 1.70 (1H, br s, OH), 3.39 (3H, s, OMe), 3.96 (1H, dt, J  7.2, 6.8, 4-H), 4.17 
(2H, dd, J  5.2, 1.2, 1-H2), 4.55 (1H, d, J  6.8, OCtfHO), 4.72 (1H, d, J  6.8, OCH//0), 5.57 
(1H, ddt, J  15.6, 7.2, 1.2, 3-H) and 5.83 (1H, dt, J  15.6, 5.2, 2-H); 6C(100 MHz, CDC13)
10.0 (CH3), 28.6 (CH2), 55.5 (CH3), 63.1 (CH2), 77.8 (CH), 93.9 (CH2), 131.4 (CH) and
132.4 (CH); mlz (Cl) 143 (MH+- H20 , 25%), 131 (55), 115 (23) and 99 (100).
(35,4/?)-3-(Trichloromethylcarbonylamino)-4-(methoxymethoxy)hexa-l-ene (262a), 
(3/?,4/?)-3-(trichloromethyIcarbonylamino)-4-(methoxymethoxy)hexa-l-ene (262b) 
and (3£')-l-(trichloromethylcarbonyIamino)-2-hydroxyhexa-3-ene (262c).
1)Cl3CCN OMOM OMOM
DBU 'OMOM
'0H 2) PdCI2 (MeCN) 2  
Toluene
The reaction was carried out according to general procedure 8 using (2E,4S)-4- 
(methoxymethoxy)hex-2-en-l-ol 271 (0.1 g, 0.6 mmol) then bis(acetonitrile)palladium(II) 
chloride (10 mol%) in toluene (10 mL). Purification was carried out by flash column 
chromatography (10% diethyl ether / petroleum ether) to give (3Zs)-l- 
(trichloromethylcarbonylamino)-2-hydroxyhexa-3-ene 262c (28 mg, 15% over two steps).
SH (400 MHz, CDCI3) 1.03 (3H, t, J  7.6, 6-H3), 1.27 (1H, br s, NH), 2.11 (2H, m, 5-H2), 
4.31 (2H, dd, J  8.4, 8.0, 1-H2), 4.77 (1H, d, J  8.4, OH), 4.84 (1H, dt, J  8.4, 7.6, 2-H), 5.47 
(1H, ddt, J  15.6, 7.6, 1.6, 3-H) and 5.88 (1H, dt, J  15.6, 6.4, 4-H); 6C(100 MHz, CDC13)
13.1 (CH3), 25.3 (CH2), 68.8 (CH), 76.3 (CH2), 87.8 (C), 126.4 (CH), 136.9 (CH) and 
162.8 (C); mlz (Cl) 260.0014 (MH+. C8H130 2N35C13 requires 260.0012), 242 (50%), 226 
(35) 190 (23) and 162 (16). Further elution (20% diethyl ether / petroleum ether) gave 
(3S,4fi)-3-(trichloromethylcarbonylamino)-4-(methoxymethoxy)hexa-1 -ene 262a and
(3/?,4/?)-3-(trichloromethylcarbonylamino)-4-(methoxymethoxy)hexa-l-ene 262b (0.1 g, 
54% combined yield, over two steps) in a ratio of 16 : 1 (35 : 3R), as a colourless oil. 
(35,4^)-3-(Trichloromethylcarbonylamino)-4-(methoxymethoxy)hexa-l-ene 262a: [a]D27 -
72.9 (c 1.0, CHC13); D j c m '1 (neat): 3285 (NH), 2938 (CH), 1715 (CO), 1644 (C=C), 
1518, 1036 and 823; 6H (400 MHz, CDC13) 0.98 (3H, t, J  7.6, 6-H3), 1.61 (2H, m, 5-H2), 
3.44 (3H, s, OMe), 3.50 (1H, ddd, J  8.4, 5.6, 2.0, 4-H), 4.41 (1H, dd, J  8.4, 6.4, 3-H), 4.67 
(1H, d, J  6.8, OCHHO), 4.76 (1H, d, J  6.8, OCH//O), 5.34 (2H, m, 1-H2), 5.85 (1H, ddd, J 
17.2, 10.4, 6.4, 2-H) and 8.26 (1H, br d, J  6.4, NH); 6C (100 MHz, CDC13) 10.2 (CH3), 25.9 
(CH2), 55.9 (CH), 56.4 (CH3), 85.2 (CH), 93.0 (C), 98.2 (CH2), 118.9 (CH2), 131.6 (CH) 
and 161.4 (C); (3/?,4/?)-3-(trichloromethylcarbonylamino)-4-(methoxymethoxy)hexa-l-ene 
262b: [a]D25 +13.2 (c 4.5, CHC13), 6H (400 MHz, CDC13) 0.98 (3H, t, J 7.6, 6-H3), 1.63 
(2H, m, 5-H2), 3.40 (3H, s, OMe), 3.69 (1H, ddd, J  7.6, 5.6, 2.4, 4-H), 4.55 (1H, m, 3-H), 
4.66 (1H, d, J  6.8, OCHHO), 4.70 (1H, d, J  6.8, OCH//O), 5.29 (2H, m, 1-H2), 5.90 (1H, 
ddd, J  17.2, 10.8, 5.2, 2-H), 7.16 (1H, br d, J  6.4, NH); Sc (100 MHz, CDC13) 9.9 (CH3),
24.7 (CH2), 55.1 (CH), 56.0 (CH3), 80.1 (CH), 93.0 (C), 96.0 (CH2), 116.7 (CH2), 135.3 
(CH) and 161.7 (C); mlz (Cl) 304.0281 (MH+. C)0H17O3N35Cl3 requires 304.0274), 272 
(100%), 234 (23), 214 (46) and 174 (19).
(3S,4/?)-3-(But-3,-enoylamino)-4-(methoxymethoxy)hexa-l-ene (272).
H N ^ O
CCI3
1) NaOH, H20
2) NEt3, DCM
O
Cl
(35,4/?)-3-(Trichloromethylcarbonylamino)-4-(methoxymethoxy)hexa-l-ene 262a (1.14 g, 
3.73 mmol) was suspended in 2 M sodium hydroxide solution (10 mL) and stirred 
vigorusly for 12 h. The solution was extracted with DCM ( 3x15  mL) and ethyl acetate (3 
x 15 mL) and the organic layers were combined, dried (MgS04) and concentrated in vacuo
to give the amine as a yellow liquid. The amine was dissolved in DCM (10 mL) and 
cooled to 0 °C. Triethylamine (2.6 mL, 18.7 mmol) was added and the solution was 
stirred for 0.5 h. 3-Butenoyl chloride (0.8 mL, 7.5 mmol) was added and the reaction 
mixture was allowed to stir for 1 h. Concentration in vacuo followed by purification by 
flash column chromatography (100% diethyl ether / petroleum ether) gave (3S,4/?)-3-(but- 
3’-enoylamino)-4-(methoxymethoxy)hexa-l-ene 272 (0.44 g, 52% over two steps). [a]D24 
-86.4 (c 1.0, CHC13); u j c m '1 (neat): 3308 (NH), 2937 (CH), 1655 (CO), 1540 (C=C), 
1036 and 919; 6H (400 MHz, CDC13) 0.96 (3H, t, 7 7.2, 6-H3), 1.45-1.67 (2H, m, 5-H2),
3.05 (2H, dt, 7 7.2, 1.2, 2’-H2), 3.42 (3H, s, OMe), 3.43-3.46 (1H, m, 3H), 4.52-4.56 (1H, 
m, 4-H), 4.65 (1H, d, 7 6.8, OCflHO), 4.73 (1H, d, 7 6.8, OCH/70), 5.22-5.27 (4H, m, 1- 
H2 and 4 ’-H2), 5.82 (1H, m, 2-H), 5.98 (1H, m, 3’-H) and 6.85 (1H, br d, 7 6.8, NH); 6C 
(100 MHz, CDC13) 10.2 (CH3), 25.6 (CH2), 42.0 (CH2), 53.8 (CH), 55.9 (CH3), 85.2 (CH),
97.9 (CH2), 117.5 (CH2), 119.4 (CH2), 131.4 (CH), 133.3 (CH) and 169.8 (C); mlz (Cl) 
228.1609 (MH+. C12H22N 03 requires 228.1600), 196 (31%), 169 (5), 127 (6) and 113 (28).
(I’/?,6S)-6-[l’-(Methoxymethoxy)propyl]-3,6-dihydro-l/7-pyridin-2-one (273).
Grubb's (I) 
cat.
(35,4/?)-3-(But-3,-enoylamino)-4-(methoxymethoxy)hexa-l-ene 272 (0.13 g, 0.44 mmol) 
and bis(tricyclohexylphosphine) benzylidine ruthenium(IV) chloride (18 mg, 0.02 mmol) 
were dissolved in DCM (10 mL) and heated under reflux for 12 h. Concentration in vacuo 
followed by purification by flash column chromatography (100% ethyl acetate) gave 
( l ’/?,65)-6-[r-(methoxymethoxy)propyl]-3,6-dihydro-l//-pyridin-2-one 273 (0.09 g,
100%) as brown liquid. [a ]D25 -2.1 (c 1.0, CHC13); u j c m '1 (neat) 3253 (NH), 2936 (CH), 
1716 (CO), 1653 (C=C), 1457 and 1034; SH (400 MHz, CDC13) 0.94 (3H, t, 7 6.8, 3’-H3), 
1.38-1.55 (2H, m, 2’-H2), 2.91 (2H, m, 3-H2), 3.38 (3H, s, OMe), 3.50 (1H, dt, 7 8.4, 3.6, 
l ’-H), 4.31 (1H, m, 6-H), 4.65 (1H, d, 7 6.8, OC//HO), 4.71 (1H, d, 7 6.8, OCH/ZO), 5.58-
5.61 (1H, m, 5-H), 5.80-5.85 (1H, m, 4-H) and 6.44 (1H, br s, NH); 6C(100 MHz, CDC13)
10.3 (CH3), 22.1 (CH2), 31.6 (CH2), 56.0 (CH3), 57.1 (CH), 81.6 (CH), 96.5 (CH2), 121.9 
(CH), 123.9 (CH) and 169.7 (C); mlz (Cl) 200.1286 (MH+. C10H18NO3 requires 200.1287), 
168 (9%), 141 (3) and 113 (4).
( l ’/?,65)-6-[l’-(Methoxymethoxy)propyl]piperidin-2-one (274).
H2, Pd/C
( l ’/?,65')-6-[r-(Methoxymethoxy)propyl]-3,6-dihydro-l//-pyridin-2-one 273 (0.13 g, 0.65 
mmol) and 10% palladium on carbon (0.07 g, 0.07 mmol) were dissolved in ethyl acetate 
(10 mL) and stirred under an atmosphere of hydrogen for 17 h. The reaction mixture was 
then filtered through a short pad of Celite® and the filtrate concentrated in vacuo. 
Purification was carried out by flash column chromatography (100% ethyl acetate) to give 
(r/?,6S)-6-[r-(methoxymethoxy)propyl]piperidin-2-one 274 (0.17 g, 100%) as a clear 
liquid. [a]D24 -14.6 (c 1.0, CHC13); u j c m '1 (neat) 3429 (NH), 2966 (CH), 1636 (CO), 
1481, 1105 and 1033; SH (400 MHz, CDC13) 0.99 (3H, t, 7 7.2, 3’-H3), 1.43-2.00 (6H, m, 
2’-H2, 4-H2 and 5-H2), 2.23-2.46 (2H, m, 3-H2), 3.40 (3H, s, OMe), 3.42-3.46 (1H, m, 1’-
H), 3.65 (1H, dt, J  10.4, 4.0, 6-H), 4.66 (1H, d, J  7.2, OC/7HO), 4.69 (1H, d, J  7.2, 
OCUHO) and 5.92 (1H, br s, NH); Sc (100 MHz, CDC13) 10.2 (CH3), 20.1 (CH2), 22.4 
(CH2), 24.0 (CH2), 31.6 (CH2), 55.5 (CH), 55.9 (CH3), 80.8 (CH), 96.3 (CH2) and 172.4 
(C); mlz (Cl) 202.1441 (MH+. C10H20NO3 requires 202.1443), 188 (3%), 170 (8), 156 (15) 
and 143 (3).
(1 ’R,2S)-2-[l’-(Hydroxy)propyl]piperidine (253). 138
1 ) b h 3. t h f
2 ) 6  M HCI
OH
HN.
( l ’/?,65)-6-[r-(Methoxymethoxy)propyl]piperidin-2-one 274 (0.07 g, 0.32 mmol) was 
dissolved in THF (10 mL) and cooled to 0 °C. Borane-THF complex (1 M in THF) (5 mL) 
was added and the reaction mixture was heated under reflux for 4 h. The reaction was 
quenched with water (3 mL), concentrated and the resulting residue dissolved in ethyl 
acetate (10 mL). This solution was washed with 6 M hydrochloric acid solution, dried 
(MgS04) and concentrated in vacuo. The amine (0.32 mmol) was then dissolved in 6 M 
hydrochloric acid solution (3 mL) and stirred at room temperature for 2 h. The reaction 
mixture was neutralized with saturated sodium hydrogen carbonate solution and extracted
with DCM (3 x 10 mL) and ethyl acetate (3 x 10 mL). The combined organic layers were 
dried (MgS04) and concentrated in vacuo. Purification was carried out by flash column 
chromatography (10% methanol / ethyl acetate) to give {V R,2S)-2-[V - 
(hydroxy)propyl]piperidine 253 (0.02 g, 42% over two steps) as a white solid, [a ]^  +4.0 
(c 1.7, EtOH), (Lit.138 [a ]D27 +8.9 (EtOH)); SH (400 MHz, CDC13) 0.99 (3H, t, J  7.2, 3’-H3),
1.27-1.65 (7H, m, 2 ’-H2, 3-H2, 4-HH and 5-H2), 1.86 (1H, m, 4-HH), 2.51 (2H, br s, NH 
and OH), 2.60-2.65 (1H, m, 2-H), 2.72 (1H, td, J  12.0, 2.8, 6-HH), 3.17 (1H, m, 6-UH) and 
3.49 (1H, m, l ’-H); 6C(100 MHz, CDC13) 10.5 (CH3), 24.5 (CH2), 25.2 (CH2), 25.4 (CH2),
26.5 (CH2), 47.1 (CH2), 60.1 (CH) and 76.0 (CH); mlz (Cl) 144.1387 (MH+. C8H18NO 
requires 144.1388), 126 (10%), 113 (29), 85 (88) and 71 (100).
( l ’/f,65)-6-[l,-(Hydroxy)propyl]piperidin-2-one (260).
OH
6 MHCI
HN
O
HN
O
( l ’/?,6S')-6-[r-(Methoxymethoxy)propyl]piperidin-2-one 274 (40 mg, 0.20 mmol) was 
dissolved in 6 M hydrochloric acid solution (3 mL) and stirred at room temperature for 2 h. 
The reaction mixture was neutralized with saturated sodium hydrogen carbonate solution 
and extracted with DCM (3 x 10 mL) and ethyl acetate (3 x 10 mL). The combined 
organic layers were dried (MgSOJ and concentrated in vacuo. Purification was carried out 
by flash column chromatography (10% methanol / ethyl acetate) to give (r /? ,6S)-6- [ l ’- 
(hydroxy)propyl]piperidin-2-one 260 (25 mg, 81%) as a white solid. [a ]D25 -53.5 (c 0.6, 
CHC13); v mJ c m l (neat) 3406 (OH and NH), 2963 (CH), 1638 (CO), 1482, 1413, 1330 and 
733; SH (400 MHz, CDC13) 1.02 (3H, t, J  7.2, 3’-H3), 1.45-1.95 (6H, m, 2’-H2, 4-H2 and 5- 
H2), 2.21-2.42 (2H, m, 3-H2), 3.03 (1H, br s, OH), 3.48 (1H, m, 6-H), 3.54 (1H, m, l ’-H), 
6.78 (1H, br s, OH); 6C(100 MHz, CDC13) 10.7 (CH3), 19.9 (CH2), 22.4 (CH2), 24.7 (CH2),
31.6 (CH2), 57.9 (CH), 74.6 (CH) and 173.9 (C); mlz (Cl) 158.1180 (MH+. C8H16N 02 
requires 158.1181), 139 (5%), 127 (5), 113 (30) and 97 (30).
(3S,4/?)-3-(te/?-Butoxycarbonylamino)-4-(methoxymethoxy)hexa-l-ene (276).
1) NaOH
2) Boc20
H N y 0
CCI3
H N ^ O
OlBu
(3S,4/?)-3-(Trichloromethylcarbonylamino)-4-(methoxymethoxy)hexa-l-ene 262a (0.4 g,
1.3 mmol) was dissolved in 2 M sodium hydroxide solution and stirred vigorously for 12 h 
at room temperature. Di-tert-butyl dicarbonate (0.72 g, 3.28 mmol) was added and the 
solution was stirred for 6 h before a further portion of Di-tert-butyl dicarbonate (0.72 g, 
3.28 mmol) was added and the reaction mixture stirred for a further 12 h. The reaction 
mixture was then extracted with ethyl acetate (4 x 15 mL) and the combined organic layers 
dried (MgS04) and concentrated in vacuo. Purification was carried out by flash column 
chromatography (30% diethyl ether / petroleum ether) to give (3S,4/?)-3-(ter/- 
butoxycarbonylamino)-4-(methoxymethoxy)hexa-l-ene 276 (0.25 g, 74% over two steps) 
as a yellow liquid. [a]D25 -45.0 (c 4.7, CHC13); (Found: C, 60.2; H, 9.8; N, 5.4. C13H25N 04 
requires C, 60.2; H, 9.7; N, 5.3%); v mJcrnA (neat) 3358 (NH), 2975 (CH), 1716 (CO), 
1509, 1366, 1171 and 1039; SH (400 MHz, CDC13) 0.94 (3H, t, J  7.2, 6-H3), 1.45 (9H, s, 
OC(CH3)3), 1.43-1.65 (2H, m, 5-H2), 3.41 (3H, s, OMe), 3.49 (1H, m, 4-H), 4.19 (1H, m,
3-H), 4.66 (1H, d, J  6.8, OOTHO), 4.71 (1H, d, J  6.8, OCH//O), 5.24 (2H, m, 1-H2), 5.43 
(1H, br d, J  6.4, NH), 5.81 (1H, ddd, J  17.2, 10.8, 6.4, 2-H); Sc (100 MHz, CDC13) 10.1 
(CH3), 25.0 (CH2), 28.4 (CH3), 55.3 (CH), 55.8 (CH3), 79.2 (C), 83.7 (CH), 97.2 (CH2),
117.0 (CH2), 134.2 (CH) and 155.4 (C); mlz (Cl) 260 (MH+, 19%), 228 (4), 204 (100), 172 
(35), 145 (13) and 128 (10).
(3S,4/?)-3-(Prop-2-ene-teft-butoxycarbonyIamino)-4-(inethoxymethoxy)hexa-l-ene
(277).
(3S,4/?)-3-(tert-Butoxycarbonylamino)-4-(methoxymethoxy)hexa-l-ene 276 (0.22 g, 0.85 
mmol) and allyl bromide (0.15 mL, 1.7 mmol) were dissolved in DMF (20 mL) and cooled 
to 0 °C. Sodium hydride (60% in mineral oil) (0.07 g, 1.7 mmol) was added portionwise
over 3 h. The reaction mixture was allowed to warm to room temperature and stirred for 
12 h. The reaction was quenched by the addition of water (15 mL) and extracted with 
ethyl acetate (3 x 15 mL). The combined organic layers were washed with water (2 x 20 
mL), dried (MgS04) and concentrated in vacuo. Purification was carried out by flash 
column chromatography (30% diethyl ether / petroleum ether) to give (3.S,4/?)-3-(prop-2- 
ene-terr-butoxycarbonylamino)-4-(methoxymethoxy)hexa-l-ene 277 (0.18 g, 72%) as a 
yellow liquid. [a]D23 -8.0 (c 1.0, CHC13); (Found: C, 64.4; H, 10.0; N, 4.8. C)6H29N 04 
requires C, 64.2; H, 9.8; N, 4.7%); (neat): 2975 (CH), 1695 (CO), 1658 (C=C),
1396, 1165, 1040 and 910; 6H (400 MHz, CDC13) 0.96 (3H, t, J  7.6, 6-H3), 1.47 (9H, s, 
OC(CH3)3), 1.54 (2H, m, 5-H2), 3.38 (3H, s, OMe), 3.83 (2H, m, 4-H and 3-H), 3.84-4.31 
(2H, m, l ’-H2), 4.62 (1H, d, J  6.8, OCHHO), 4.66 (1H, d, J  6.8, OCHtfO), 5.09 (2H, m, 
3’-H2), 5.25 (2H, d, J  10.4, 1-H2), 5.80 (1H, m, 2’-H) and 6.03 (1H, m, 2-H); 6C(100 MHz, 
CDC13) 9.2 (CH3), 24.3 (CH2), 28.5 (CH3), 48.0 (CH2), 55.9 (CH3), 61.4 (CH), 79.9 (C),
80.3 (CH), 96.8 (CH2), 115.8 (CH2), 118.8 (CH2), 134.5 (CH), 135.6 (CH) and 155.2 (C); 
mlz (Cl) 300 (MH+, 100%), 268 (19), 244 (98), 212 (46) and 168 (65).
(2S,l’/?)-2-(l’-(Methoxymethoxy)propyI)-/V-(tert-butoxycarbonyl)-2,5-dihydropyrrole
(278).
Grubb's (I) 
Cat
BocN
(3S,4i?)-3-(Prop-2-ene-ter?-butoxycarbonylamino)-4-(methoxymethoxy)hexa-l-ene 277 
(0.1 g, 0.34 mmol) and bis(tricyclohexylphosphine) benzylidine ruthenium(IV) chloride 
(17 mg, 0.02 mmol) were dissolved in DCM (10 mL) and heated under reflux for 20 h. 
Concentration in vacuo followed by purification by flash column chromatography (30% 
diethyl ether / petroleum ether) gave (2S, 1 ’/?)-2-( r-(methoxymethoxy)propyl)-yV-(tert- 
butoxycarbonyl)-2,5-dihydropyrrole 278 (0.09 g, 92%) as a brown liquid. [a]D26 -116.7 (c
1.0, CHC13); (Found: C, 62.0; H, 9.3; N, 5.0. C14H25N 04 requires C, 62.0; H, 9.3; N, 5.2%); 
,uniax/cm'1 (neat) 2970 (CH), 1700 (CO), 1627 (C=C), 1400, 1366, 1174, 1124, 1108 and 
1038; (2 S, 1 ’/?)-2-( 1 ’-(methoxymethoxy)propyl)-Af-(tert-butoxycarbonyl)-2,5-
dihydropyrrole 278 exists as a 8 : 7 mixture of rotamers, signals for major rotamer are: SH 
(400 MHz, CDC13) 1.03 (3H, t, J  7.2, 3’-H3), 1.48 (9H, s, OC(CH3)3), 1.60 (2H, m, 2’-H2), 
3.33 (3H, s, OMe), 3.96-4.27 (3H, m, l ’-H and 5-H2), 4.34-4.64 (3H, m, 2-H and OCH20) 
and 5.57-5.97 (2H, m, 3-H and 4-H); Sc (100 MHz, CDC13) 10.67 (CH3), 25.4 (CH2), 28.49
(CH3), 53.8 (CH2), 55.5 (CH3), 67.0 (CH), 78.5 (CH3), 79.8 (C), 96.3 (CH2), 125.3 (CH),
127.3 (CH) and 153.9 (C); mlz (Cl) 272 (MH+, 9%), 256 (6), 240 (5), 216 (63) and 69 
( 100).
(25,1 ’l?)-2-(l ’-(Methoxymethoxy)propyl)-A^-(^/t-butoxycarbonyl)pyrrolidine (279).
(25,1 ’/?)-2-( 1 ’-(Methoxymethoxy)propyl)-./V-(te7t-butoxycarbonyl)-2,5-dihydropyrrole 278 
(0.15 g, 0.55 mmol) and 10% palladium on carbon (0.06 g, 0.06 mmol) were dissolved in 
ethyl acetate (10 mL) and stirred under an atmosphere of hydrogen for 12 h. The reaction 
mixture was then filtered through Celite® and the filtrate concentrated in vacuo. 
Purification was carried out by flash column chromatography (30% diethyl ether / 
petroleum ether) to give (25,rR)-2-(r-(methoxymethoxy)propyl)-./V-(terf- 
butoxycarbonyl)pyrrolidine 279 (0.15 g, 98%) as a colourless oil. [a]D24 -77.0 (c 1.0, 
CHC13); (Found: C, 61.6; H, 10.0; N, 5.2. C14H27N 04 requires C, 61.5; H, 10.0; N, 5.1%); 
u j c m '1 (neat) 2972 (CH), 1695 (CO), 1395, 1168 and 1037; (2S,VR)-2-{V- 
(methoxymethoxy)propyl)-Af-(rm-butoxycarbonyl)pyrrolidine 279 exists as an 8 : 6 
mixture of rotamers, signals for major rotamer are: SH (400 MHz, CDC13) 0.98 (3H, m, 3’- 
H3), 1.49 (9H, s, OC(CH3)3), 1.50 (2H, m, 2’-H2), 1.82 (2H, m, 4-H2), 1.97 (2H, m, 3-H2),
3.27-3.54 (2H, m, 5-H2), 3.35 (3H, s, OMe), 3.81 (1H, m, 2-H), 4.02 (1H, m, l ’-H) and
4.61 (2H, m, OCH20); Sc (100 MHz, CDC13) 10.5 (CH3), 24.7 (CH2), 25.7 (CH2), 28.6 
(CH3), 46.9 (CH2), 55.4 (CH3), 59.4 (CH), 78.9 (CH), 79.4 (C), 96.1 (CH2), 97.0 (CH2) and
153.9 (C); mlz (Cl) 274 (MH+, 65%), 242 (12), 218 (100) and 186 (36).
(25,1 ’/?)-2-(l’-(Hydroxy)propyl)pyrrolidine hydrochloride (259).139
(25,r/?)-2-(r-(Methoxymethoxy)propyl)-Af-(terr-butoxycarbonyl)pyrrolidine 279 (0.15 g, 
0.42 mmol) was dissolved in 6 M hydrochloric acid (10 mL) and stirred at room 
temperature for 12 h. Concentration in vacuo give (2S,l’R)-2-(r- 
(hydroxy)propyl)pyrrolidine hydrochloride 259 (0.07 g, 100%) as a white solid. [a]D29 -
41.0 (c 1.0, CHCI3); u max/cm‘' (neat) 3347 (OH and NH), 2917 (CH), 1396, 1316 and 965; 
6„ (400 MHz, D20 ) 1.01 (3H, t, J  7.2, 3’-H3), 1.56 (2H, m, 2’-H2), 2.00 (4H, m, 3-H2 and
4-H2), 3.36 (2H, t, J  6.4, 5-H2), 3.71 (1H, m, 2-H2) and 3.90 (1H, m, l ’-H); 5C(100 MHz, 
D20 ) 9.4 (CH3), 23.1 (CH2), 23.4 (CH2), 26.7 (CH2), 45.8 (CH2), 63.4 (CH) and 70.3 (CH); 
mlz (Cl) 130.1233 (MH+. C7H16ONrequires 130.1232), 128 (22%), 112 (17) and 100 (6).
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